Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.133537202823029,0.00281375355741934,0.128022245850487,0.139052159795571,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,39980,-0.475958413019632,0.0112199982338255,-0.49794960955793,-0.453967216481334,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,40356,-0.202116302894159,0.00471363456044912,-0.211355026632639,-0.192877579155679,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,40332,-0.176412022720957,0.00375414336278265,-0.183770143712011,-0.169053901729903,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.127427753420999,0.00280639592809123,0.12192721740194,0.132928289440058,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,0.104707430735118,0.00246765186928802,0.0998708330713138,0.109544028398923,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,37998,-0.159888052563377,0.00378760378511809,-0.167311755982208,-0.152464349144545,0
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,40516,-0.178760925769575,0.00487009258486083,-0.188306307235903,-0.169215544303248,2.57664448130533e-283
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,-0.0980536455191859,0.00267259318732447,-0.103291928166342,-0.09281536287203,7.34824969963293e-283
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,40293,-0.134748411472984,0.00368051271417767,-0.141962216392772,-0.127534606553195,9.01058802971585e-282
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,37990,-0.257287046334759,0.00724693686460215,-0.271491042589379,-0.243083050080139,4.663865020797e-264
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,40372,0.0858431010560547,0.00245503276021338,0.0810312368460365,0.0906549652660729,3.83360029177094e-258
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,40489,-0.21085280423197,0.00610027533856387,-0.222809343895555,-0.198896264568384,1.44782071828069e-252
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PYY,Peptide YY,37562,-0.296615398749289,0.00866310035985938,-0.313595075454614,-0.279635722043965,3.70137922258186e-246
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,40305,-0.280310213540635,0.00845445446113321,-0.296880944284456,-0.263739482796814,4.01063344597325e-233
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,38013,0.202019847619662,0.00609887712713445,0.190066048450479,0.213973646788846,1.95520763279492e-231
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,37987,0.0718002481429865,0.00222269345594,0.0674437689693441,0.0761567273166289,1.33468073249156e-220
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,40042,-0.197172410876031,0.00618287653559315,-0.209290848885794,-0.185053972866269,3.03341179173187e-216
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,-0.0898960771022945,0.00295448348700054,-0.0956868647368155,-0.0841052894677734,1.1826677854946e-197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,40359,0.127266864863067,0.0042407819611856,0.118954932219143,0.135578797506991,1.60692595478992e-192
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,40471,-0.355474325744395,0.0122293847247154,-0.379443919804837,-0.331504731683953,4.52267287131194e-181
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,40280,-0.209282462787558,0.00721400439882186,-0.223421911409248,-0.195143014165867,2.44955448798037e-180
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,-0.140936446947992,0.00510807065895741,-0.150948265439549,-0.130924628456435,1.0227650177577e-163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,40471,0.0552323270424143,0.00202556011962302,0.0512622292079532,0.0592024248768755,4.52661762884475e-160
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,40461,0.0865526375130403,0.0031791474243143,0.0803215085613843,0.0927837664646963,1.3805374747814e-159
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,40489,-0.0854521725191797,0.00314118222416991,-0.0916088896785527,-0.0792954553598067,2.36967514244392e-159
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,-0.135617156274683,0.00506446701166834,-0.145543511617553,-0.125690800931814,6.08728620135308e-154
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,0.2909245006493,0.0109147331134098,0.269531623747017,0.312317377551583,3.3861858641593e-153
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,40352,-0.186341158209444,0.00708162896200022,-0.200221150974965,-0.172461165443924,2.09529602593925e-149
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,-0.16449741088703,0.00627751459024107,-0.176801339483902,-0.152193482290157,3.34504916692997e-148
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FURIN,Furin,40411,-0.0813470068659843,0.00312948509577576,-0.0874807976537048,-0.0752132160782638,6.245882376227e-146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,-0.111285712955384,0.00429812072575756,-0.119710029577869,-0.102861396332899,7.9031657942749e-145
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,40309,-0.073032491024186,0.00283686766236215,-0.0785927516424159,-0.0674722304059562,3.23596446600754e-143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,40470,-0.0471215189363934,0.00186150975101005,-0.0507700780483731,-0.0434729598244136,1.18629507494531e-138
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,0.0800579193056447,0.00317615390960597,0.073832657642817,0.0862831809684724,1.67045446917374e-137
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,40400,-0.0800505721616839,0.00318006542915229,-0.0862835004028224,-0.0738176439205454,3.75295294387368e-137
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,40536,-0.100460738298906,0.00401701860694746,-0.108334094768523,-0.0925873818292893,1.87551872181942e-135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,40357,-0.121749528623986,0.00493088745284747,-0.131414068031567,-0.112084989216405,4.0371031872662e-132
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,-0.0737829763879785,0.00298530310513119,-0.0796341704740356,-0.0679317823019214,8.20932764490768e-132
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,-0.0974370717866326,0.00395386630160461,-0.105186649737778,-0.0896874938354875,1.39433554495238e-131
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,40338,0.10437322153386,0.00424812991597344,0.0960468868985523,0.112699556169168,7.37681378127477e-131
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,40489,0.0788505969109921,0.00321807866240581,0.0725431627326767,0.0851580310893075,3.41194854206729e-130
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,-0.124983145445517,0.00510170016844299,-0.134982477775665,-0.114983813115368,4.50682722907529e-130
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,40309,-0.121293667655282,0.00499545098195177,-0.131084751579908,-0.111502583730657,6.6892285868852e-128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,40332,-0.0963480812104116,0.00397175860840692,-0.104132728082889,-0.0885634343379341,1.12581216621937e-127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,40359,-0.134479389400885,0.0055510587212504,-0.145359464494536,-0.123599314307235,2.38271385755784e-127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,40536,-0.119653595131494,0.00494133498775901,-0.129338611707501,-0.109968578555486,2.91636181663619e-127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,40341,-0.120324059730948,0.00498565096663494,-0.130095935625552,-0.110552183836344,2.04775473169975e-126
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,37572,-0.176949361654785,0.00735919432770355,-0.191373382537084,-0.162525340772486,4.72234931153791e-125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,-0.0767213622288655,0.00322032696227609,-0.0830332030749266,-0.0704095213828043,2.6474190965241e-123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,-0.0573772623760208,0.00242520515744634,-0.0621306644846156,-0.0526238602674259,2.96681661256372e-121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,-0.100846304757862,0.00428807255517301,-0.109250926966001,-0.092441682549723,3.17249364530519e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,0.0672118093406781,0.002853415771669,0.0616191144282068,0.0728045042531493,3.29384386649926e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,-0.083747421784849,0.00356238916421308,-0.0907297045467066,-0.0767651390229913,3.51810038046869e-120
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,40516,-0.0572801245208892,0.00245218265741712,-0.0620864025294268,-0.0524738465123517,1.05822371113422e-118
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,-0.0717553261108363,0.00307689646475994,-0.0777860431817658,-0.0657246090399068,2.52645047961413e-118
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.0583837872815921,0.0025141925547462,0.0534559698742895,0.0633116046888946,2.44108606028111e-117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,-0.0909042280235121,0.0039153688949697,-0.0985783510576527,-0.0832301049893714,2.62668757245575e-117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,40044,-0.165853301118459,0.00715014011957395,-0.179867575752824,-0.151839026484094,4.77101131484771e-117
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,-0.11995360544373,0.00519826823738516,-0.130142211189004,-0.109764999698455,7.04220961923184e-116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,-0.162219143722992,0.00703737004992646,-0.176012389020848,-0.148425898425136,2.39501874704597e-115
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,0.0637030573601161,0.0027798897258971,0.0582544734973577,0.0691516412228744,2.28125276143601e-114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,37981,0.0774006705466101,0.00339465851082035,0.0707471398654022,0.084054201227818,5.9883949648405e-113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,-0.0797377916858104,0.00352663677662072,-0.086649999767987,-0.0728255836036338,4.34506273469424e-111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,40516,-0.0722478305673635,0.00320091128023426,-0.0785216166766227,-0.0659740444581044,4.43006168882837e-111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,40415,-0.0721101073231084,0.00319760063110107,-0.0783774045600665,-0.0658428100861503,6.99100009355334e-111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,40372,-0.0379276984473334,0.00168416557241675,-0.0412286629692702,-0.0346267339253966,1.39667532260343e-110
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,-0.10289169809322,0.00457351671356721,-0.111855790851811,-0.0939276053346279,2.50015572649327e-110
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,40419,-0.122646583629804,0.00546911495844864,-0.133366048948364,-0.111927118311245,1.0948805468892e-109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,40332,0.0787768084305623,0.0035251859447598,0.0718674439788331,0.0856861728822915,6.1564620803348e-109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,37345,0.0933000358747525,0.00417967451179784,0.0851078738316288,0.101492197917876,2.49829048381634e-108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,-0.0640938769196807,0.00287799145705783,-0.069734740175514,-0.0584530136638473,3.25234485782094e-108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,40337,-0.209118227401022,0.00943147766489055,-0.227603923624207,-0.190632531177836,2.67806076029681e-107
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,39961,-0.103768085940153,0.00469849162227264,-0.112977129519808,-0.0945590423604989,1.89790465537739e-106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,-0.071308572508904,0.00324362911325616,-0.0776660855708861,-0.0649510594469219,1.47030706128924e-105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,40372,-0.0695410164769294,0.00316977022493028,-0.0757537661177927,-0.063328266836066,3.9768542686124e-105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,-0.061205023608629,0.00279814243869064,-0.0666893827884626,-0.0557206644287953,1.60601208689362e-104
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,40453,-0.239032312688782,0.0109428157597911,-0.260480231577972,-0.217584393799591,2.9584081110828e-104
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,39243,-0.0815824654022643,0.003734501299835,-0.0889020879499409,-0.0742628428545877,3.76619834251154e-104
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,-0.0894360164916302,0.00410226200030286,-0.0974764500122238,-0.0813955829710366,7.91497229633627e-104
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,40126,0.108415678416368,0.00499403860091332,0.098627362758578,0.118203994074158,5.51693718497512e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C9,Complement component C9,37987,0.0992246115222091,0.00457079409604867,0.0902658550939537,0.108183367950465,9.58013530940241e-103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,40422,-0.0831309264107934,0.00383685106479869,-0.0906511544977988,-0.0756106983237879,1.27204038128684e-102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,40332,0.0543487742881332,0.00252235882324068,0.0494049509945814,0.0592925975816849,1.60558565601327e-101
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,37671,-0.0841907482648982,0.00391917973426101,-0.0918723405440498,-0.0765091559857466,1.20226111515166e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,37990,-0.183628973560265,0.00855143029072798,-0.200389776930092,-0.166868170190438,1.30310576502444e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,40332,-0.0475141894356365,0.00221647336404695,-0.0518584772291685,-0.0431699016421045,1.60378103742367e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,-0.296751427088409,0.0138652667632324,-0.323927349944344,-0.269575504232473,3.41320076926961e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,40502,0.108702305030359,0.00508181328384036,0.0987419509940319,0.118662659066686,4.08003655303484e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,40330,-0.0579647490271543,0.00271088383336776,-0.0632780813405551,-0.0526514167137535,5.0107869439143e-100
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,-0.0738658100025335,0.00346355278405726,-0.0806543734592857,-0.0670772465457813,1.54510848712119e-99
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,40516,-0.0599239864855074,0.00281653901124558,-0.0654444029475488,-0.0544035700234661,4.41740868462949e-99
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,37628,-0.103409776315945,0.00485331525447828,-0.112922274214722,-0.0938972784171675,4.54465246424935e-99
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,-0.147164185580226,0.00698818323790867,-0.160861024726527,-0.133467346433925,4.22714036215188e-97
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,-0.12134564076441,0.00577943060585203,-0.132673324751879,-0.11001795677694,1.55580816607253e-96
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,40333,-0.161896044371474,0.00775464782529009,-0.177095154109042,-0.146696934633905,1.64658647597615e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,-0.164142872920321,0.00788476741271827,-0.179597017049249,-0.148688728791394,5.83456100602208e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,40536,-0.086931076174762,0.00417789522425,-0.0951197508142921,-0.078742401535232,6.58020443888507e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,37642,-0.070838001183326,0.003400331805766,-0.0775026515226274,-0.0641733508440247,7.32021704876568e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,-0.141718369868264,0.00680659500258822,-0.155059296073337,-0.128377443663191,8.52997402096181e-95
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,-0.0676283386846733,0.00325616786602232,-0.074010427702077,-0.0612462496672695,1.4413532755561e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,-0.0526424252925199,0.00253976208939454,-0.0576203589877332,-0.0476644915973066,3.40312333443565e-94
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,40471,-0.122133868027724,0.00593695314379574,-0.133770296189563,-0.110497439865884,7.75636537336146e-93
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,40465,-0.0509577681777733,0.00248015418541091,-0.0558188703811787,-0.0460966659743679,1.29812229491321e-92
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,0.0666223681307605,0.00324829858136346,0.0602557029112881,0.0729890333502329,2.65515742637858e-92
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,40345,-0.0595632338970402,0.00291914658573347,-0.0652847612050778,-0.0538417065890026,2.26093036490855e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,40305,-0.105524200047197,0.00518799300364571,-0.115692666334342,-0.0953557337600511,8.17459465347978e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,37671,-0.0552292923511324,0.00271190670640073,-0.0605446294956778,-0.049913955206587,8.3224780710927e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.104430266008031,0.00513614251984016,-0.114497105346918,-0.0943634266691445,9.51634675661539e-91
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,40309,0.0592449488841417,0.00292574185105816,0.0535104948560677,0.0649794029122157,4.91829304101139e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.0741053337606462,0.00366109790860406,-0.0812810856615102,-0.0669295818597822,5.79144200904611e-90
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,40424,0.0534835763685368,0.00264736193637312,0.0482947469732455,0.0586724057638282,1.22149291798982e-89
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,-0.0703865547523224,0.00350133213050779,-0.0772491657281176,-0.0635239437765271,8.60221175166687e-89
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,40376,-0.0563041366130233,0.00281368626865534,-0.0618189616995877,-0.0507893115264588,5.33913771001734e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,-0.148246275713004,0.00741951453454847,-0.162788524200719,-0.133704027225289,9.74612173023758e-88
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,39963,-0.110351107838479,0.0055891840217383,-0.121305908521086,-0.099396307155872,1.02347152397647e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,-0.142582848709934,0.00722809337176127,-0.156749911718586,-0.128415785701282,1.36265212642165e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,-0.0427586911739667,0.00217515890355175,-0.0470220026249281,-0.0384953797230053,5.03595343982846e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,-0.0525164739671953,0.00267450566449337,-0.0577585050696024,-0.0472744428647883,7.62171017772088e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,-0.100390115836011,0.00511296741867156,-0.110411531976607,-0.0903686996954147,8.29653871249343e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,-0.108045625267245,0.00550466886394438,-0.118834776240576,-0.0972564742939143,9.47180626189662e-85
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,40375,0.0370481863561034,0.0018903123711375,0.0333431741086739,0.0407531986035329,1.56089947394696e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0638170801778115,0.00326070545811382,-0.0702080628757146,-0.0574260974799084,2.62727723367226e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,-0.07606038529768,0.0038967702772467,-0.0836980550410835,-0.0684227155542765,7.31469227747668e-84
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,40359,-0.108873443879177,0.00558619826532547,-0.119822392479215,-0.0979244952791391,1.2656950264777e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,-0.152260731114929,0.00781254889903099,-0.16757332695703,-0.136948135272828,1.90303410036897e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,-0.0528675543685482,0.00271734258275553,-0.0581935458307491,-0.0475415629063474,2.43473118999259e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,0.112331491972536,0.00578813170770494,0.100986753825434,0.123676230119638,6.17574552518932e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,40350,-0.0585566148191402,0.00301966625158885,-0.0644751606722544,-0.0526380689660261,8.18375940866388e-83
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,-0.0998646245505774,0.00515736298959959,-0.109973056010193,-0.0897561930909622,1.42239750242682e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MENT,Protein MENT,37671,0.0395737780244935,0.00204311065942254,0.0355692811320254,0.0435782749169617,1.93501964508351e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,40305,-0.0897675691041733,0.00465559469230361,-0.0988925347010883,-0.0806426035072582,6.62656407143853e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,-0.0538799353988224,0.00279587286059665,-0.0593598462055918,-0.0484000245920529,7.98791339897089e-82
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,40398,-0.115624814510337,0.00601834102130258,-0.12742076291209,-0.103828866108584,2.43129007930257e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,37959,-0.0831225540498633,0.00433409415115129,-0.0916173785861198,-0.0746277295136068,6.60414500570934e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,40392,-0.0579064905703364,0.00302503798385011,-0.0638355650186826,-0.0519774161219902,9.01367712794293e-81
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,40536,0.049509471001106,0.00259919058644616,0.0444150574516715,0.0546038845505405,5.17885111466296e-80
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,40536,0.0292281546741307,0.00154075739238499,0.0262082701850561,0.0322480391632053,2.21866932859935e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,-0.18625167767434,0.00984514448758052,-0.205548160869998,-0.166955194478682,5.98349368991024e-79
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,40305,-0.0634181936530228,0.00339559406750807,-0.0700735580253386,-0.056762829280707,5.1405442314457e-77
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,39980,-0.132348392262056,0.00711711050607628,-0.146297928853966,-0.118398855670147,2.3420469202257e-76
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,40359,-0.0451584943346266,0.00243197608983377,-0.0499251674707008,-0.0403918211985524,3.67528648442208e-76
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OCLN,Occludin,37959,-0.0761950643185982,0.00410462186697115,-0.0842401231778617,-0.0681500054593348,5.60401398853834e-76
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,0.0469656853938849,0.00254002300386943,0.0419872403063008,0.051944130481469,1.53405619418282e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,-0.139682687437783,0.00756079871000748,-0.154501852909398,-0.124863521966168,2.12297666460833e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,-0.0353199846219226,0.00191284243700277,-0.039069155798448,-0.0315708134453972,2.44633366971044e-75
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,-0.065078142187999,0.0035422483254975,-0.0720209489059741,-0.0581353354700238,1.30319252742371e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,40516,-0.0561520541222854,0.00305867204095321,-0.0621470513225537,-0.0501570569220171,1.63629798682464e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,0.054773340531084,0.00298649783334908,0.0489198047777198,0.0606268762844482,2.29670779812061e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,40470,-0.0574103044958868,0.0031376850689906,-0.0635601672311084,-0.0512604417606652,4.95706276644648e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,37819,-0.0468330748008828,0.00255712106602679,-0.0518450320902953,-0.0418211175114703,5.06140629706796e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.0422786775708815,0.00231207852885097,0.0377470036543336,0.0468103514874294,6.14185806415631e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,-0.150771254840022,0.00825129352630109,-0.166943790151572,-0.134598719528472,7.84769573386401e-74
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,-0.0662082396679426,0.00364477945406944,-0.0733520073979188,-0.0590644719379665,7.55600712658641e-73
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,40332,-0.0963859686509237,0.00531217715050707,-0.106797835865918,-0.0859741014359298,7.73890020919857e-73
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,40414,-0.101075998701981,0.00558018490874661,-0.112013161123124,-0.0901388362808375,1.33216510559744e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,-0.156182119709231,0.00863194223300029,-0.173100726485911,-0.13926351293255,1.97299952998735e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,40434,-0.0809040872335388,0.00447396950608212,-0.0896730674654598,-0.0721351070016178,2.27042881865834e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,-0.0464590705820633,0.00257186523446586,-0.0514999264416164,-0.0414182147225102,3.21217152190392e-72
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,40422,0.0750517759522212,0.00417252245435148,0.0668736319416923,0.0832299199627501,1.2500039181265e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,40203,-0.0497998173575348,0.00277003073087354,-0.0552290775900469,-0.0443705571250226,1.50055229774231e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,-0.063366937150876,0.00352622043655686,-0.0702783292065274,-0.0564555450952245,1.71964934111612e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,40372,-0.04750335797169,0.00264571994767619,-0.0526889690691354,-0.0423177468742447,2.22507934021429e-71
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,-0.0890523202893015,0.00498815790081499,-0.0988291097748989,-0.0792755308037041,1.34552782386821e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,-0.0518338152166341,0.00290393866871401,-0.0575255350073136,-0.0461420954259546,1.41062010199827e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,40489,0.0274451145418731,0.00153968183557934,0.0244273381441376,0.0304628909396086,2.15099831487096e-70
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,-0.0646427028949947,0.003643355187522,-0.0717836790625378,-0.0575017267274516,1.21284992686826e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,40341,-0.0796433448029512,0.00450362753302065,-0.0884704547676717,-0.0708162348382308,2.55684725824693e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,37901,-0.184255365319379,0.0104268394847431,-0.204691970709476,-0.163818759929283,4.2095122984014e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,40536,-0.0935227009170229,0.00530765698791,-0.103925708613326,-0.0831196932207193,7.62214096442916e-69
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MME,Neprilysin,40305,-0.134706117580991,0.00765279439892375,-0.149705594602882,-0.119706640559101,1.06602769611555e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,-0.051469631015976,0.00292435386246005,-0.0572013645863977,-0.0457378974455543,1.45097975960398e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,40228,-0.0596169237823945,0.00339715389549947,-0.0662753454175734,-0.0529585021472155,2.69138131004461e-68
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,-0.0577859458875947,0.00332610673775221,-0.064305115093589,-0.0512667766816003,5.4422036379314e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,-0.0708141052672799,0.00408316466486736,-0.0788171080104199,-0.0628111025241399,9.18802893002287e-67
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,40341,-0.0649693149175882,0.00375441871883485,-0.0723279756065045,-0.0576106542286719,1.76110636099531e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,40411,-0.0660508216940862,0.00383029990032832,-0.0735582094987297,-0.0585434338894427,4.896932575495e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,0.0449233378474464,0.00260891510054121,0.0398098642503856,0.0500368114445071,7.50707286010342e-66
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,-0.118512491911066,0.00689575100012247,-0.132028163871306,-0.104996819950826,1.33385478428118e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,40192,-0.0888556514259181,0.00517630363808455,-0.0990012065565639,-0.0787100962952724,1.88539534538312e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,37901,-0.110681876867879,0.00645280145395034,-0.123329367717621,-0.098034386018136,2.97071750963158e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,-0.0546150843302907,0.00319104239798153,-0.0608695274303345,-0.0483606412302469,4.37764478161317e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,-0.0343221641552346,0.00201101985429206,-0.038263763069647,-0.0303805652408221,9.79523904383725e-65
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,40456,-0.0938271200368879,0.0055257388189646,-0.104657568122059,-0.0829966719517173,4.20316288310379e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,-0.0832911142950242,0.00490585391616802,-0.0929065879707135,-0.0736756406193349,4.3490452709618e-64
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,40516,-0.0433755190912621,0.00256355016966249,-0.0484000774238006,-0.0383509607587236,1.13844767758037e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,40011,-0.0491404505814325,0.00290695878785144,-0.0548380898056213,-0.0434428113572437,1.53978265389201e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,40341,0.0540329194700495,0.00320518867232521,0.047750749672292,0.0603150892678069,3.24828142636548e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,-0.0525260794231069,0.00312140717108355,-0.0586440374784306,-0.0464081213677831,5.3529646031257e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,40447,-0.0587131835675946,0.00349177556746118,-0.0655570636798185,-0.0518693034553707,6.60461729285297e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,-0.0490253933868859,0.00291340410843244,-0.0547356654394134,-0.0433151213343583,6.6693709452736e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,-0.0598869769124671,0.00356591750198123,-0.0668761752163503,-0.0528977786085839,9.22817498452965e-63
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,40042,-0.0846037705160527,0.00505425526861331,-0.0945101108425348,-0.0746974301895706,2.38018993238981e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,40411,-0.0404171663837833,0.00242225462017386,-0.0451647854393241,-0.0356695473282425,5.57335593957222e-62
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,-0.158300536941905,0.00955279137118408,-0.177024008029426,-0.139577065854384,3.81553671667776e-61
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,37990,-0.0439665345939042,0.00266664121600465,-0.0491931513772733,-0.0387399178105351,1.74894547245633e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,-0.0436159096111874,0.00265259826582589,-0.0488150022122062,-0.0384168170101687,3.01186894026832e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,-0.101037681551541,0.00617016324792535,-0.113131201517475,-0.0889441615856076,8.79574306479559e-60
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,40469,-0.0949846687144445,0.00580825877142185,-0.106368855906431,-0.0836004815224577,1.25153027835003e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,37917,-0.0456253522943179,0.00279264859875391,-0.0510989435478756,-0.0401517610407603,1.9843532787318e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,40341,-0.0659710213893237,0.00405513006950645,-0.0739190763255564,-0.0580229664530911,4.95031550076369e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.0556058611333743,0.0034230581270772,-0.0623150550624456,-0.0488966672043029,7.28526999042213e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,40341,-0.0810072178381496,0.00499196080285831,-0.0907914610117519,-0.0712229746645473,9.55613097060296e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,-0.0538089188877604,0.00331629173510072,-0.0603088506885579,-0.047308987086963,9.97939337898147e-59
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,37987,0.0827202578058215,0.00510042754099325,0.0727234198254748,0.0927170957861683,1.33487086277191e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,0.0970579366999186,0.00599150745062686,0.08531458209669,0.108801291303147,1.48738300262978e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,37628,-0.0829893649642822,0.00514472593634252,-0.0930730277995135,-0.0729057021290509,5.54807532139982e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELE,E-selectin,40536,-0.075918856529037,0.0047155615684253,-0.0851613572031506,-0.0666763558549234,7.26767135399235e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,-0.0870543850612636,0.00540726751753672,-0.0976526293956356,-0.0764561407268916,9.13658509273291e-58
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,40068,0.0453772093847245,0.00282385065211463,0.0398424621065799,0.0509119566628692,1.21430976559621e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,-0.0925993824113496,0.00576331636414737,-0.103895482485078,-0.0813032823376207,1.23562336392042e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.102690315617362,0.00640271976852079,-0.115239646363663,-0.0901409848710611,1.94503672842777e-57
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,-0.102106653154644,0.00641281812063873,-0.114675776671096,-0.0895375296381926,1.5031122282585e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,40516,-0.066663023642889,0.00419985712182548,-0.074894743601667,-0.0584313036841111,2.62406606496446e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,0.0726577213051519,0.00457544742165898,0.0636898443587003,0.0816255982516035,2.8152299515539e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,40516,-0.0601057393818891,0.0038020773620832,-0.0675578110115721,-0.052653667752206,7.1518023367782e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,-0.0922180365349647,0.00583510757057306,-0.103654847373288,-0.0807812256966415,7.77343814921716e-56
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,40330,-0.0441746932634971,0.00280104895555434,-0.0496647492163837,-0.0386846373106106,1.3065410401387e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,-0.0725086094379505,0.00459455515761034,-0.0815139375468668,-0.0635032813290342,1.34287789808258e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,40403,-0.0746616386350684,0.00474130125633927,-0.0839545890974934,-0.0653686881726434,1.88148747450569e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,37981,-0.0406472193001064,0.00258701039342789,-0.0457177596712251,-0.0355766789289877,3.84002828626428e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,0.0941607965288787,0.00601558438206041,0.0823702511400403,0.105951341917717,9.88232196692657e-55
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGRN,Agrin,40422,-0.0488995469082812,0.00312898323246014,-0.055032354043903,-0.0427667397726593,1.19297117245578e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POSTN,Periostin,37998,0.0557138792032089,0.00357612950019351,0.0487046653828296,0.0627230930235882,2.96993013486278e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,40489,-0.190973456662617,0.0122780811822461,-0.21503849577982,-0.166908417545415,3.71547330526372e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,-0.064627701054695,0.00416443813657827,-0.0727899998023884,-0.0564654023070015,6.35942105222799e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,-0.0394725819656239,0.00254594546854236,-0.0444626350839669,-0.0344825288472808,9.49134095640438e-54
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,40305,-0.11445357959669,0.0073964471999632,-0.128950616108618,-0.0999565430847621,1.27919742347292e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,40353,0.0789023703101679,0.00510013313216024,0.0689061093711338,0.088898631249202,1.34554724610947e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REN,Renin,40359,-0.10415497602983,0.00673472687030812,-0.117355040695633,-0.0909549113640257,1.45848507930573e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,-0.0864602013893366,0.00559614294679698,-0.0974286415650587,-0.0754917612136145,1.85126200219342e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,40367,0.05377253954482,0.00349270276117218,0.0469268421329225,0.0606182369567174,4.22361123558343e-53
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,-0.0520632574878685,0.00339767662390204,-0.0587227036707165,-0.0454038113050205,1.29844393949703e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,-0.055547217523727,0.00362644851053337,-0.0626550566043724,-0.0484393784430816,1.39164004275409e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,-0.0835062407963777,0.00545688062156298,-0.0942017268146411,-0.0728107547781142,2.01966249687751e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFM,Afamin,38013,-0.0269795132683292,0.00176384892860769,-0.0304366571684002,-0.0235223693682581,2.22994995810033e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,-0.0656307376200236,0.00430656581644843,-0.0740716066202625,-0.0571898686197846,5.33331998145362e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,40145,-0.0514953009832572,0.00338888089964039,-0.0581375075465523,-0.044853094419962,8.86488220985648e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,-0.0823592679279726,0.00541802964418291,-0.0929786060305711,-0.0717399298253741,9.33655816663848e-52
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PXN,Paxillin,39961,-0.0740626560954338,0.00488156625845175,-0.0836305259619992,-0.0644947862288683,1.27388732068115e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,37628,-0.0925240703942549,0.00609737296744064,-0.104474921410439,-0.0805732193780712,1.4244542814307e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,40516,-0.0502668281210059,0.00331891776812715,-0.0567719069465351,-0.0437617492954766,1.83761837262628e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,40489,-0.0383640370302964,0.00253854883072344,-0.0433395927385144,-0.0333884813220785,3.01510062994034e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,-0.0491712120222986,0.00325843508633759,-0.0555577447915203,-0.0427846792530769,4.23817718358801e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,40489,-0.0642297965935789,0.0042598487545952,-0.0725791001525855,-0.0558804930345723,5.05992930595463e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,40516,-0.0770139990918008,0.00511841083479606,-0.0870460843280011,-0.0669819138556005,8.08242158335054e-51
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,40516,-0.110100005308455,0.00732473430082567,-0.124456484538073,-0.0957435260788362,1.01366656269605e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,40341,-0.0869845913500712,0.00579704469060994,-0.0983467989436667,-0.0756223837564758,1.51135640727647e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,40374,-0.0656794079368449,0.004413281809653,-0.0743294402837648,-0.0570293755899251,9.28789248458704e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,0.034175999941958,0.00229719109069294,0.0296735054041998,0.0386784944797161,9.96822948182353e-50
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFI,Complement factor I,38013,-0.0282988705561399,0.00190176807207565,-0.0320263359774081,-0.0245714051348716,1.09088154621479e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,0.0542734516477782,0.00365190761823986,0.047115712716028,0.0614311905795283,1.25908449469099e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,-0.0293546609968955,0.00197992572317379,-0.0332353154143161,-0.0254740065794749,2.10834202860157e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,-0.0532396825669356,0.00359240979356892,-0.0602808057623306,-0.0461985593715405,2.41715082797927e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,37628,-0.0455952119699617,0.00307675356943525,-0.0516256489660548,-0.0395647749738686,2.74148948060734e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,-0.0479533277762103,0.00324278222201513,-0.05430918093136,-0.0415974746210606,3.69765404008792e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,-0.0802269089082824,0.00544240139703896,-0.0908940156464788,-0.0695598021700861,8.4345762011291e-49
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,40305,-0.0708506879194712,0.00481460066585691,-0.0802873052245508,-0.0614140706143917,1.06940781687922e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,40224,0.0394725676247374,0.00268352553872938,0.0342128575688278,0.044732277680647,1.18147727934852e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,-0.0353879269626379,0.00241587846870778,-0.0401230487613051,-0.0306528051639706,2.86899213704442e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,-0.0678205249839095,0.00463613779858983,-0.0769073550691455,-0.0587336948986734,3.75792508518045e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSN,Gelsolin,37928,0.0264294056178099,0.00180620746769428,0.0228892389811291,0.0299695722544907,4.07236214176112e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,40341,-0.107919499025505,0.00738386888217613,-0.122391882034571,-0.0934471160164403,4.58277675498746e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,-0.0408530382676267,0.002796211780171,-0.0463336133567619,-0.0353724631784916,4.98240319805942e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,-0.0419793651225703,0.00287158578280038,-0.047607673256859,-0.0363510569882815,5.05763241771794e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAST,Gastrin,37942,-0.179620262251456,0.0123083056004047,-0.203744541228249,-0.155495983274662,7.1616971137959e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,-0.0727476993050992,0.00499172465351304,-0.0825314796259848,-0.0629639189842137,8.54314772519734e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.0473601066826333,0.00325075943961768,-0.053731595184284,-0.0409886181809827,9.00169698921959e-48
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,40292,-0.0649446257456627,0.00447033946623882,-0.0737064910994908,-0.0561827603918347,1.62996988915199e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,40268,-0.0991579310357292,0.00683650758186217,-0.112557485896179,-0.0857583761752794,2.29552348909041e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,40536,-0.0783917781676167,0.00540703615826822,-0.0889895690378224,-0.067793987297411,2.47626818859918e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,-0.0750408093624726,0.00518342435215924,-0.0852003210927048,-0.0648812976322405,3.44692299526021e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,40228,0.0456527923330068,0.00316581418008725,0.0394477965400358,0.0518577881259779,7.62914019373181e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,-0.059607770102051,0.00413886917021467,-0.0677199536756718,-0.0514955865284302,9.92069952533499e-47
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,-0.112027555797058,0.00778001640167086,-0.127276387944333,-0.0967787236497835,1.04341820886916e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,40293,-0.04245680863816,0.00295569871949374,-0.0482499781283677,-0.0366636391479523,1.69606967479103e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,40382,0.052523522972741,0.00367250912628396,0.0453254050852245,0.0597216408602576,4.11409217859732e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,40228,-0.0468936276233412,0.00327989200580321,-0.0533222159547155,-0.0404650392919669,4.41327349379577e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,40471,0.0502424841719565,0.00351819722440441,0.0433468176121239,0.0571381507317892,5.52591049196397e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,-0.0369111235810169,0.00258950129192046,-0.041986546113181,-0.0318357010488528,8.06901380261299e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_E,,40341,-0.0387288994183378,0.00271827714407465,-0.0440567226207241,-0.0334010762159515,8.88143899499403e-46
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASPN,Asporin,37990,0.0367572655096714,0.00258217750828167,0.0316961975934394,0.0418183334259035,1.18613551127947e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,-0.0370851287989508,0.00260677086836362,-0.0421943997009435,-0.0319758578969581,1.19702007183592e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,40228,-0.0546897755797611,0.00385005197617111,-0.0622358774530565,-0.0471436737064657,1.62893185582019e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,40359,0.0487788216698386,0.00344002968651928,0.0420363634842608,0.0555212798554164,2.30997539863626e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,-0.0599369368537855,0.00423057108720965,-0.0682288561847164,-0.0516450175228546,2.75347490820082e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,40489,-0.0381213623972658,0.00269392966878682,-0.043401464548088,-0.0328412602464437,3.45164595040787e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,40411,-0.0421479683451194,0.00297974059465561,-0.0479882599106443,-0.0363076767795944,3.76610339233338e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,-0.0289140149000581,0.00204626932793073,-0.0329247027828023,-0.0249033270173139,4.60870230683022e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,0.0458525275648372,0.00324500184959374,0.0394923239396335,0.052212731190041,4.63098913462133e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,-0.0374377765208613,0.00265158352944889,-0.0426348802385812,-0.0322406728031415,5.42104727256538e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,37998,0.0807887734901365,0.00572319015841204,0.0695713207796489,0.0920062262006241,6.29630286104025e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,40422,-0.089886034539764,0.00637426226353454,-0.102379588576292,-0.0773924805032363,6.92127384506762e-45
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,40471,-0.0548910512100693,0.00390428382594061,-0.0625434475089129,-0.0472386549112257,1.24634720666657e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,40489,-0.074676539370396,0.00531886952117278,-0.0851015236318946,-0.0642515551088973,1.6293228390176e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,40216,-0.049851877944084,0.00355707507718821,-0.0568237450953729,-0.0428800107927952,2.33438034090556e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,-0.0768816796298798,0.00549176197902031,-0.0876455331087596,-0.066117826151,2.86998095014487e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,37998,-0.0329344428313827,0.0023530405782574,-0.0375464023647672,-0.0283224832979981,3.32389265582214e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,37990,-0.0568211125004126,0.00407791282474483,-0.0648138216369125,-0.0488284033639127,7.91514877546153e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,-0.0591322777996928,0.00424773275091556,-0.0674578339914873,-0.0508067216078983,8.55139537958798e-44
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,-0.0351125108835823,0.00252583521261633,-0.0400631479003103,-0.0301618738668543,1.13627713233189e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,-0.0671282725924935,0.00482989165212262,-0.0765948602306538,-0.0576616849543331,1.29494756736643e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,-0.088342960965655,0.00636699137064729,-0.100822264052124,-0.0758636578791863,1.62942895664018e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,-0.0786244114832559,0.00566718067912949,-0.0897320856143497,-0.0675167373521621,1.64362970316068e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MLN,Promotilin,40341,-0.11587192436712,0.0083649092334754,-0.132267146464732,-0.0994767022695081,2.20673856565226e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,38013,-0.0416740084372326,0.00300964174840425,-0.0475729062641049,-0.0357751106103602,2.61996924858093e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,37575,-0.0359316071852664,0.00259490845913678,-0.0410176277651745,-0.0308455866053583,2.67455256041349e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,0.0491385659943673,0.00355359831414583,0.0421735132986414,0.0561036186900931,3.07545722652995e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,-0.0714289967504785,0.00516783599843198,-0.0815579553074051,-0.0613000381935518,3.34675429732853e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,37671,-0.0593242089760858,0.004297483093793,-0.0677472758399201,-0.0509011421122515,4.76712241749631e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,40359,-0.0833276181634236,0.0060402044454356,-0.0951664188764774,-0.0714888174503698,4.80020165909782e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RETN,Resistin,40283,-0.0539065156227701,0.00391895072182839,-0.0615876590375537,-0.0462253722079864,8.33770967700873e-43
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,0.0526533386882456,0.00383872888405543,0.045129430075497,0.0601772473009943,1.41709423773215e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,-0.0342937373883467,0.00250161308229953,-0.0391968990296537,-0.0293905757470396,1.57377346315402e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,40341,-0.0786016796119175,0.00573612522437959,-0.0898444850517015,-0.0673588741721334,1.70088619133928e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,-0.134648253915632,0.0098448572122533,-0.153944174051649,-0.115352333779616,2.42483231384396e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,-0.109103035329615,0.0079738645981133,-0.124731809941917,-0.0934742607173127,2.51485852686143e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,-0.140347528696305,0.0102736937867347,-0.160483968518305,-0.120211088874305,3.05132757429748e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0658293042412173,0.00482445622248192,-0.0752852384372818,-0.0563733700451527,3.73243045578325e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,40489,-0.0469661109484097,0.00344286064137299,-0.0537141178055007,-0.0402181040913186,3.89333319682678e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,-0.0666463738571879,0.00489280352175347,-0.0762362687598247,-0.0570564789545511,5.14095986795484e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,-0.0874200879902428,0.00641635163625681,-0.0999961371973062,-0.0748440387831795,5.43360131095529e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,40341,-0.0682061943665618,0.00502345236052883,-0.0780521609931983,-0.0583602277399253,9.30363555016607e-42
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,40422,-0.0545255671714054,0.0040186772107271,-0.0624021745044306,-0.0466489598383803,1.05493731625898e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,40403,-0.0391446301092406,0.00288885553190445,-0.0448067869517733,-0.0334824732667078,1.34210120667564e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,37901,-0.12009180437644,0.00889817718275375,-0.137532231654637,-0.102651377098243,3.05339321529683e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,-0.0864777848935486,0.0064169811929221,-0.0990550680316759,-0.0739005017554213,3.62942984970731e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,40228,-0.0473249121767542,0.00352265668574261,-0.0542293192808097,-0.0404205050726987,6.37779958188212e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,37598,-0.0571114834033561,0.00425037829618657,-0.0654422248638818,-0.0487807419428304,6.84852802756965e-41
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,40097,-0.0529268669013318,0.00395625987480251,-0.0606811362559447,-0.0451725975467189,1.35880844243382e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,0.0664440461774244,0.00498313052694194,0.0566771103446182,0.0762109820102306,2.42589506442193e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,0.0534614532982021,0.00401414568851522,0.0455937277487122,0.0613291788476919,2.97303899414731e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,-0.0476071266710085,0.00357677698152812,-0.0546176095548036,-0.0405966437872133,3.37209313059359e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,39960,-0.0495855344084843,0.00373204631617935,-0.0569003451881958,-0.0422707236287728,4.59528878669003e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,-0.0334883415429981,0.00252616830416231,-0.0384396314191562,-0.0285370516668399,6.74850228860796e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,-0.0924836973635341,0.00698344536247362,-0.106171250273982,-0.0787961444530858,8.05013236554691e-40
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,40341,0.0596220877207995,0.00450919543165609,0.0507840646747536,0.0684601107668455,1.05686127356885e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,40436,-0.0498248057733526,0.00377325198145521,-0.0572203796570048,-0.0424292318897004,1.32809010348716e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,-0.0814916303251185,0.00617457388680043,-0.0935937951432474,-0.0693894655069897,1.58162103420797e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,-0.105278358482457,0.0080034379466222,-0.120965096857837,-0.0895916201070775,2.84773598571182e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,37598,-0.103779627985027,0.00789264370629852,-0.119249209649372,-0.0883100463206818,3.05314146829263e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,-0.0982058125616378,0.00748049328745161,-0.112867579405043,-0.0835440457182326,3.99693652743154e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,-0.0604334703039248,0.00462218698157496,-0.0694929567878117,-0.0513739838200378,7.35971039141367e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,-0.0528387740011162,0.00404786842931647,-0.0607725961225764,-0.0449049518796559,9.57611945338522e-39
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,37628,-0.0754849194521004,0.00578248633275316,-0.0868185926642966,-0.0641512462399042,1.04708711780166e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,0.0531472466782686,0.00407474423194052,0.0451607479836652,0.0611337453728721,1.0996961975374e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,-0.0518928320025826,0.00398114426166926,-0.0596958747554543,-0.0440897892497108,1.22689679874097e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,40360,0.0470450054789428,0.00361193315096771,0.0399656165030461,0.0541243944548395,1.39149390949177e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,40332,-0.054812087579559,0.0042118031164474,-0.0630672216877959,-0.0465569534713221,1.60505683418409e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,-0.106175863992496,0.00816584185506238,-0.122180914028418,-0.0901708139565734,2.01633591902296e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,-0.0573085372967301,0.00441113636271885,-0.0659543645676591,-0.0486627100258012,2.31368186562441e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,-0.0606121563164083,0.00466857223898299,-0.069762557904815,-0.0514617547280017,2.39286049179435e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,-0.0515242587153327,0.00397856163352568,-0.059322239517043,-0.0437262779136224,3.64102676207376e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,-0.111316722953468,0.00860597050476718,-0.128184425142811,-0.094449020764124,4.44795675698956e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,40305,-0.0367875057184699,0.00284596922764542,-0.0423656054046549,-0.0312094060322848,4.98615282883479e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,-0.0590763424560673,0.00457769161262225,-0.0680486180168069,-0.0501040668953277,6.52439008424751e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,-0.0462439948731561,0.00358731362138284,-0.0532751295710665,-0.0392128601752458,7.79596269458464e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,37901,-0.128218369619219,0.00994862675172737,-0.147717678052604,-0.108719061185833,8.79449944048303e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,-0.0630833696895748,0.00490013390206224,-0.0726876321376168,-0.0534791072415328,9.84982613775437e-38
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,-0.0322270999674546,0.00250569302825414,-0.0371382583028328,-0.0273159416320765,1.13969558918189e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,-0.0380956322718328,0.0029630632560292,-0.04390323625365,-0.0322880282900155,1.20653733784319e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,0.0316324116759527,0.00246043209572875,0.0268099647683244,0.0364548585835811,1.31331425480977e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,-0.0401226555117562,0.00312446429910711,-0.0462466055380061,-0.0339987054855062,1.59954188740195e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,40359,-0.0427330180317099,0.00333355460706752,-0.0492667850615622,-0.0361992510018576,1.96496433045978e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0313360741579876,0.00244729226035521,0.0265393813276914,0.0361327669882838,2.35957819515302e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,38013,0.0335179328040585,0.00261867469252716,0.0283853304067053,0.0386505352014118,2.70922552307558e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,-0.0694149036577528,0.00543659922757149,-0.0800706381437929,-0.0587591691717127,3.77502793593988e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,-0.0679414322877465,0.00531985465164062,-0.0783683474049621,-0.0575145171705308,3.94694050180653e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,-0.102036690445823,0.00799933106373198,-0.117715379330738,-0.0863580015609082,4.44244532579576e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,40228,-0.0805902761479367,0.00632341598698584,-0.0929841714824289,-0.0681963808134444,5.07767941988699e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,40332,0.0307137656103406,0.00241040372704388,0.0259893743053346,0.0354381569153466,5.23175979763929e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,-0.112065343133385,0.00879801158012646,-0.129309445830433,-0.0948212404363375,5.54189942194576e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,40359,0.0626389889368285,0.00492282965528766,0.0529902428124647,0.0722877350611923,6.56723477901522e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,40228,-0.106953991363535,0.0084170975806844,-0.123451502621676,-0.0904564801053931,8.21715426095515e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,-0.0783715437618839,0.00617139930819154,-0.0904674864059393,-0.0662756011178284,9.02017844593635e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,-0.146645998046257,0.0115538414660098,-0.169291527319636,-0.124000468772878,9.83316617937159e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,-0.0648456934625074,0.00510931731227824,-0.0748599553945727,-0.054831431530442,9.91722623492969e-37
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,37671,-0.0510586976884774,0.00402361585118579,-0.0589449847568016,-0.0431724106201533,1.10287309376491e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,0.028424313036877,0.00224811960306516,0.0240179986148693,0.0328306274588848,1.82036263510252e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTR,Transthyretin,37871,-0.0306143938780059,0.00242297404863387,-0.0353634230133283,-0.0258653647426835,2.18013885552919e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,40044,-0.0567235200060197,0.00449890009532658,-0.0655413641928598,-0.0479056758191796,2.8562811494438e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,38013,-0.0209560685235238,0.00166252903780988,-0.0242146254376312,-0.0176975116094165,3.16576133612126e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,-0.038450792585078,0.00305638637962764,-0.0444413098891482,-0.0324602752810078,4.02324368186719e-36
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,40228,0.0297275648705759,0.00237925695273616,0.0250642212432131,0.0343909084979388,1.18025666849365e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,-0.104750107894595,0.00839833178104165,-0.121210838185437,-0.0882893776037535,1.56140503024195e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,0.0234592300911788,0.00188278351020513,0.0197689744111767,0.0271494857711808,1.81155304163701e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,40516,-0.0887559523564777,0.00713632978599683,-0.102743158737032,-0.074768745975924,2.38798395883594e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,40417,-0.0784347913112495,0.00630743802279249,-0.0907973698359228,-0.0660722127865762,2.45095499370407e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,-0.0509707263940968,0.00409785575702038,-0.0590025236778568,-0.0429389291103369,2.55553530018308e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,40305,-0.0388260824011328,0.00312403006273995,-0.0449491813241031,-0.0327029834781625,2.68281080940609e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,-0.0583096819864612,0.00469351640330445,-0.067508974136938,-0.0491103898359845,2.86784140407929e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,37990,-0.029519232134754,0.00237572399177239,-0.0341756511586279,-0.0248628131108801,2.96316744522425e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,40489,-0.0770563121033562,0.0062067981959891,-0.0892216365674948,-0.0648909876392176,3.15253181992847e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,37998,-0.131929358294741,0.0106263501099649,-0.152757004510273,-0.11110171207921,3.35457495598455e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,-0.0341061094397635,0.00274915075534015,-0.0394944449202302,-0.0287177739592968,3.53015699871082e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EZR,Ezrin,40471,-0.02770953236502,0.00223463884094369,-0.0320894244932696,-0.0233296402367703,3.78830058051052e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,40516,-0.0484733320258442,0.00391148200688867,-0.056139836759346,-0.0408068272923425,4.14832985672342e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,-0.103970113555136,0.00839628607692826,-0.120426834265915,-0.0875133928443562,4.71067363535643e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,40471,-0.0429462007811229,0.00347236976130506,-0.0497520455132808,-0.036140356048965,5.62531359761701e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,37671,-0.0733040349535365,0.00592466370641979,-0.0849163758181193,-0.0616916940889537,5.73487889709627e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,40333,0.0256659964993397,0.00207589080071485,0.0215972505299386,0.0297347424687408,5.9381674986225e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,40152,-0.0432905072328903,0.00350151618086464,-0.050153478947385,-0.0364275355183956,5.99926860722804e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,40471,-0.0397946594162033,0.0032229134507139,-0.0461115697796025,-0.0334777490528041,7.24714375482539e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,39806,-0.0468720782316525,0.00379661691011337,-0.0543134473754747,-0.0394307090878303,7.51469137051956e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,37671,0.0631176823532816,0.00511274437842128,0.0530967033715759,0.0731386613349874,8.04480766594587e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,37900,-0.0519422626444571,0.00420886142341884,-0.0601916310343581,-0.0436928942545562,8.38709124378963e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,-0.0994347244878567,0.00806519159929011,-0.115242500022465,-0.0836269489532481,9.13861216425628e-35
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,37057,-0.0287521767639887,0.00233459072221323,-0.0333279745795266,-0.0241763789484508,1.17917983337214e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,40311,-0.106255861126037,0.00863386464979969,-0.123178235839644,-0.0893334864124296,1.19719345114066e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,-0.03041057639302,0.00247164291671991,-0.035254996509791,-0.025566156276249,1.23921819343167e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,40489,-0.0450296402925529,0.00366100066739595,-0.052205201600649,-0.0378540789844569,1.30017391058246e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0447585187932629,0.00364481790359933,0.0376146757022082,0.0519023618843176,1.6735724321865e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,37671,-0.0308162942697156,0.00250894169523134,-0.035733819992369,-0.0258987685470621,1.73197853784238e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,40295,0.0740037289780267,0.00603545310957882,0.0621742408832522,0.0858332170728012,2.08758047742983e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,-0.0814373267443735,0.00665074093220434,-0.094472778971494,-0.068401874517253,2.74899993959137e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,-0.0809426544637147,0.00662317633181468,-0.0939240800740715,-0.0679612288533579,3.44199331007754e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,-0.0838594187249873,0.00686491537697462,-0.0973146528638576,-0.0704041845861171,3.92221951365955e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,40490,-0.0565969742926345,0.00463730018799409,-0.0656860826611029,-0.0475078659241661,4.15519040914455e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFH,Complement factor H,37301,-0.0268213462316835,0.00220043833988631,-0.0311342053778606,-0.0225084870855063,5.47336291982231e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,-0.0704951151339332,0.00578944062825123,-0.0818424187653056,-0.0591478115025607,5.8764603597846e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,39759,-0.0355803351166527,0.00292217784949492,-0.0413078037016628,-0.0298528665316427,5.99195996998618e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,40228,-0.0558787463002594,0.00459029465793873,-0.0648757238298193,-0.0468817687706995,6.1279278933852e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,-0.0777009821103476,0.00639150963192921,-0.0902283409889288,-0.0651736232317663,7.42133098159013e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,37990,-0.0796669337664538,0.00655793128275884,-0.0925204790806611,-0.0668133884522465,8.79167079496225e-34
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDK,Midkine,40352,-0.0580772966083426,0.00478970866744016,-0.0674651255965253,-0.0486894676201599,1.0907198368506e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,37598,-0.0533772076926706,0.00440670190065823,-0.0620143434179608,-0.0447400719673805,1.36516344989779e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,39757,-0.106591589744537,0.00881218555119962,-0.123863473424888,-0.0893197060641855,1.57830911507878e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,-0.0535767113710769,0.00443874163119765,-0.0622766449682243,-0.0448767777739295,2.14009176888017e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,40305,-0.129411654768237,0.0107301057568755,-0.150442662051713,-0.108380647484761,2.38643956464718e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,40305,-0.0610453221026101,0.0050627473797271,-0.0709683069668753,-0.051122337238345,2.47019237172511e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,40042,0.0269248291120231,0.00223640917289655,0.0225414671331458,0.0313081910909003,3.10020891971268e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,-0.123587291523338,0.0102702954983401,-0.143717070700084,-0.103457512346591,3.5126230865888e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,37987,-0.0276383828489591,0.00229711246957777,-0.0321407232893315,-0.0231360424085866,3.57080298545553e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,39980,-0.0837906281833823,0.00696820881146395,-0.0974483174538516,-0.0701329389129129,3.69945312884875e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,40305,-0.0873322275008837,0.00726716965472662,-0.101575880024148,-0.0730885749776195,4.01190442308403e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,40422,-0.0770268077305993,0.00641068921696411,-0.0895917585958489,-0.0644618568653496,4.09906506024961e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,37598,-0.104065795015387,0.0086681597165378,-0.121055388059802,-0.0870762019709734,4.94644061645537e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.0411623143597391,0.00343081671619369,-0.0478867151234787,-0.0344379135959995,5.06679681353728e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,0.0356068137842608,0.00296994495258847,0.0297857216771874,0.0414279058913342,5.87508763631928e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,40305,-0.0827459557607898,0.00690969545596784,-0.0962889588544868,-0.0692029526670929,6.63455425155647e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD248,Endosialin,37998,0.0454587365834651,0.00379725973454786,0.0380161075037513,0.052901365663179,7.34400718124054e-33
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,37990,-0.0628929275420252,0.00527941790469177,-0.0732405866352211,-0.0525452684488294,1.47534994570652e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,-0.0709063057409676,0.00596271571872615,-0.0825932285496708,-0.0592193829322644,1.81021784627825e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,-0.157247948322889,0.0132224302253492,-0.183163911564573,-0.131331985081205,1.88245065601759e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,40472,-0.0262306795932554,0.00220736522218397,-0.0305571154287359,-0.0219042437577748,1.9792756548609e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,40305,-0.0769920830972454,0.0064906428736976,-0.0897137431296927,-0.0642704230647981,2.55418045943264e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,40177,-0.0378540405866231,0.00319355215568507,-0.0441134028117658,-0.0315946783614803,2.83976675447651e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,37628,-0.0638969217925567,0.00539014589984362,-0.0744616077562502,-0.0533322358288632,2.97792554360521e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,40471,-0.0888906109764944,0.00751168217143951,-0.103613508032516,-0.074167713920473,3.56066446328964e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,-0.0555398161922163,0.00469159388339631,-0.064735340203673,-0.0463442921807595,3.61384943787524e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,-0.0310025836885317,0.00262027289017039,-0.0361383185532657,-0.0258668488237978,3.65035912943043e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,40332,-0.0400507758968955,0.00338936670328177,-0.0466939346353278,-0.0334076171584632,4.36640966309924e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,37990,-0.102432213745347,0.00867795138991738,-0.119440998469585,-0.0854234290211091,5.35781585541428e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,37967,-0.0632446619269603,0.00536390019335682,-0.0737579063059397,-0.0527314175479809,6.24182628274107e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,0.0382792975452743,0.00325081360342364,0.0319077028825639,0.0446508922079846,7.10010668600935e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,-0.0855391593967671,0.00727435448723327,-0.0997968941917443,-0.0712814246017899,8.59517536212619e-32
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,37931,-0.120740233155166,0.0102942354584838,-0.140916934653794,-0.100563531656538,1.29058530285527e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,-0.0908801265483017,0.00775377476964149,-0.106077525096799,-0.0756827279998044,1.34292031557106e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,-0.107664172082708,0.00919236096558378,-0.125681199575252,-0.0896471445901638,1.48630370846504e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,-0.0541508951844158,0.00462485008832052,-0.0632156013575241,-0.0450861890113076,1.56176434655028e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,0.0268442889331268,0.00229492780543079,0.0223462304344824,0.0313423474317711,1.7662152953858e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,40516,-0.0601740575369132,0.0051582823460953,-0.07028429093526,-0.0500638241385665,2.55762167310494e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,40422,-0.0478231904649051,0.00410125826006481,-0.0558616566546321,-0.0397847242751781,2.71271564626783e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,37671,0.0317358746714633,0.00273126161753883,0.0263826019010872,0.0370891474418394,4.64389756372217e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,-0.0451181678055836,0.00388536580178032,-0.0527334847770731,-0.0375028508340942,4.74485861970537e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,-0.083998038255421,0.00723282592181018,-0.0981743770621689,-0.069821699448673,4.94643091723721e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,39961,-0.0655604622234803,0.00567190420901702,-0.0766773944731537,-0.0544435299738069,8.90741329929367e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,-0.0872392282376685,0.00754684839992967,-0.102031051101531,-0.0724474053738064,9.21604914992474e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,37878,-0.0456796251442318,0.00395386906746445,-0.0534292085164622,-0.0379300417720015,9.94359642348788e-31
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,40453,-0.0303408318583496,0.0026302189049957,-0.0354960609121412,-0.025185602804558,1.15556080079469e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,37671,-0.0565506778460426,0.0049025224814207,-0.0661596219096271,-0.046941733782458,1.2315501678818e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,-0.10488781656313,0.00909767492862837,-0.122719259423241,-0.0870563737030179,1.24358314422903e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0360958989795,0.00313201425806564,0.0299571510336913,0.0422346469253086,1.37391078372034e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,-0.0915049470078289,0.00794531477010629,-0.107077763957237,-0.0759321300584205,1.50829155625897e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,-0.0337449873075771,0.00293570419468345,-0.0394989675291566,-0.0279910070859975,1.8507077045469e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,-0.129701905659744,0.011279835263562,-0.151810382776325,-0.107593428543162,1.87668691754026e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,0.0456309660347337,0.00397125929794024,0.0378472978107708,0.0534146342586965,1.94801725200249e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,40359,0.0388424714451631,0.00338379486970934,0.0322102335005328,0.0454747093897934,2.21650964815662e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,-0.0661433013518149,0.0057653242869193,-0.0774433369541767,-0.054843265749453,2.4001630149566e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,-0.0480035109171018,0.00418456942921611,-0.0562052669983654,-0.0398017548358382,2.41543295918964e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,-0.0454372319342336,0.00397074785753306,-0.0532198977349984,-0.0376545661334688,3.34304803022809e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,40432,-0.0746651964647134,0.00653111956999288,-0.0874661908218994,-0.0618642021075273,3.78039013044612e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,40332,0.0262756782261599,0.00230207591303614,0.0217636094366091,0.0307877470157107,4.66730199401001e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,37942,-0.039990642944011,0.0035037943048653,-0.046858079781547,-0.0331232061064751,4.91564273085048e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,40471,-0.064292882490684,0.00563557324193856,-0.0753386060448836,-0.0532471589364845,4.95813819674236e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,40471,-0.0628700574826306,0.00551138838395712,-0.0736723787151866,-0.0520677362500747,5.02083550893799e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,40341,-0.0362424360772297,0.00317831050133942,-0.042471924659855,-0.0300129474946045,5.28141903429622e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,40346,0.0298566151023806,0.00261894138257819,0.0247234899925273,0.0349897402122338,5.45155508738232e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,-0.033607504415069,0.00294990466935545,-0.0393893175670057,-0.0278256912631324,5.92488222330534e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,-0.0666734727374072,0.005852782633766,-0.0781449266995886,-0.0552020187752259,6.29490547696431e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,37987,-0.0280452218819194,0.0024655566821561,-0.0328777129789454,-0.0232127307848935,7.62702931636097e-30
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,-0.0437933626605269,0.00386111106539806,-0.0513611403487071,-0.0362255849723467,1.06044144609052e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,37714,-0.138568790704894,0.0122190527353718,-0.162518134066223,-0.114619447343565,1.13378982920109e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,37671,-0.0332281486708315,0.00293306641533979,-0.0389769588448975,-0.0274793384967655,1.29376093979696e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,-0.0538437247612014,0.0047558358231961,-0.0631651629746658,-0.0445222865477371,1.34025479586004e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,-0.0321378387750727,0.00283842366750997,-0.0377011491633923,-0.0265745283867532,1.38317352057548e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,-0.0564760691317186,0.00499687711686078,-0.0662699482807657,-0.0466821899826715,1.65751540448866e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,-0.0557529100511449,0.00493649982879674,-0.0654284497155865,-0.0460773703867033,1.90361035544388e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,40341,-0.0773698649517117,0.00685745208210877,-0.0908104710326449,-0.0639292588707785,2.06948903871472e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,-0.059033836541561,0.0052346677219709,-0.069293785276624,-0.048773887806498,2.20630339116874e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,-0.030857729956548,0.0027356348646291,-0.036219574291221,-0.025495885621875,2.24608460510812e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,-0.0544317606445798,0.004831250045801,-0.0639010107343497,-0.0449625105548098,2.59554171051307e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,-0.076979866176816,0.00683603167157223,-0.0903784882530975,-0.0635812441005344,2.63880128054552e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,-0.0741316609561137,0.00658644632552858,-0.0870410957541498,-0.0612222261580777,2.83198641798476e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,-0.0400614065737395,0.0035592012487989,-0.0470374410213854,-0.0330853721260937,2.92917188906144e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,-0.0244092786899817,0.00216961502436524,-0.0286617241377375,-0.0201568332422258,2.97085678770363e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,-0.0404810852586462,0.00360050963232134,-0.0475380841379961,-0.0334240863792964,3.24219463453365e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,39980,-0.0585465572928242,0.00521101508984226,-0.068760146868915,-0.0483329677167334,3.55088555691486e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,0.0275567760899831,0.00245663372181232,0.0227417739952309,0.0323717781847352,4.50470139763193e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,0.0299993571935289,0.00267890059372085,0.024748712029836,0.0352500023572217,5.32627825265948e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,37990,-0.0842541637920518,0.00753612240588037,-0.0990249637075773,-0.0694833638765262,6.83362399629648e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,-0.0783684301724038,0.00702121285749527,-0.0921300073730945,-0.0646068529717131,8.38850983072302e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,40341,0.0449984986739379,0.00403738714770737,0.0370852198644315,0.0529117774834443,9.63237522229801e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,40332,0.0302251633972705,0.00271228920198126,0.0249090765613873,0.0355412502331538,9.81438798949304e-29
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,40396,-0.0601415062559852,0.00540190472224425,-0.0707292395115839,-0.0495537730003865,1.10084890633628e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,40192,-0.0844007917406392,0.00758925162251695,-0.0992757249207724,-0.0695258585605059,1.26620635640807e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,37671,-0.0312885913391322,0.00281498715027827,-0.0368059661536777,-0.0257712165245868,1.41936980113247e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,-0.0534190607526548,0.00481400496200142,-0.0628545104781776,-0.043983611027132,1.65460351119366e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,0.0339941946908156,0.00306291630269039,0.0279908787375424,0.0399975106440888,1.7046352086209e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,-0.0271390640852623,0.00244785166772336,-0.0319368533540001,-0.0223412748165246,1.84487912838684e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,-0.0778892306642077,0.00702323451147229,-0.0916547703066934,-0.0641236910217221,1.87267992015433e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,40536,-0.0587427399154642,0.00530012568098198,-0.0691309862501888,-0.0483544935807395,1.91716081795607e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,40379,-0.0510773665640198,0.00461047584575868,-0.0601138992217068,-0.0420408339063328,2.02500428973301e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,38013,-0.031168887218077,0.00281530303854315,-0.0366868811736215,-0.0256508932625324,2.28848928151017e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,-0.108334348015761,0.00978524478885411,-0.127513427801915,-0.0891552682296072,2.29487526215322e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,-0.0807668296037104,0.00730474162896672,-0.0950841231964852,-0.0664495360109356,2.68665386226872e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,40228,-0.0539376140907741,0.00488489565564402,-0.0635120095758364,-0.0443632186057118,3.05061315850542e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,-0.0882480061965043,0.00805143088718747,-0.104028810735392,-0.0724672016576169,7.48375574950725e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,-0.0444468841736355,0.00405609214028828,-0.0523968247686005,-0.0364969435786705,7.64723854253667e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELN,Elastin,37990,-0.036534982841964,0.00333301747740423,-0.0430676970976763,-0.0300022685862517,7.65894704425145e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,-0.0437026545550219,0.00399164863558887,-0.0515262858807761,-0.0358790232292677,8.48203032217622e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NADK,NAD kinase,40359,-0.0555163695207627,0.00507227970867882,-0.0654580377497732,-0.0455747012917522,8.81612881353759e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,40341,-0.0339438279481503,0.0031014033227283,-0.0400225784606978,-0.0278650774356028,8.85569949871276e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,39980,-0.064313495094559,0.00587626928050125,-0.0758309828843415,-0.0527960073047766,8.90787798751262e-28
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,40261,-0.0803950428185696,0.00736630938651328,-0.0948330092161356,-0.0659570764210036,1.24147332152985e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,37681,0.0219037159100598,0.00200740048864032,0.0179692109523248,0.0258382208677949,1.33173521600063e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,40203,-0.0537432238029029,0.00493136086863766,-0.0634086911054327,-0.0440777565003731,1.47359942388934e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,40422,0.0643805896709563,0.00591580262878994,0.052785616518528,0.0759755628233845,1.73827653469805e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,-0.0463115958757793,0.00426009756984042,-0.0546613871126665,-0.0379618046388921,1.98187416197505e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,40357,-0.0263132717935198,0.00242229885665915,-0.0310609775525717,-0.0215655660344678,2.16011815691543e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,40228,-0.0539791462800409,0.00497055729889309,-0.0637214385858714,-0.0442368539742105,2.23954915087015e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,-0.0658798950727272,0.00607897180133841,-0.0777946798033504,-0.0539651103421039,2.86738873810171e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,-0.0855840869526207,0.00789750719638248,-0.10106320105753,-0.0701049728477111,2.99747593041639e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,-0.0588527014706868,0.00544717632074297,-0.0695291670593431,-0.0481762358820306,4.08135657915129e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,-0.0586428408417061,0.00544676107472636,-0.0693184925481697,-0.0479671891352424,6.37528991460112e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,-0.0338539929429621,0.00314585301841141,-0.0400198648590484,-0.0276881210268757,6.47326674502848e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,-0.0229656759097355,0.00213819440397986,-0.0271565369415361,-0.018774814877935,8.45594117377879e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,40516,0.00878937104271541,0.00081885207656599,0.00718442097264607,0.0103943211127848,8.70891652441124e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,40471,-0.0543156239448198,0.00506581403005483,-0.0642446194437272,-0.0443866284459123,9.88934147075835e-27
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,-0.0338818051191402,0.00316733986460879,-0.0400897912537734,-0.0276738189845069,1.29110254367375e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,-0.0551971526134379,0.00516121793539626,-0.0653131397668146,-0.0450811654600612,1.32948625704435e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,40305,-0.0556033017401669,0.00519998172263118,-0.0657952659165241,-0.0454113375638098,1.35272328227418e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,-0.0186616614504222,0.00174788253414784,-0.022087511217352,-0.0152358116834925,1.61872362031348e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,40341,-0.083366292664914,0.00781287349145076,-0.0986795247081575,-0.0680530606216705,1.72193933826314e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.0244661780984731,0.0022943332428512,0.0199692849424848,0.0289630712544615,1.84679293783629e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COCH,Cochlin,37990,-0.0471339879617258,0.00442336621108946,-0.0558037857354611,-0.0384641901879904,2.08720541140074e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NBN,Nibrin,40044,-0.0513052091735139,0.00481903528647113,-0.0607505183349973,-0.0418599000120305,2.23362083302294e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,40214,-0.0232197373631107,0.00218131816205872,-0.0274951209607458,-0.0189443537654756,2.26566123859021e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,40359,-0.0244329800588655,0.00229675918474346,-0.0289346280609627,-0.0199313320567684,2.43127143369195e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,-0.0457435342907569,0.00430337673285248,-0.0541781526871478,-0.0373089158943661,2.65895660028215e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,40422,-0.0475773101455364,0.00448049629720897,-0.056359082888066,-0.0387955374030068,2.9823296803403e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,-0.100258385897762,0.00945668454802076,-0.118793487611883,-0.0817232841836412,3.56515428730031e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,-0.0476589985782337,0.00449510751453189,-0.0564694093067162,-0.0388485878497512,3.67938074143828e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,-0.0360271471176822,0.00340780465047992,-0.0427064442326228,-0.0293478500027415,4.90832932005627e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,-0.0396417231483393,0.00374990653542774,-0.0469915399577777,-0.032291906338901,5.11235843459021e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,-0.121956660905778,0.0115397314602256,-0.14457453456782,-0.0993387872437353,5.30801309402287e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,38013,-0.0653511263630279,0.00620183302776809,-0.0775067190974534,-0.0531955336286024,7.31198184963782e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,37671,-0.0507591718412897,0.00481726330299128,-0.0602010079151526,-0.0413173357674268,7.39097785063097e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,-0.0740350893219516,0.00702786027749598,-0.0878096954658437,-0.0602604831780595,7.5817412537528e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,-0.0866604019470704,0.00823258726210716,-0.1027962729808,-0.0705245309133403,7.92907097586789e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,40489,-0.0407362923589874,0.00387183840005828,-0.0483250956231017,-0.0331474890948732,8.37449857328766e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,40403,-0.0999167223575739,0.00950149509706093,-0.118539652747813,-0.0812937919673345,8.86300591387718e-26
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,40288,-0.0297457459527844,0.00283587007258181,-0.0353040512950447,-0.024187440610524,1.17654343133846e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,-0.0755336294621153,0.0072064770768454,-0.0896583245327323,-0.0614089343914984,1.27614532619816e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,37959,-0.0535428634321825,0.00511205820545172,-0.0635624975148678,-0.0435232293494971,1.42758137852511e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,-0.0781919816558557,0.0074692202096744,-0.0928316532668175,-0.0635523100448939,1.4657325963152e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,-0.0193033563537341,0.00184360781180234,-0.0229168276648666,-0.0156898850426015,1.47872946230498e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,-0.094118537210757,0.00900005535733873,-0.111758645711141,-0.0764784287103731,1.63740664824496e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,0.0261808744924257,0.00250398515751323,0.0212730635836997,0.0310886854011516,1.67049466051706e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,-0.0515536096912791,0.00493937244514221,-0.0612347796837578,-0.0418724396988003,2.02476747586303e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,-0.0316823174469474,0.00303644685245526,-0.0376337532777597,-0.025730881616135,2.09130446292654e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,-0.0660278608824971,0.00633853395601422,-0.078451387436285,-0.0536043343287093,2.50130380143238e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,37959,-0.101939720650137,0.00978604849667802,-0.121120375703626,-0.082759065596648,2.59052070089254e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,40516,-0.0924192032118201,0.00887827979549789,-0.109820631610996,-0.0750177748126443,2.69830473133686e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,40341,-0.0922014260210691,0.00888061116859597,-0.109607423911517,-0.074795428130621,3.59177206598794e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,-0.0928957439674836,0.00895626372840879,-0.110450020875165,-0.0753414670598023,3.99801727963903e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,40014,-0.0390613345822055,0.00377190265348541,-0.046454263783037,-0.0316684053813741,4.74685013994814e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,39980,-0.0599482615608748,0.00579296971171232,-0.071302482195831,-0.0485940409259187,5.12879454061235e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,-0.0273005082163268,0.00264081000068424,-0.0324764958176679,-0.0221245206149857,5.69458451315014e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,-0.031238552302044,0.00302154777970288,-0.0371607859502617,-0.0253163186538264,5.84214206771286e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,-0.0390084325217249,0.00377437070501758,-0.0464061991035593,-0.0316106659398904,5.86389476970217e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAYN,Layilin,40192,-0.0336097837831503,0.00325448865844997,-0.0399885815537122,-0.0272309860125883,6.37560701311713e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,-0.0328206719868142,0.00317856956715038,-0.0390506683384289,-0.0265906756351995,6.47087811612415e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,-0.0707273785432643,0.00685484066031691,-0.0841628662374855,-0.0572918908490432,7.24295358176451e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,-0.0732380403744538,0.00711412456938112,-0.0871817245304408,-0.0592943562184668,9.23634068520662e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,40324,-0.0809403142805638,0.00786614087207386,-0.0963579503898286,-0.0655226781712991,9.37912359236533e-25
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,-0.0684878698439417,0.00665766869515571,-0.0815369004864469,-0.0554388392014365,1.00009754166641e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,-0.0542419429815344,0.00529224755567649,-0.0646147481906603,-0.0438691377724084,1.41862167989237e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,-0.0261230285659579,0.00255069769208135,-0.0311223960424374,-0.0211236610894785,1.53934464221184e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,-0.0604783875566767,0.00591362703781782,-0.0720690965507996,-0.0488876785625538,1.84434638275885e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,-0.0472052491288445,0.00461645867030093,-0.0562535081226344,-0.0381569901350547,1.8835005274275e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,37900,-0.0951225833922729,0.00932148787128764,-0.113392699619997,-0.0768524671645491,2.31848357042729e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,-0.0590987920045231,0.00579367973362684,-0.0704544042824318,-0.0477431797266145,2.35315146813508e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,-0.0931416799733965,0.00913889606019775,-0.111053916251384,-0.075229443695409,2.57169295343338e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,39991,-0.0479535872535829,0.00470784415906403,-0.0571809618053484,-0.0387262127018174,2.73293213825851e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,-0.0553843487750595,0.00543827294090865,-0.0660433637392404,-0.0447253338108785,2.77952700736116e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,0.0508148624166721,0.00499423561569703,0.0410261606099059,0.0606035642234383,3.05186987185063e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,39934,-0.0664712693025928,0.00653339740327744,-0.0792767282130166,-0.053665810392169,3.08529241443349e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,-0.0778418375014005,0.00765204170532436,-0.0928398392438363,-0.0628438357589648,3.22729330192522e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.0388871563954806,0.00382403982009071,-0.0463822744428583,-0.0313920383481028,3.23505591039161e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,37998,-0.0336690834968509,0.00331477627329189,-0.040166044992503,-0.0271721220011988,3.75367641277285e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,-0.0363847248073816,0.00358436313271686,-0.0434100765475067,-0.0293593730672566,3.90013101410111e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,40332,0.0279338832036634,0.00275356042189625,0.0225369047767467,0.03333086163058,4.14613161672795e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,40483,0.0319828592644186,0.00315406443434225,0.0258008929731078,0.0381648255557294,4.33068896776516e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,-0.0611068106966949,0.00602667499589537,-0.0729190936886499,-0.04929452770474,4.53168695135231e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,-0.0491228242068342,0.00484750126425396,-0.058623926684772,-0.0396217217288965,4.63661373403046e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,-0.0585404374140835,0.00578282068830957,-0.0698747659631702,-0.0472061088649967,5.15033989726075e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,40411,-0.0382799575726065,0.00378862431173126,-0.0457056612235997,-0.0308542539216132,6.26454456552384e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELP,P-selectin,40403,-0.0552488159208042,0.00546938791511398,-0.0659688162344276,-0.0445288156071807,6.42308700209706e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,40411,-0.027992947160104,0.0027733779990997,-0.0334287680383394,-0.0225571262818686,6.96570241622018e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,38013,-0.0179680958993538,0.00177993083687314,-0.0214567603396252,-0.0144794314590824,7.07158280342676e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,37942,-0.0613989682439639,0.00608435243284317,-0.0733242990123365,-0.0494736374755913,7.33663420281034e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0352190804306647,0.00349197559165594,0.028374808271019,0.0420633525903103,7.76182676242285e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,40332,-0.0333624495000711,0.0033100642501691,-0.0398501754304025,-0.0268747235697396,8.06117939142601e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,-0.106875207229272,0.0106025191534395,-0.127656144770013,-0.0860942696885305,8.23655835457636e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,40376,-0.0878227117590655,0.00871872503989943,-0.104911412837268,-0.0707340106808626,8.57951991995069e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBIN,Erbin,40305,-0.0975871059191602,0.00969938620156016,-0.116597902874218,-0.0785763089641023,9.66486562361778e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,40516,-0.0435325874954634,0.00432820914465409,-0.0520158774189854,-0.0350492975719413,9.9695604102249e-24
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,40471,-0.021348605254533,0.00212269781993967,-0.0255090929816147,-0.0171881175274512,1.00323055288026e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,40516,-0.0433820822513896,0.00431822720929286,-0.0518458075816036,-0.0349183569211756,1.1207416956393e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,-0.0402970488118017,0.00401092326248532,-0.0481584584062729,-0.0324356392173305,1.15282767222974e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,40471,0.0221387049495828,0.002204452234521,0.0178179785699216,0.026459431329244,1.1620613382311e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,37973,0.0701901520309076,0.00699177006757865,0.0564862826984534,0.0838940213633617,1.24313276949323e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,37628,0.0667698470484983,0.00665107733043984,0.0537337354808362,0.0798059586161604,1.24951189714883e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,40358,-0.0547186161301437,0.00545880584036498,-0.0654178755772591,-0.0440193566830283,1.40589216703028e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,0.0247046387718828,0.00246542718052832,0.0198724014980473,0.0295368760457183,1.45349585851693e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,-0.0387693467999845,0.00387434484627602,-0.0463630626986855,-0.0311756309012835,1.67391977976683e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,40332,-0.0718786086786565,0.00718764031960111,-0.0859663837050746,-0.0577908336522383,1.7827142537849e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,-0.0392583479138597,0.00392669397064372,-0.0469546680963213,-0.031562027731398,1.82661143347237e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,-0.101788745005398,0.010179363828947,-0.121740298110134,-0.0818371919006619,1.84822337715537e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,-0.0557318964708724,0.0055745392600281,-0.0666579934205274,-0.0448057995212173,1.89175417462327e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,40411,-0.0779724936460401,0.00780606056018674,-0.0932723723440061,-0.0626726149480741,2.00098540634301e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,-0.0825698068099293,0.00826820613832939,-0.0987754908410549,-0.0663641227788037,2.04772853828927e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,-0.0522636507638462,0.00523433157443134,-0.0625229406497316,-0.0420043608779608,2.09053370296187e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,40309,-0.0631364639706792,0.00634344482466622,-0.075569615827025,-0.0507033121143334,2.86268832664059e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPSE,Heparanase,37848,-0.08778964986952,0.00881866526496241,-0.105074233788846,-0.0705050659501937,2.88917240567476e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,40489,0.0432867358264891,0.00435102859147043,0.0347587197872071,0.0518147518657711,2.98615113026276e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,40422,-0.0984054002556836,0.00989276599671333,-0.117795221609242,-0.0790155789021255,3.03055528285356e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,-0.0648785043399239,0.00652723936958761,-0.0776718935043156,-0.0520851151755321,3.28011502786853e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,40332,-0.0500677737456404,0.00504239559980083,-0.05995086912125,-0.0401846783700307,3.62419155017739e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,40332,0.0843242106810295,0.00849263595933328,0.0676786442007363,0.100969777161323,3.63377463177122e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,-0.0685766460305953,0.00691012063244013,-0.0821204824701779,-0.0550328095910126,3.83073820859945e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,-0.0560708482753515,0.00566105832939291,-0.0671665226009616,-0.0449751739497414,4.75905427317818e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,40516,-0.0457788534419926,0.00462770575394389,-0.0548491567197226,-0.0367085501642626,5.22869056736912e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,-0.03664783664061,0.00370872633933476,-0.0439169402657061,-0.0293787330155139,5.82085258861527e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,-0.0721750664195659,0.00730235016338625,-0.0864876727398029,-0.0578624600993288,5.85485883423075e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,-0.0542140346612461,0.00549105848756843,-0.0649765092968802,-0.043451560025612,6.35432939279263e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,40341,-0.0761449472053722,0.0077229706926744,-0.0912819697630141,-0.0610079246477304,7.25022967381151e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,37998,-0.026129625046663,0.00265084151985466,-0.0313252744255781,-0.0209339756677478,7.62266767602034e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,40341,-0.0623712219694648,0.00633186818321858,-0.0747816836085732,-0.0499607603303564,7.93915538943605e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,-0.0392450985631651,0.00398353021126106,-0.0470528177772368,-0.0314373793490934,8.06492224378914e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,37966,-0.0416772039938007,0.00423435502158037,-0.0499765398360983,-0.0333778681515032,8.79785501190881e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,-0.0894499885158616,0.00909406844881928,-0.107274362675547,-0.0716256143561758,9.38642993167297e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,40309,-0.0364039423484216,0.0037032286222802,-0.0436622704480908,-0.0291456142487524,9.68044429933058e-23
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,-0.0322624390014349,0.00328591831197058,-0.0387028388928972,-0.0258220391099726,1.08899724663859e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,-0.0258900558598389,0.00263839509723557,-0.0310613102504206,-0.0207188014692572,1.14920385236906e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,-0.0374047594622363,0.00381375038559128,-0.0448797102179952,-0.0299298087064774,1.23965396581914e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,-0.0980369038281673,0.0100203324517671,-0.117676755433631,-0.0783970522227038,1.53020330044434e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,40341,-0.0782113502384687,0.00799801381084613,-0.0938874573077271,-0.0625352431692103,1.60645566361642e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEP,Leptin,40359,-0.0591486229175114,0.00605283624078231,-0.0710121819494448,-0.0472850638855781,1.71699988442179e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASN,Vasorin,40116,0.0254771971782263,0.00260853698434682,0.0203644646889066,0.0305899296675461,1.8108932857313e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,40471,-0.0557477609664834,0.00571502900798219,-0.0669492178221285,-0.0445463041108383,2.03557605461345e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,-0.0409344701260123,0.00419532765411139,-0.0491573123280706,-0.032711627923954,2.04496831805358e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,-0.0905714166962202,0.00928405103751259,-0.108768156729745,-0.0723746766626955,2.07886352385963e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,-0.0769794652487628,0.00790480773410276,-0.0924728884076042,-0.0614860420899214,2.45294717640083e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,0.029177157617824,0.00299758637242818,0.0233018883278648,0.0350524269077833,2.49954000276803e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,40516,0.0359789168063397,0.00369907051347091,0.0287287385999368,0.0432290950127427,2.6789641028589e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,-0.0583336359212943,0.00600085801909226,-0.0700953176387152,-0.0465719542038735,2.90573163458898e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,40411,-0.0478423875384564,0.0049459208050275,-0.0575363923163103,-0.0381483827606025,4.5104977570916e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.0245392440792015,0.00253618556956514,0.0195683203628538,0.0295101677955492,4.51256428138806e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,40147,-0.0424852123665914,0.00439350142556428,-0.0510964751606974,-0.0338739495724854,4.65873979528733e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,40303,-0.0250234514003381,0.00258868183180573,-0.0300972677906774,-0.0199496350099989,4.81445700895947e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,37900,-0.0188185453516743,0.00194890502293983,-0.0226383991966363,-0.0149986915067122,5.46624810033346e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,40305,-0.0860485060080198,0.0089139669654659,-0.103519881260333,-0.0685771307557067,5.47557416458958e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,40029,-0.0351369425155377,0.00364001375726537,-0.0422713694797778,-0.0280025155512976,5.50252261149053e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,-0.0774290894831642,0.00803540161595708,-0.0931784766504401,-0.0616797023158884,6.6315254091143e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,0.101804834361358,0.0105732246495282,0.0810813140482824,0.122528354674433,7.19479655704581e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,-0.0697506679242564,0.00724983012950491,-0.0839603349780861,-0.0555410008704268,7.66504631134633e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,-0.0773873894601998,0.00805117496006802,-0.0931676923819331,-0.0616070865384665,8.16232470788809e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0348301976598467,0.00362646701154618,0.0277223223172161,0.0419380730024772,8.77351990545577e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,40489,0.0311261822866056,0.00324197773540272,0.0247719059252163,0.0374804586479949,9.06106086495126e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,-0.0628169231298853,0.0065439618982678,-0.0756430884504902,-0.0499907578092804,9.45316396113045e-22
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,40341,-0.0832785611283987,0.00869373110844252,-0.100318274100946,-0.0662388481558513,1.11970268128103e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,39961,-0.0321595697609441,0.00335959237079292,-0.0387443708076982,-0.02557476871419,1.19806714529049e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,-0.0336403754911133,0.00351392592184108,-0.0405276702979218,-0.0267530806843048,1.21696055775574e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,37900,-0.03232495584522,0.0033777167956915,-0.0389452807647753,-0.0257046309256646,1.25206322900872e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,0.0342733379248234,0.00358284739056958,0.027250957039307,0.0412957188103397,1.27328105187753e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,39980,-0.0344927661042037,0.00360701227994175,-0.0415625101728895,-0.0274230220355178,1.31575661883687e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,40299,-0.0256584049843583,0.00268728193845207,-0.0309254775837244,-0.0203913323849922,1.50975443932444e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,37781,-0.0217750879617933,0.00228123648948436,-0.0262463114811826,-0.017303864442404,1.590046391456e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,40536,-0.0223036092446896,0.0023379207497649,-0.0268859339142288,-0.0177212845751504,1.62939158434706e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0233190380007385,0.00244529638146439,0.0185262570930682,0.0281118189084087,1.6898797428069e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,-0.0801933982973883,0.00841058125963331,-0.0966781375662696,-0.063708659028507,1.75460223169498e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,-0.0401452669347455,0.00422052446517176,-0.0484174948864821,-0.0318730389830088,2.14064181146126e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,37942,-0.0675586515629331,0.00711663343767423,-0.0815072531007746,-0.0536100500250916,2.61471661065276e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,40411,-0.0518141655192125,0.00546361147718694,-0.0625228440144989,-0.0411054870239261,2.79756861570413e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0271449280168343,0.002866153651522,-0.0327625891738175,-0.0215272668598512,3.23189766879158e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,37970,-0.0412420633088709,0.00435682779066665,-0.0497814457785775,-0.0327026808391643,3.37956015893575e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,-0.0613958632661563,0.00648611736322278,-0.0741086532980729,-0.0486830732342396,3.40606702275044e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,37628,-0.0662286531185836,0.00700185638467455,-0.0799522916325457,-0.0525050146046215,3.63812804025584e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,0.018453999742365,0.00195226427493617,0.0146275617634901,0.0222804377212399,3.85558121290288e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,37990,-0.0669473778480683,0.00708320006623372,-0.0808304499778864,-0.0530643057182502,3.87793043693295e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,40332,-0.0351437027917868,0.00372009822262844,-0.0424350953081386,-0.0278523102754351,3.96245355349124e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,0.0758916093713977,0.00804034365565802,0.0601325358063079,0.0916506829364874,4.27825162913927e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,-0.0305182794508655,0.00323415983101151,-0.0368572327196481,-0.024179326182083,4.4853398387779e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,37934,-0.0752911343368389,0.00797995766319797,-0.0909318513567069,-0.0596504173169709,4.53951163746366e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,40536,-0.0378466729948169,0.00401703058605671,-0.045720052943488,-0.0299732930461458,5.0351633451999e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,-0.102047198152025,0.0108352885311496,-0.123284363673078,-0.0808100326309716,5.33362825851963e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,40312,-0.0545877702805504,0.00579821922135371,-0.0659522799544037,-0.0432232606066971,5.38862625423202e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,37628,-0.0551270163173065,0.00585675901681874,-0.0666062639902713,-0.0436477686443418,5.63530700109699e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,-0.0848460274391634,0.00902030202004298,-0.102525819398448,-0.0671662354798791,5.83297991376209e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,-0.0260078449733958,0.0027699199431431,-0.0314368880619563,-0.0205788018848353,6.98842472297286e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALB2,Calretinin,39961,-0.0280194964596277,0.00298670518905844,-0.0338734386301823,-0.0221655542890732,7.39288588812707e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,-0.0761526354475671,0.00811793379104699,-0.0920637856780192,-0.060241485217115,7.40884442350818e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,37901,-0.0253311530366263,0.00270122919145647,-0.030625562251881,-0.0200367438213716,7.81009144479577e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,-0.0513266243464838,0.00547744985512276,-0.0620624260625244,-0.0405908226304432,8.19237742220127e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,-0.0440369288752506,0.00470761903223397,-0.0532638621784292,-0.034809995572072,9.78097144722273e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,-0.110696386396792,0.0118387607517893,-0.133900357470299,-0.087492415323285,9.87006515706111e-21
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,37919,-0.0531558982966923,0.00568484108759893,-0.0642981868283862,-0.0420136097649984,1.00832262851952e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,37990,-0.0890747680314755,0.00953090818566771,-0.107755348075384,-0.0703941879875668,1.0518369204682e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,-0.0742727092055758,0.00795084927658614,-0.0898563737876847,-0.058689044623467,1.07362277527027e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,40228,0.037549591248735,0.00402333322884886,0.0296638581201912,0.0454353243772788,1.16379720908908e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,-0.0421404288128212,0.00452606451662319,-0.0510115152654027,-0.0332693423602398,1.46534221138354e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,40203,-0.0401726361032741,0.00431814713009878,-0.0486362044782677,-0.0317090677282805,1.53822212743755e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,-0.121356963884195,0.0130455159819157,-0.14692617520875,-0.0957877525596402,1.54612810179073e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,-0.0393429823970916,0.00423305676845547,-0.0476397736632643,-0.0310461911309188,1.66972807963943e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,39980,-0.0367652264039535,0.00395710406974869,-0.0445211503806609,-0.0290093024272461,1.72819793589164e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,-0.0413878618016502,0.00445501856104774,-0.0501196981813038,-0.0326560254219966,1.73597245450071e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,37998,-0.036087593518817,0.0038838952498257,-0.0437000282084754,-0.0284751588291587,1.7485293105407e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,-0.020391095626014,0.002196306252353,-0.0246958558806259,-0.0160863353714021,1.87234766562589e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,37987,-0.0214245420170043,0.002308208338544,-0.0259486303605506,-0.0169004536734581,1.91451598204172e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,40411,-0.0490467676306461,0.00528547239179473,-0.0594062935185637,-0.0386872417427284,1.91604353452307e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,-0.0572301835865769,0.00617497758073039,-0.0693331396448085,-0.0451272275283453,2.17951657636048e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,40332,0.0258006064831894,0.00278515593237636,0.0203417008557317,0.031259512110647,2.22425267610525e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,40341,-0.0796803027590113,0.00860851024435044,-0.0965529828379382,-0.0628076226800845,2.38773038371837e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,-0.0266154196336392,0.0028758865672489,-0.0322521573054471,-0.0209786819618314,2.41507272935556e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,37901,-0.0724348527283204,0.00782573630956131,-0.0877732958950605,-0.0570964095615802,2.43936038232299e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,0.0318805339823141,0.00344788829535937,0.0251226729234097,0.0386383950412185,2.61056484494268e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,40290,-0.0383579257311821,0.00414972967414367,-0.0464913958925037,-0.0302244555698605,2.68367624246666e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,-0.0474663600660991,0.00513885090856197,-0.0575385078468806,-0.0373942122853176,2.85772322704225e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BGN,Biglycan,39956,0.106462497117332,0.0115343913608701,0.0838550900500268,0.129069904184637,3.0491626548044e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,-0.0611297937571154,0.00662619717332301,-0.0741171402168285,-0.0481424472974023,3.17373460698679e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,-0.0331049451279156,0.00359149329957832,-0.0401442719950891,-0.0260656182607421,3.41161489565803e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,40471,-0.0309484003273055,0.00335763521467178,-0.0375293653480622,-0.0243674353065488,3.41700873218858e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,-0.0628371049527262,0.00681824159308955,-0.0762008584751818,-0.0494733514302707,3.46145687013528e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,40489,-0.0960195777363082,0.0104273006030917,-0.116457086918368,-0.0755820685542484,3.70839542134707e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,40359,0.0267652201705583,0.00290864343155489,0.0210642790447107,0.0324661612964059,3.94287457300631e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,-0.02127776928448,0.00231386497932844,-0.0258129446439638,-0.0167425939249963,4.26013408971385e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,39924,-0.0592910954864978,0.00645049564457221,-0.0719340669498594,-0.0466481240231363,4.34902869608986e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,-0.0398252618843116,0.00433640663278278,-0.0483246188845659,-0.0313259048840574,4.65930989667661e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,-0.0896140909604971,0.00978178782107373,-0.108786395089802,-0.0704417868311926,5.87493721918023e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,40266,-0.0335019695009601,0.00365948204963253,-0.0406745543182399,-0.0263293846836804,6.09687449203796e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,37562,-0.0589242878027837,0.00644035087644317,-0.0715473755206123,-0.0463012000849551,6.57053570678249e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,40228,-0.053324619688981,0.00583409267297477,-0.0647594413280116,-0.0418897980499505,6.98002344845821e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,37936,-0.0655869291252156,0.0071749668325498,-0.0796498641170132,-0.051523994133418,7.05576473577638e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,-0.0587241196291864,0.00642967968837187,-0.0713262918183952,-0.0461219474399775,7.42127283102441e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,-0.0672657006677134,0.00737858494885971,-0.0817277271674784,-0.0528036741679483,8.88121443858472e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,37977,0.0290893772398678,0.00319194984024649,0.0228331555529847,0.0353455989267509,9.09625952917333e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,-0.0349025270207222,0.00383099284319466,-0.0424112729933837,-0.0273937810480607,9.17706422161472e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,-0.0260745515211332,0.00286424150319748,-0.0316884648674002,-0.0204606381748661,9.96129168510905e-20
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,40376,-0.0582649667389004,0.00640932302753511,-0.0708272398728692,-0.0457026936049316,1.09824140055961e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,-0.0671287850236973,0.00738536176707225,-0.0816040940871589,-0.0526534759602356,1.11171473711377e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,-0.0341884242126004,0.00376313242866904,-0.0415641637727917,-0.0268126846524091,1.17891046451082e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,0.0152461234393846,0.00167872166304245,0.0119558289798214,0.0185364178989478,1.18925879769511e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,40204,-0.044299742790766,0.00487800281696859,-0.0538606283120244,-0.0347388572695076,1.19525686173038e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,37959,-0.0676115986205596,0.00744469034634303,-0.0822031916993919,-0.0530200055417272,1.21367970055407e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,-0.0403496641738587,0.00445109245885841,-0.0490738053932212,-0.0316255229544962,1.41477150619262e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,-0.0649667594912065,0.00717185259701422,-0.0790235905813543,-0.0509099284010586,1.4732231860305e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,-0.0957352002213397,0.0105709035899955,-0.116454171257731,-0.0750162291849486,1.50250359457088e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,37990,-0.0705369091887209,0.00778816992713599,-0.0858017222459074,-0.0552720961315343,1.52306259617966e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,40359,-0.103415540860463,0.0114378530860054,-0.125833732909033,-0.080997348811892,1.72000507352384e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,-0.0616178582009472,0.00681849067984482,-0.0749820999334431,-0.0482536164684514,1.79209038199052e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,40341,-0.0333291136737955,0.00369040114086471,-0.0405622999098903,-0.0260959274377006,1.88780224431705e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,40516,-0.0321233290086134,0.00356463922072907,-0.0391100218812424,-0.0251366361359844,2.25378449898828e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,40359,-0.0332163021413557,0.00369110337678091,-0.0404508647598463,-0.0259817395228652,2.53023949830433e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,-0.064743016521346,0.00720046708861206,-0.0788559320150256,-0.0506301010276664,2.75921425104868e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,-0.0383252548871754,0.00426385448685558,-0.0466824096814123,-0.0299681000929384,2.84716394775406e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0301440446452355,0.00336057077177958,-0.0367307633579235,-0.0235573259325476,3.28951277207137e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,37900,-0.0331095656568319,0.00369468685830003,-0.0403511518991,-0.0258679794145639,3.62315759591189e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,37882,-0.0305935129153655,0.00341452218291297,-0.0372859763938749,-0.0239010494368561,3.67564294540027e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,-0.0502412078312488,0.00560916722692614,-0.061235175596024,-0.0392472400664735,3.70324314095867e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,-0.0875871039066998,0.00980413079832279,-0.106803200271412,-0.0683710075419871,4.56433092686974e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,0.0280079074062385,0.00313445073019093,0.0218643839750642,0.0341514308374127,4.57043128595553e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,37441,-0.0609090123839541,0.00681916823939093,-0.0742745821331603,-0.0475434426347478,4.73979917644134e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,-0.0602681061874972,0.00675558548236569,-0.0735090537329339,-0.0470271586420604,5.10388911387781e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,37567,-0.0364044848057517,0.00408179946411041,-0.0444048117554081,-0.0284041578560953,5.33448669404895e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,-0.045535908717811,0.00511109563190414,-0.0555536561563431,-0.0355181612792788,5.81745589456815e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,40471,-0.0561808907399397,0.00631083861303522,-0.0685501344214887,-0.0438116470583907,6.04708339718722e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,-0.0309450342138268,0.00347842116447289,-0.0377627396961937,-0.02412732873146,6.51707842262077e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,-0.033715270036192,0.00379084418875846,-0.0411453246461586,-0.0262852154262254,6.65971798352695e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,40228,-0.0292191966036107,0.00329082585930243,-0.0356692152878434,-0.0227691779193779,7.46166782915609e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNST,Consortin,40359,-0.0907552135408425,0.0102218634060705,-0.110790065816741,-0.0707203612649443,7.48536711535501e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,-0.0667102079543322,0.00751668616352194,-0.0814429128348352,-0.0519775030738292,7.88713447682621e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,37598,-0.0457810660325019,0.00515967642998713,-0.0558940318352767,-0.0356681002297271,8.04128347011504e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,37598,0.0255702437711685,0.0028851745461573,0.0199153016607002,0.0312251858816368,8.80941587612563e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,-0.0537365710102859,0.00607246128609054,-0.0656385951310234,-0.0418345468895485,9.72527955639075e-19
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,40536,0.0245966041715445,0.002780964758219,0.0191459132454352,0.0300472950976537,1.0120874995412e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,-0.081369746591064,0.00920268651567919,-0.0994070121617952,-0.0633324810203328,1.03777658399774e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,37541,-0.0329200452686358,0.0037291512944857,-0.0402291818058278,-0.0256109087314439,1.20228664686691e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,37942,-0.0229323221230118,0.00259961345785208,-0.0280275645004018,-0.0178370797456217,1.26729695071768e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,37959,-0.0459676276691567,0.00521229449338209,-0.0561837248761855,-0.0357515304621278,1.29392756467253e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,-0.0293644306905135,0.00333068392577103,-0.0358925711850247,-0.0228362901960023,1.30628941865533e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,40042,-0.0495213821187408,0.00561856567664151,-0.0605337708449582,-0.0385089933925235,1.33453896780344e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,-0.0546784844820125,0.00620397926187964,-0.0668382838352966,-0.0425186851287285,1.33743311008952e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,40185,-0.0484679630605477,0.00549996681490088,-0.0592478980177535,-0.037688028103342,1.35090085721211e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,40349,-0.0355200646259157,0.00404006880798916,-0.0434385994895745,-0.027601529762257,1.61814611392942e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,39961,-0.0518078348310885,0.00589256212910423,-0.0633572566041328,-0.0402584130580442,1.62019943796454e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,-0.0611381768067423,0.00695413086057006,-0.0747682732934596,-0.047508080320025,1.64989458074252e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,37849,0.0242875460111361,0.00276304135324169,0.0188719849587824,0.0297031070634898,1.67370316337067e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PI3,Elafin,40074,-0.0446036366927596,0.00507770335927557,-0.0545559352769397,-0.0346513381085795,1.73572418013751e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,-0.0651782607399215,0.00743400103617096,-0.0797489027708165,-0.0506076187090264,2.01182656632404e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KAZN,Kazrin,37901,-0.0863918386462856,0.009860712688131,-0.105718835515022,-0.0670648417775488,2.16032188670462e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.0240853376512109,0.00275071075947862,0.0186939445626329,0.029476730739789,2.22034045195919e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0371958096120624,0.00425037625947791,0.0288650721434857,0.0455265470806391,2.31932881936825e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,-0.0301418873380699,0.00344394921918518,-0.0368920278076729,-0.023391746868467,2.34655818471047e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,40502,-0.0439808424418188,0.00503192228874708,-0.0538434101277631,-0.0341182747558745,2.54996394665521e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,40453,-0.0486430704420097,0.00556880303819102,-0.0595579243968641,-0.0377282164871553,2.67592021966902e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,40346,-0.0427573593769283,0.00490097967280889,-0.0523632795356337,-0.0331514392182228,2.94132595421e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,-0.0558978636524015,0.00640638095591492,-0.0684543703259948,-0.0433413569788083,2.96843489855153e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BSG,Basigin,40502,-0.0166798655509265,0.00191388846842792,-0.0204310869490453,-0.0129286441528078,3.18272322733457e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,40263,-0.0701750643002753,0.00805498865679206,-0.0859628420675878,-0.0543872865329629,3.27714320226691e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.0175285959454012,0.00201311963040454,0.0135828814698083,0.0214743104209941,3.47215876655042e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,37598,-0.0467749669382432,0.00537332402474065,-0.0573066820267349,-0.0362432518497515,3.54978061887415e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,-0.0531646986124349,0.00611757509851167,-0.0651551458055178,-0.0411742514193521,4.02923327415836e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,40442,-0.0602555334585823,0.00693707325975397,-0.0738521970477001,-0.0466588698694645,4.11154792148294e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,40471,-0.107721720075149,0.0124083896125764,-0.132042163715799,-0.0834012764344993,4.28185568749927e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,37942,-0.0672381700987385,0.00774651115312467,-0.0824213319588628,-0.0520550082386141,4.41488440939379e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,40403,0.0250643270667029,0.00289035732366332,0.0193992267123228,0.030729427421083,4.66106132513592e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,-0.0632405394634934,0.00729755391181877,-0.0775437451306582,-0.0489373337963286,4.99486907362617e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,-0.0337995953233078,0.00390226305250745,-0.0414480309062224,-0.0261511597403932,5.17974171565784e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,-0.0282297349437852,0.00325990714784548,-0.0346191529535623,-0.021840316934008,5.18846998504972e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,40516,-0.0278814348570303,0.00322278021701067,-0.0341980840823713,-0.0215647856316894,5.5637984550256e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,37562,-0.0385665622690128,0.00446018942215256,-0.0473085335364318,-0.0298245910015938,5.90418163016163e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,40396,-0.0240471450034671,0.00278439064494873,-0.0295045506675666,-0.0185897393393676,6.34230216404965e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,-0.054841717056446,0.00635288556410696,-0.0672933727620957,-0.0423900613507964,6.57378940559357e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWC2,Brorin,40167,-0.0318018119868405,0.00368455633759027,-0.0390235424085174,-0.0245800815651635,6.65050681956438e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,37901,-0.0574959215898352,0.00667113335452722,-0.0705713429647086,-0.0444205002149618,7.52667956665081e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,-0.0434137221089773,0.00504756104734606,-0.0533069417617755,-0.033520502456179,8.795569427069e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,-0.029148641721236,0.00339316237925233,-0.0357992399845706,-0.0224980434579015,9.63672753096849e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C3,Complement C3,37360,-0.0385599382686488,0.00449024696699251,-0.0473608223239541,-0.0297590542133435,9.90061983783913e-18
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,40332,0.0320727129184438,0.0037427637014605,0.0247368960635812,0.0394085297733064,1.13611096665224e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,0.0275187097856377,0.00321466057945967,0.0212179750498967,0.0338194445213786,1.22654140860281e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,37598,-0.0360150447238527,0.0042155756433467,-0.0442775729848122,-0.0277525164628932,1.44658743747755e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,40305,-0.0731043889315573,0.00858991208213461,-0.0899406166125411,-0.0562681612505734,1.88511465852185e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,40139,-0.0618041595968225,0.00726509258756463,-0.0760437410684491,-0.0475645781251958,1.94419385225172e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,37901,-0.0476686419268343,0.00560240145931024,-0.0586493487870824,-0.0366879350665863,1.94497187163041e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,37882,-0.0373282206322436,0.00438847395124872,-0.0459296295766911,-0.0287268116877961,1.98979301212437e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.0507678857822012,0.00597361897936995,0.0390595925826361,0.0624761789817663,2.08617494305195e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,37628,-0.043420612578548,0.00510860564516014,-0.0534334796430618,-0.0334077455140341,2.10718048667547e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,-0.0488465411657352,0.00574998192402562,-0.0601165057368254,-0.037576576594645,2.18275622556633e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,40359,-0.0341625418132602,0.00402713951234886,-0.042055735257464,-0.0262693483690564,2.38383948963792e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPARC,SPARC,40411,-0.0568701135191207,0.00670466059122366,-0.070011248277919,-0.0437289787603223,2.40167259656258e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,40198,0.0272442055451102,0.00321645995411806,0.0209399440350388,0.0335484670551816,2.66264289972996e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,-0.0579212228219805,0.00684706796988105,-0.0713414760429474,-0.0445009696010137,2.97321076203477e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,37562,-0.0347962434987609,0.00411608905662431,-0.0428637780497445,-0.0267287089477772,3.11774089384443e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,40359,-0.0456665999078992,0.00540490341515568,-0.0562602106016043,-0.0350729892141941,3.18652876070696e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,40332,-0.0268533444698023,0.00317854673479932,-0.033083296070009,-0.0206233928695956,3.2086956376025e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGRN,Neugrin,37942,-0.0176870946697323,0.00209358987233714,-0.0217905308195131,-0.0135836585199515,3.25823307143182e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,40411,-0.0550053181523738,0.00651225902677417,-0.0677693458448512,-0.0422412904598964,3.25927133333972e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,40250,-0.0229815093074568,0.00272336732782486,-0.0283193092699935,-0.0176437093449201,3.4857873811206e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,-0.0454939303931118,0.00538996334038426,-0.056058258540265,-0.0349296022459587,3.48821091342003e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,40341,-0.0657616427851898,0.00780960739126024,-0.0810684732720598,-0.0504548122983197,4.06169783775351e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,-0.0525626336056926,0.00624492570322206,-0.0648026879840078,-0.0403225792273774,4.19056004564068e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,-0.0305331746475084,0.00363278129593458,-0.0376534259875401,-0.0234129233074766,4.63918816869027e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,-0.02166367529844,0.00257764131957993,-0.0267158522848167,-0.0166114983120634,4.72411035732199e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,37987,-0.0374297035512865,0.00446052338669981,-0.0461723293892182,-0.0286870777133549,5.27985000039445e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,37990,-0.051150305498246,0.00610090652786977,-0.0631080822928708,-0.0391925287036213,5.61491030654905e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,-0.0427753332234271,0.00511593827099536,-0.052802572234578,-0.0327480942122762,6.71340565882386e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,40044,-0.0900665393813331,0.0107777180848988,-0.111190866827735,-0.0689422119349314,6.98606085869689e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,37959,-0.0437576865386619,0.00523643441793692,-0.0540210979978182,-0.0334942750795055,7.09341734319589e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,-0.0217063099883772,0.00259811975800508,-0.0267986247140672,-0.0166139952626873,7.2027170199437e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TF,Serotransferrin,38013,-0.017359258612203,0.00207788142979048,-0.0214319062145924,-0.0132866110098137,7.21640514403881e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,-0.049133981003859,0.00588197979470292,-0.0606626614014767,-0.0376053006062413,7.30157181730127e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,-0.0377434397937555,0.00452015333441106,-0.0466029403292012,-0.0288839392583098,7.48199955260015e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,39665,-0.0178893131239912,0.00214393307564962,-0.0220914219522645,-0.013687204295718,7.78289602319733e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,-0.0591288499367133,0.00708779232815173,-0.0730209228998907,-0.0452367769735359,7.88661599578686e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,40332,-0.0196827920820629,0.00235990572857364,-0.0243082073100673,-0.0150573768540586,7.99893554594583e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,39961,-0.0566880836942757,0.0068060940224637,-0.0700280279783046,-0.0433481394102469,8.8265872082347e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,-0.0517809763166595,0.00622720121038942,-0.0639862906890228,-0.0395756619442962,9.90484131399341e-17
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,37987,-0.0572979091851367,0.00689556586042968,-0.0708132182715788,-0.0437826000986945,1.05289133812654e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,-0.0487734617702355,0.00587096084059662,-0.0602805450178049,-0.0372663785226661,1.06894244039546e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,-0.037992696873678,0.00458039129132193,-0.046970263804669,-0.029015129942687,1.17490329260947e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,-0.0698917158661588,0.00842650081648751,-0.0864076574664743,-0.0533757742658433,1.19811132130189e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOC,Myocilin,40332,0.0360595741192717,0.00435040027615186,0.0275327895780141,0.0445863586605294,1.23465315388683e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,-0.0505887229336394,0.00610925310646621,-0.0625628590223132,-0.0386145868449656,1.33966929272143e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,40309,-0.0899884935793597,0.0108827572200559,-0.111318697730669,-0.0686582894280501,1.45815923008927e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,-0.0804922139223724,0.0097508974999596,-0.0996039730222933,-0.0613804548224516,1.66170261617587e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,37628,-0.0324856546487838,0.00393996481809613,-0.0402079856922522,-0.0247633236053154,1.8045725697631e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,0.0187490535625155,0.00227528005905847,0.0142895046467609,0.0232086024782701,1.84982425318536e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,-0.0558929371254509,0.00678579607836305,-0.0691930974390424,-0.0425927768118593,1.9347218072477e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,40192,-0.0504421714465626,0.00612547395887947,-0.0624481004059663,-0.0384362424871588,1.93827760469478e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,40332,-0.0185541063484287,0.00225399630846979,-0.0229719391130295,-0.0141362735838279,1.98874777065572e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,-0.0392873881051793,0.00477508834506707,-0.0486465612615107,-0.0299282149488478,2.05704275427855e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,37778,-0.085598344591066,0.0104090901014764,-0.10600016118996,-0.0651965279921722,2.15973715001081e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,-0.0633598439505463,0.00771595651926536,-0.0784831187283064,-0.0482365691727861,2.3867926999388e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,-0.0511450254424728,0.00624121610255536,-0.0633778090034813,-0.0389122418814643,2.73637523721444e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,-0.0444474072027669,0.00543421563645648,-0.0550984698502216,-0.0337963445553122,3.07736596122018e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,-0.0515411968184472,0.00630824921478144,-0.0639053652794188,-0.0391770283574756,3.3077763887992e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,37628,0.0330174732832777,0.00404128453143778,0.0250965556016597,0.0409383909648958,3.36218296745701e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,-0.0613614157769299,0.00751911067811364,-0.0760988727060327,-0.0466239588478272,3.57724956046472e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,37934,-0.0755066412184794,0.00925557916605366,-0.0936475763839445,-0.0573657060530142,3.7070348220126e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,39980,-0.0414550117104977,0.00508681148227735,-0.0514251622157613,-0.0314848612052341,3.93053431356506e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,-0.0596391460712761,0.0073206681547048,-0.0739876556544975,-0.0452906364880547,4.06849697606951e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,-0.0464193432146869,0.00570519438570713,-0.0576015242106729,-0.0352371622187009,4.38102985868166e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,-0.0702918779286789,0.00864598294905288,-0.0872380045088225,-0.0533457513485352,4.66485300207708e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGN,Mimecan,40332,-0.0314080874549666,0.00386435068911892,-0.0389822148056397,-0.0238339601042935,4.69699454466888e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,40192,0.0391651098324046,0.00481893452453074,0.0297199981643244,0.0486102215004849,4.71196828881281e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,40341,-0.0640711198042374,0.00790296842682313,-0.0795609379208107,-0.048581301687664,5.55362389829374e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,37671,-0.0542013387155536,0.00668905154726127,-0.0673118797481857,-0.0410907976829215,5.83060408446128e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,-0.0405557101556225,0.00501581656032053,-0.0503867106138507,-0.0307247096973942,6.72147168635454e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,37931,-0.0494409775409101,0.00611907533732053,-0.0614343652020583,-0.0374475898797618,7.03531639238966e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,-0.0510813054491621,0.00632547662618729,-0.0634792396364892,-0.038683371261835,7.29760779363925e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,-0.027249916143371,0.0033797857920286,-0.033874296295747,-0.0206255359909949,8.00640704969058e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,37987,-0.0482272469759947,0.00598523153908211,-0.0599583007925956,-0.0364961931593937,8.42121659527082e-16
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,37598,-0.0333595940364723,0.0041521739490901,-0.0414978549766889,-0.0252213330962557,1.02140659212189e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,37562,-0.0454556559199465,0.00565830413522933,-0.056545932024996,-0.034365379814897,1.02833887902693e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,37900,-0.0625684170620004,0.0077964815178721,-0.0778495208370297,-0.0472873132869711,1.09708181809337e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,-0.0457234800062963,0.00569931934787583,-0.0568941459281329,-0.0345528140844596,1.1082734431836e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,37628,-0.0584486020750636,0.0072855624164874,-0.072728304411379,-0.0441688997387483,1.12307243963617e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,37572,-0.0373680374909003,0.00465894739620286,-0.0464995743874579,-0.0282365005943427,1.14015365403729e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,-0.0328739233645566,0.00410040372947307,-0.0409107146743239,-0.0248371320547894,1.1724049917428e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,40332,-0.0425583862682061,0.00531132001438648,-0.0529685734964036,-0.0321481990400086,1.1989194540269e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,-0.0238564928740564,0.00297956874469405,-0.0296964476136567,-0.0180165381344561,1.27665278405469e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,-0.0470486722378756,0.00588847491932168,-0.0585900830797461,-0.0355072613960051,1.46208297822387e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,-0.0292856946365115,0.00366620912814698,-0.0364714645276796,-0.0220999247453435,1.48236293051503e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,-0.0601276347148549,0.00753305294954492,-0.0748924184959629,-0.0453628509337468,1.55740859713102e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,37810,0.0811645168154097,0.0101756868173947,0.0612201706533161,0.101108862977503,1.62972602777113e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,-0.0864379720223313,0.0108378998989904,-0.107680255824352,-0.0651956882203102,1.63873811857299e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,37628,-0.0677884784355139,0.00851589899250857,-0.0844796404608307,-0.0510973164101971,1.85716232749531e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,-0.0695274735147583,0.00873863039894375,-0.0866551890966881,-0.0523997579328286,1.8931899545169e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,37671,-0.0862971598911272,0.0108478383178727,-0.107558922994158,-0.0650353967880968,1.9326363695475e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,-0.0223524262388524,0.00281105021983519,-0.0278620846697294,-0.0168427678079754,1.96546685104959e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,37598,-0.0304637225284795,0.00383157131943943,-0.0379736023145807,-0.0229538427423782,2.00511504886123e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,37484,-0.0413369616850056,0.00520221459693025,-0.0515333022949889,-0.0311406210750223,2.08335275066743e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,40471,-0.0210912611713907,0.00265537822994571,-0.0262958025020843,-0.0158867198406971,2.10633294728581e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,-0.048726580033093,0.00613364538522972,-0.0607485249881432,-0.0367046350780427,2.10893368040971e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,39961,-0.0506176855266679,0.00637279499576383,-0.063108363718365,-0.0381270073349708,2.11193814894706e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,-0.0264563482254797,0.00333727815470029,-0.0329974134086923,-0.0199152830422672,2.41095422583273e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,37628,-0.0374309753442779,0.00472453552593816,-0.0466910649751167,-0.0281708857134391,2.51023492924679e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,-0.0324510388123309,0.00409852781794364,-0.0404841533355005,-0.0244179242891614,2.57827754265853e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,37628,-0.0383110889015649,0.00483909892439126,-0.0477957227933718,-0.028826455009758,2.62720882890577e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,39934,-0.067048838518335,0.00847859962780353,-0.0836668937888299,-0.0504307832478401,2.79098735350888e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,-0.0772386574420691,0.00978230067464017,-0.0964119667643638,-0.0580653481197743,3.07350014887368e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,-0.0635622009509623,0.00805241220482501,-0.0793449288724193,-0.0477794730295052,3.16933741699428e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,40341,-0.0364134894179041,0.00462542511378512,-0.0454793226409229,-0.0273476561948852,3.70044957590742e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,40228,-0.0720788180674733,0.00915592012310047,-0.0900244215087502,-0.0541332146261964,3.70475874805572e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,-0.0504182579296379,0.00640815380043902,-0.0629782393784984,-0.0378582764807774,3.84537599142986e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,40444,0.0316392490216532,0.00402320741518007,0.0237537624879002,0.0395247355554061,3.95093824650277e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,-0.0241507333975345,0.00307295585255731,-0.0301737268685469,-0.0181277399265222,4.11553885319682e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,-0.0982611649101218,0.0125092263197059,-0.122779248496745,-0.0737430813234983,4.24747481559482e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREH,Trehalase,37998,-0.0555380754174355,0.00707280910086757,-0.0694007812551359,-0.041675369579735,4.38935145373172e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,39925,-0.0332394524376852,0.00423463973105372,-0.0415393463105505,-0.0249395585648199,4.45221026851176e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,40396,-0.0427755861882852,0.00545138200408265,-0.0534602949162872,-0.0320908774602832,4.53934946745434e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,-0.0509737975839507,0.00649515988633586,-0.063704310961169,-0.0382432842067324,4.54520936021361e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,-0.0543676040979434,0.00693311374555099,-0.0679565070392233,-0.0407787011566634,4.72476410875845e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,-0.0627596308561679,0.0080061164303411,-0.0784516190596365,-0.0470676426526994,4.88936574989171e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,-0.0429161235294792,0.00549294662229648,-0.0536822989091803,-0.0321499481497781,5.94244866013508e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,-0.0470011222283337,0.00601733686891795,-0.0587951024914129,-0.0352071419652545,6.03716110671637e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,-0.0218129580137901,0.00279303399265682,-0.0272873046393975,-0.0163386113881828,6.08779005982291e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,37572,-0.0304697539925527,0.00390320260575559,-0.0381200310998337,-0.0228194768852718,6.33176443050758e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,37671,-0.0403168892890425,0.00516543233855563,-0.0504411366726115,-0.0301926419054734,6.38922836713323e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,40374,-0.0219005214964349,0.0028068626786141,-0.0274019723465185,-0.0163990706463512,6.44462536761124e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,-0.0664787144995046,0.00853910437695295,-0.0832153590783323,-0.0497420699206768,7.47884597472241e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,37900,-0.0357228538473678,0.00458988146629822,-0.0447190215213123,-0.0267266861734232,7.60034709876904e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,-0.0275973763041466,0.00354667735631756,-0.034548863922529,-0.0206458886857641,7.62430877320131e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,0.0327842023488143,0.00421346812621279,0.0245258048214372,0.0410425998761914,7.64539364581201e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,-0.0530529412588714,0.00682449644409836,-0.0664289542893042,-0.0396769282284386,8.15936612294418e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,37901,-0.0768134096440292,0.00989244257915641,-0.0962025970991758,-0.0574242221888827,8.76278612704712e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,-0.0329878428213386,0.00424920228239336,-0.0413162792948296,-0.0246594063478476,8.8832261207116e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,39980,-0.071946794654253,0.00927043693298266,-0.090116851042899,-0.053776738265607,8.95699932652278e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,40305,-0.0439059303116477,0.00566599312625365,-0.0550112768391048,-0.0328005837841905,9.81877241482924e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,40228,-0.0530286025378501,0.00684377688514248,-0.0664424052327294,-0.0396147998429709,9.86676384425474e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,37671,-0.0544865038210418,0.00703166419362681,-0.0682685656405504,-0.0407044420015333,9.9564359925224e-15
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.0201819278631412,0.0026069766591903,-0.0252916021151542,-0.0150722536111283,1.0415685915682e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,-0.0247970106251292,0.00320465403266595,-0.0310781325291545,-0.018515888721104,1.07138519647337e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,37671,-0.0499168162338228,0.00646300283119787,-0.0625843017829706,-0.037249330684675,1.21330509838761e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,40374,-0.0779667994258961,0.0101007390142725,-0.0977642478938702,-0.0581693509579221,1.24257240569791e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,-0.0344507714456631,0.00446723843215257,-0.0432065587726821,-0.025694984118644,1.3261696205553e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,40536,-0.0387922809598534,0.00503251082515318,-0.0486560021771536,-0.0289285597425532,1.34888541333249e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,-0.0176677525430631,0.00229600511497351,-0.0221679225684112,-0.0131675825177151,1.49853014560371e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,-0.0851886263051188,0.0110726471131304,-0.106891014646854,-0.0634862379633833,1.52970882842529e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,40270,-0.0575386609133836,0.00748359813473693,-0.072206513257468,-0.0428708085692992,1.57426278609375e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,39980,-0.0707860699569642,0.00920857022861333,-0.0888348676050463,-0.0527372723088821,1.59641209811159e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,37987,0.0433630010054949,0.00564243157255413,0.0323038351232888,0.054422166887701,1.63294822358672e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,-0.0810206185581359,0.0105770959886787,-0.101751726695946,-0.0602895104203256,1.96606953523376e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,37900,-0.0462024771078627,0.0060313654814635,-0.0580239534515312,-0.0343810007641943,1.98048886786739e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,40333,-0.0656562072490358,0.0085865012902289,-0.0824857497778845,-0.0488266647201872,2.1840484256855e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,-0.0366368056462584,0.00480044181625233,-0.0460456716061129,-0.0272279396864038,2.4706769798217e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,40516,-0.0641621640797853,0.00840993554529335,-0.0806456377485602,-0.0476786904110103,2.49170435004252e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,37901,-0.0556686365705207,0.00729899855227071,-0.0699746737329713,-0.0413625994080701,2.56605325109465e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,-0.0444178414642596,0.00582402267165514,-0.0558329259007037,-0.0330027570278155,2.56983645395736e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,40203,-0.0382423221152511,0.00501625473252859,-0.0480741813910071,-0.028410462839495,2.6056455055017e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0174438574783644,0.00228931916762237,0.0129567919098245,0.0219309230469042,2.68636800201526e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,0.0326585825459662,0.00428748124030089,0.0242551193149765,0.041062045776956,2.73687485127669e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,37990,-0.0218989722946277,0.00287547732187637,-0.0275349078455054,-0.01626303674375,2.7946810323002e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,-0.106716350955185,0.0140163049203229,-0.134188308599018,-0.0792443933113521,2.84018065059133e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,37572,-0.0945006442721571,0.0124210852793781,-0.118845971419738,-0.0701553171245761,2.9712412622588e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,40517,-0.0171426301094373,0.0022552996870575,-0.02156301749607,-0.0127222427228046,3.09929005771478e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,40434,-0.0433296310458428,0.00570260701738216,-0.0545067407999119,-0.0321525212917738,3.16840716559115e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANG,Angiogenin,40309,-0.0248904202512199,0.00327587149388232,-0.0313111283792292,-0.0184697121232105,3.17238479716883e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,-0.0236906277761026,0.0031185689002513,-0.0298030228205952,-0.0175782327316101,3.20818258495673e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,38013,0.0221041433050705,0.00291212176892647,0.0163963846379746,0.0278119019721664,3.39723163668613e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTD,Biotinidase,38013,-0.0149331237965713,0.00196738024922715,-0.0187891890850565,-0.0110770585080861,3.39805236318419e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,-0.0419612516492442,0.0055459242492125,-0.0528312631777007,-0.0310912401207877,4.05500859483918e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,-0.0382196734896631,0.00505188944950922,-0.0481213768107011,-0.028317970168625,4.11678612234792e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,40536,0.0194231898564051,0.00256951850924672,0.0143869335782815,0.0244594461345286,4.27770743761678e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,-0.0653065440164653,0.0086440878197513,-0.0822489561431778,-0.0483641318897527,4.45688148389882e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,-0.0741557746747237,0.00981754706597603,-0.0933981669240367,-0.0549133824254107,4.46973838993798e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,40291,-0.029435547018261,0.003899904232008,-0.0370793593129967,-0.0217917347235253,4.6685035866307e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,-0.0214101518193329,0.00283942608526523,-0.0269754269464528,-0.0158448766922131,4.94151093085878e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,0.0149510460856051,0.0019853348228897,0.0110597898327412,0.0188423023384689,5.3211991589975e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,40359,-0.0249125208624344,0.00331003034036829,-0.0314001803295563,-0.0184248613953126,5.49581248856827e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,37562,-0.0476789580298815,0.00633568585977495,-0.0600969023150404,-0.0352610137447226,5.59576145114777e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,-0.028622917792453,0.00380931117913408,-0.0360891677035558,-0.0211566678813501,6.09705770210491e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,37901,-0.0481036925585199,0.00640406744490947,-0.0606556647505425,-0.0355517203664973,6.21698759626168e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,-0.0636341884065835,0.00848676336902206,-0.0802682446098667,-0.0470001322033002,6.81955967612116e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,-0.025048364349654,0.00334436713560773,-0.0316033239354451,-0.0184934047638628,7.34935559261183e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,-0.0387859493756234,0.00518100479218133,-0.0489407187682988,-0.028631179982948,7.46916274453523e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLGN,Calmegin,37572,-0.031715157409791,0.0042376896399954,-0.040021029104182,-0.0234092857154001,7.66443938091592e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,39980,-0.0328129456027079,0.00438751481790815,-0.0414124746458078,-0.0242134165596079,7.90648141742612e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,-0.0322556679752314,0.00431765299494475,-0.0407182678453231,-0.0237930681051397,8.40438537603027e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,-0.0778816075401224,0.010431525978385,-0.098327398457757,-0.0574358166224877,8.6947314544913e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,-0.0365683283499302,0.00490221560005295,-0.0461766709260339,-0.0269599857738264,9.14065486330653e-14
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,37572,-0.0319720592343437,0.00429663318330703,-0.0403934602736255,-0.0235506581950619,1.05990152941005e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,-0.0605691394178683,0.00814785031471083,-0.0765389260347015,-0.044599352801035,1.120597733921e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,40470,-0.0424823474880964,0.00571731035220343,-0.0536882757784151,-0.0312764191977777,1.13660154811089e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,37987,-0.0482103494445078,0.00648920927144346,-0.060929199616537,-0.0354914992724786,1.1569990862441e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,-0.0414670927074887,0.00558527163203211,-0.0524142251062716,-0.0305199603087058,1.20166711083388e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,-0.0767875881963393,0.0103497923070409,-0.0970731811181395,-0.0565019952745391,1.24853299607429e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,37942,-0.0399684518690916,0.00540749492836878,-0.0505671419286945,-0.0293697618094888,1.53946994270619e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,40288,-0.0615298938860377,0.00833711987004706,-0.0778706488313299,-0.0451891389407455,1.65852881271869e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,-0.0408769492174559,0.00555830657114176,-0.0517712300968938,-0.0299826683380181,2.01320837838541e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,40341,-0.0260559849243289,0.00354387567846767,-0.0330019812541256,-0.0191099885945323,2.04164575379486e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,40228,-0.0917280456225699,0.0124791835644041,-0.116187245408802,-0.067268845836338,2.07169366704577e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,-0.0251043228185287,0.00341638460498582,-0.0318004366443009,-0.0184082089927565,2.12416000022085e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,39897,-0.0327847306917935,0.00446430419200381,-0.041534766908121,-0.024034694475466,2.18056537157129e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,-0.0198887200547682,0.00271194073817005,-0.0252041239015815,-0.0145733162079549,2.34609643226892e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,-0.0393874061339843,0.00537385078999405,-0.0499201536823726,-0.0288546585855959,2.42204004288178e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,-0.0696779144098166,0.00951587792889421,-0.0883290351504492,-0.0510267936691839,2.55474984848179e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,-0.0208009204158986,0.00284175051725467,-0.0263707514297177,-0.0152310894020794,2.62423853677205e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,-0.0658431738580108,0.00899676991119,-0.0834768428839432,-0.0482095048320785,2.62767162123373e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,-0.066100662821856,0.00903272794005507,-0.0838048095843639,-0.048396516059348,2.64023294071762e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,40044,-0.0638417984387474,0.00872493101422923,-0.0809426632266367,-0.0467409336508581,2.65591468329569e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,40332,-0.0324450535452293,0.00443763478914874,-0.0411428177319608,-0.0237472893584977,2.77096477937434e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,-0.0324985355453132,0.00444678693362688,-0.0412142379352219,-0.0237828331554045,2.85759103440014e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,37921,-0.022133744825032,0.00303090283728121,-0.0280743143861032,-0.0161931752639609,2.97901749339409e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,-0.0549690364255731,0.00753118531067051,-0.0697301596344873,-0.0402079132166589,3.04052713387635e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,-0.0182859838199074,0.00250729072522083,-0.0232002736413402,-0.0133716939984745,3.17053015969523e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,37901,-0.0472019956333486,0.00647325977030857,-0.0598895847831534,-0.0345144064835438,3.22826772504288e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,-0.0398657280595532,0.00547095982959338,-0.0505888093255562,-0.0291426467935501,3.35535809887391e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,39809,-0.0537419054476261,0.00738271050778697,-0.0682120180428885,-0.0392717928523636,3.51482856041349e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,-0.0720242822191269,0.00990099336411146,-0.0914302292127853,-0.0526183352254684,3.64066921562123e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,-0.0831677854317689,0.0114420692354669,-0.105594241133284,-0.0607413297302537,3.8070471831178e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,-0.0617495164134442,0.00850051357357285,-0.078410523017647,-0.0450885098092414,3.95872568932782e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,-0.0421978633512035,0.00581833258751915,-0.0536017952227411,-0.030793931479666,4.27707619534287e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,0.0225675680363786,0.00311573619660398,0.0164607250910348,0.0286744109817224,4.58726455342282e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,39980,-0.0409573088502901,0.0056546904574279,-0.0520405021468488,-0.0298741155537314,4.59241905153804e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,37177,-0.0852775113844989,0.0117737910742652,-0.108354141890059,-0.0622008808789392,4.64143550552666e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,40359,-0.0230677281238453,0.00319341621873245,-0.0293268239125609,-0.0168086323351297,5.29518936616773e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,40411,0.0282157299560611,0.00391179504470503,0.0205486116684392,0.0358828482436829,5.71952266916718e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,0.0249722145123867,0.00346417612923115,0.0181824292990936,0.0317619997256797,5.95654384485306e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,40251,-0.0396978008947507,0.00551170569914806,-0.0505007440650809,-0.0288948577244205,6.18061677257313e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,37942,-0.0426839741502542,0.00592550723010967,-0.0542979683212691,-0.0310699799792392,6.18304994844499e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,37714,-0.0264113051929671,0.00366675722890989,-0.0335981493616305,-0.0192244610243037,6.21228844990571e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,40332,-0.0503596508919986,0.00700018935940805,-0.0640800220364384,-0.0366392797475589,6.57102361918449e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,39959,0.0320546927744487,0.00445637844875047,0.0233201910148978,0.0407891945339996,6.62853540328518e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,39961,-0.0421360683547212,0.00586096972465202,-0.0536235690150392,-0.0306485676944032,6.81128595593866e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,-0.0458121048439426,0.00637360805471992,-0.0583043766311937,-0.0333198330566916,6.94169666315769e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,-0.0247687458589547,0.00344745490273583,-0.0315257574683169,-0.0180117342495925,7.03753108858592e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,37628,-0.0465911946733071,0.00648961301982174,-0.0593108361921577,-0.0338715531544565,7.37986322032035e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,40044,-0.0334143747792861,0.00465702645347421,-0.0425421466280955,-0.0242866029304767,7.55375460014229e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,-0.019770968562895,0.00275960901748251,-0.0251798022371607,-0.0143621348886292,8.21614661412971e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,38013,-0.0284995266719143,0.00398037989281241,-0.0363010712618267,-0.020697982082002,8.48293694309271e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,-0.078873793432966,0.0110183080034687,-0.100469677119765,-0.0572779097461674,8.52202405559019e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,37959,-0.0457774559121866,0.00640275124417925,-0.0583268483507779,-0.0332280634735952,9.14678500460211e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,40471,-0.0435998589746222,0.00610243867082495,-0.0555606387694391,-0.0316390791798053,9.41025240632379e-13
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,-0.0705421764861733,0.00990240919891871,-0.089950898516054,-0.0511334544562927,1.0952196200452e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,-0.0213287535671909,0.00299463015468858,-0.0271982286703806,-0.0154592784640013,1.1066825558396e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,40274,-0.0330165965911031,0.00464040263926393,-0.0421117857640604,-0.0239214074181458,1.16688183835881e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,-0.0419981888213598,0.00591235808743335,-0.0535864106727292,-0.0304099669699904,1.27765362730205e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,-0.0317498537017083,0.00447127248833767,-0.0405135477788501,-0.0229861596245665,1.29197071629077e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,40455,-0.0294791007128874,0.00415152735235351,-0.0376160943235003,-0.0213421071022746,1.29267369289088e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,-0.0275367263940639,0.00388335167260482,-0.0351480956723693,-0.0199253571157584,1.3981297623136e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,-0.0457666368095543,0.00645624540681718,-0.058420877806916,-0.0331123958121926,1.42268192736945e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,-0.0423198970776316,0.00597624301226386,-0.0540333333816687,-0.0306064607735944,1.48676659054502e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,-0.0399217375968148,0.00563928125540742,-0.0509747288574133,-0.0288687463362163,1.51173482599899e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,40341,0.0174472788997793,0.00246570592588916,0.0126144952850365,0.022280062514522,1.54597974452483e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,-0.0657115941848362,0.00929393422651115,-0.083927705268798,-0.0474954831008743,1.62322494479345e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,-0.0419176778108784,0.00592932324478968,-0.0535391513706662,-0.0302962042510906,1.63075410463467e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,-0.0325779650964486,0.00461279922102513,-0.0416190515696578,-0.0235368786232393,1.70297486746565e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,-0.0521418292286539,0.00738995506499367,-0.0666261411560415,-0.0376575173012663,1.78904517776054e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,-0.046595715108269,0.00660826922384292,-0.0595479227870011,-0.0336435074295369,1.8480701361884e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,-0.0130645539568674,0.0018535980819406,-0.016697606197471,-0.00943150171626381,1.88687389812041e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,-0.0355858111998018,0.0050521527969661,-0.0454880306818554,-0.0256835917177483,1.96283756636321e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,-0.043516396400677,0.00618094710063185,-0.0556310527179154,-0.0314017400834386,2.01173819852185e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,40307,-0.0459368535326029,0.00653589014311946,-0.058747198213117,-0.0331265088520887,2.17427218209981e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,-0.0132828782507102,0.00189070795798213,-0.0169886658483552,-0.00957709065306527,2.23770582324745e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,-0.0237121783656352,0.0033775104592164,-0.0303320988656993,-0.0170922578655711,2.29866727440446e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,40370,0.0188811579699753,0.00269071552770195,0.0136073555356795,0.0241549604042711,2.35568242682395e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,-0.0239562058419165,0.00342081565262305,-0.0306610045210577,-0.0172514071627754,2.60689790376508e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,-0.0180965570573888,0.00258420911845792,-0.0231616069295663,-0.0130315071852112,2.6094063971121e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,37598,-0.0278874762854693,0.00398550253542774,-0.0356990612549076,-0.0200758913160309,2.73723560394724e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,37998,-0.0550718871654559,0.00787348796407817,-0.0705039235750491,-0.0396398507558626,2.78502238656473e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,40516,-0.0337553991133462,0.00483867532491418,-0.043239202750178,-0.0242715954765144,3.15184370486467e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,-0.0403912783970564,0.00579442010446926,-0.0517483418018161,-0.0290342149922966,3.27728940700165e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,40411,-0.0473392930818892,0.00679808596113707,-0.0606635415657178,-0.0340150445980605,3.44572515624475e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,37959,-0.0438428044037577,0.00629533114510114,-0.056181653448156,-0.0315039553593595,3.45215958706551e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,-0.0595585882798155,0.00855754574314408,-0.0763313779363779,-0.0427857986232531,3.56503136749969e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,37959,-0.0319554412604049,0.00459222351520824,-0.0409561993502131,-0.0229546831705968,3.59516508945807e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,39961,-0.054595907861927,0.00784743179749865,-0.0699768741850243,-0.0392149415388296,3.61069530300064e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,-0.0327498911744372,0.00470952944798997,-0.0419805688924976,-0.0235192134563769,3.71495130241509e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,-0.0235354065507865,0.00338447265268883,-0.0301689729500566,-0.0169018401515164,3.72022266372728e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,37959,-0.0495209079837516,0.00712333387922604,-0.0634826423870347,-0.0355591735804686,3.76872872653784e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,40228,-0.0534745101948334,0.00770237854112093,-0.0685711721354305,-0.0383778482542364,3.99967214271251e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,0.0403259477005707,0.00581161202785787,0.0289351881259693,0.0517167072751721,4.10409417656173e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,40422,-0.0607144720463825,0.00875505774172781,-0.0778743852201691,-0.043554558872596,4.22427408683307e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,37942,0.0268738528607505,0.003874721058701,0.0192793995856965,0.0344683061358045,4.22666077215055e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,-0.0271683339818146,0.00391834439356967,-0.0348482889932112,-0.0194883789704181,4.26100970124282e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGMN,Legumain,40422,-0.023347624137505,0.00336909052597812,-0.0299510415684221,-0.0167442067065878,4.37089193692738e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,37671,-0.0373022474754785,0.00538647242634383,-0.0478597334311124,-0.0267447615198446,4.55574302099562e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,38013,0.0149178521226132,0.00215564013165743,0.0106927974645647,0.0191429067806618,4.70657725903234e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,-0.05080913712334,0.00734519479846162,-0.0652057189283248,-0.0364125553183552,4.77803848494117e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEXN,Nexilin,37987,-0.0450361930415785,0.00651214174047071,-0.0577999908529011,-0.032272395230256,4.86359701539882e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,37987,-0.0186490312082253,0.00269698262941682,-0.0239351171618823,-0.0133629452545684,4.89620612747325e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,-0.0146378565329198,0.00211788159191621,-0.0187889044530756,-0.010486808612764,5.00828030766062e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,-0.0404327814954651,0.00585276082922757,-0.0519041927207511,-0.0289613702701791,5.09458119237079e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,40209,-0.0444015631483727,0.00642880703571596,-0.057002024938376,-0.0318011013583694,5.15184179708186e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,37990,-0.0191294777640964,0.00277510195733554,-0.024568677600474,-0.0136902779277187,5.69460320308913e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.0271438059598656,0.00394034089147284,0.0194207378125789,0.0348668741071524,5.84086350783671e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,-0.0569242090985249,0.00826337750999876,-0.0731204290181225,-0.0407279891789273,5.88471681931449e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,-0.0233855647225069,0.00340038465404373,-0.0300503186444326,-0.0167208108005812,6.37500905336188e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,-0.060495190955383,0.00880944867404863,-0.0777617103565183,-0.0432286715542477,6.80150221398791e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,40044,-0.0515419142723623,0.00751333718824299,-0.0662680551613186,-0.0368157733834061,7.14231990219025e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,40341,-0.0261584387524355,0.00381607353875214,-0.0336379428883897,-0.0186789346164813,7.40375500077395e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,-0.0638089831485045,0.00931175551661602,-0.0820600239610719,-0.0455579423359372,7.56988156745117e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,-0.0548055577117447,0.00799824376203443,-0.0704821154853322,-0.0391289999381572,7.58752608262479e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,40276,-0.0217767423950252,0.00317886048502966,-0.0280073089456833,-0.0155461758443671,7.63115614569946e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAX,Protein max,39961,-0.0679036575361283,0.00991253237542442,-0.0873322209919602,-0.0484750940802965,7.64759219394767e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,37959,-0.0497330751737204,0.00726036607366113,-0.0639633926780962,-0.0355027576693445,7.70786449711413e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.0299550930637985,0.00437574278533037,-0.038531548923046,-0.0213786372045509,7.88563790405743e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,37942,-0.0298257219682396,0.00435923833854245,-0.0383698291117828,-0.0212816148246964,8.14883757550255e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,40044,-0.0455033927419287,0.00666322102239763,-0.058563305945828,-0.0324434795380293,8.86442054878081e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,37642,-0.0666828451455036,0.00977152302633323,-0.0858350302771167,-0.0475306600138904,9.22777278847403e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,-0.0457549692680552,0.00670974748242347,-0.0589060743336052,-0.0326038642025052,9.55412396736992e-12
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,-0.0533683542280722,0.00783510924388733,-0.0687251683460913,-0.038011540110053,1.00736131064691e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,40332,-0.0344655634687822,0.00507727818027548,-0.0444170287021222,-0.0245140982354423,1.17564417863161e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,40471,0.0193332295264109,0.00285149598692119,0.0137442973920453,0.0249221616607764,1.2434759991145e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,37942,-0.0596659891302254,0.00880386402148266,-0.0769215626123314,-0.0424104156481194,1.2757163587946e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,-0.0598483802155913,0.00883193764509592,-0.0771589779999793,-0.0425377824312033,1.28351391309901e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,-0.0670708902824735,0.00990159631114277,-0.0864780190523133,-0.0476637615126337,1.30800268688652e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,-0.0361321611755087,0.00534370942552176,-0.0466058316495313,-0.025658490701486,1.42203514768874e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,40341,-0.0432673709530682,0.00640331925755683,-0.0558178766978796,-0.0307168652082568,1.45751014353487e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,40483,-0.0446028591950455,0.00660790551246185,-0.0575543539994707,-0.0316513643906202,1.52995284948328e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,37598,-0.0246030563813136,0.0036481491919892,-0.0317534287976124,-0.0174526839650147,1.60545310944443e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,37562,-0.0429487502297601,0.00637906966544888,-0.0554517267740399,-0.0304457736854803,1.73406839894935e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,-0.033859293764041,0.00503094872635778,-0.0437199532677023,-0.0239986342603798,1.76439114220927e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,-0.0197898773617985,0.00294260951576174,-0.0255573920126915,-0.0140223627109055,1.81243712236933e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,-0.0373850409622102,0.00556373624022113,-0.0482899639930436,-0.0264801179313768,1.89771740913363e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,-0.0214991390020167,0.00320144040814344,-0.0277739622019779,-0.0152243158020556,1.93795142000452e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,40489,-0.0180874913699364,0.00271038460874777,-0.0233998452030821,-0.0127751375367908,2.58124877517257e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,-0.0346484097338069,0.0051921482428496,-0.0448250202897921,-0.0244717991778217,2.60218426837532e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,37900,-0.0443786526410339,0.00666001621008229,-0.0574322844127951,-0.0313250208692726,2.77898022284126e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,37598,-0.0224020917482443,0.00336688028827759,-0.0290011771132684,-0.0158030063832203,2.97210379334992e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,40422,-0.0483709796774676,0.00727127237871255,-0.0626226735397442,-0.034119285815191,2.97840039987458e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,37671,-0.0684357583082729,0.0102904756265043,-0.0886050905362214,-0.0482664260803244,3.03794605015691e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,-0.0576774550055843,0.00867394334008628,-0.0746783839521534,-0.0406765260590152,3.05696383951738e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,37901,-0.0648412877481923,0.00976712482288426,-0.0839848524010454,-0.0456977230953391,3.28540072240053e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,40305,-0.0564355944433438,0.008504424988266,-0.0731042674203451,-0.0397669214663424,3.32695803813555e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,40270,-0.0252832390915588,0.00381271017356674,-0.0327561510317496,-0.017810327151368,3.43513427264221e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,0.0383021638374819,0.00577828940176309,0.0269767166100262,0.0496276110649375,3.51688384534229e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,39980,-0.0186855329777418,0.00282110963664123,-0.0242149078655586,-0.013156158089925,3.62391860773743e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,39961,-0.0286589872940308,0.00432961877482536,-0.0371450400926885,-0.0201729344953731,3.727794279004e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,-0.0673065193349787,0.0101773332897833,-0.0872540925829539,-0.0473589460870035,3.89755304986505e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,-0.0343709591267213,0.0051987345250413,-0.0445604787958022,-0.0241814394576403,3.95300997693182e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,-0.0348708653956316,0.00528028022437305,-0.0452202146354028,-0.0245215161558604,4.15517731140794e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,37671,-0.0435173757867353,0.00659009719144001,-0.0564339662819577,-0.0306007852915128,4.17053236691566e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.0297167119300653,0.00450553695855065,-0.0385475643688246,-0.0208858594913061,4.36879420297431e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,40044,-0.0537490134501101,0.00816943515772569,-0.0697611063592524,-0.0377369205409677,4.87787100340282e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,-0.023231068946862,0.00353325008873702,-0.0301562391207865,-0.0163058987729374,5.01781415229882e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,-0.0349444521569385,0.00532281331195507,-0.0453771662483705,-0.0245117380655066,5.3664149752063e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,40516,-0.0393598024542634,0.00599607429726168,-0.0511121080768963,-0.0276074968316305,5.38928773393214e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,39980,-0.0268644570558903,0.00409303972953202,-0.034886814925773,-0.0188420991860075,5.42432393920225e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,-0.0296495107867173,0.00451821466057823,-0.0385052115214506,-0.020793810051984,5.49468221902389e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,40324,-0.0639859850088758,0.00975376143002142,-0.0831033574117177,-0.0448686126060338,5.54220119861804e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,0.072634771951421,0.0110872125283932,0.0509038353957704,0.0943657085070717,5.88351499477731e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,37900,-0.019931503036641,0.00304301615619103,-0.0258958147027754,-0.0139671913705065,5.96626343197674e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,40471,-0.0162048913097113,0.00247612859730218,-0.0210581033604235,-0.011351679258999,6.15285408734984e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPART,Spartin,37671,-0.0481206141532976,0.00735933947351562,-0.0625449195213882,-0.033696308785207,6.43307831887941e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,-0.0180364224226828,0.00275861966353192,-0.0234433169632054,-0.0126295278821602,6.45094227821347e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,-0.0595954613219579,0.00912718144773147,-0.0774847369595116,-0.0417061856844042,6.80141319157691e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,40359,-0.0785179822264584,0.0120396671145345,-0.102115729770946,-0.0549202346819708,7.16548003990741e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,-0.0389498403655539,0.00597712025157668,-0.0506649960586442,-0.0272346846724636,7.4141640693996e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,-0.0494512955470061,0.0075891414167919,-0.0643260127239182,-0.034576578370094,7.4349520141871e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,-0.0374401487066275,0.00574687400525615,-0.0487040217569295,-0.0261762756563254,7.53224372090153e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,40359,0.0431993964644301,0.00663209208402728,0.0302004959797366,0.0561982969491235,7.55263128117135e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,-0.0335601681082333,0.00515178634600106,-0.0436576693463953,-0.0234626668700712,7.56217371794514e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,37901,-0.0209564626527205,0.00321873175737761,-0.0272651768971806,-0.0146477484082604,7.741476011001e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,37942,-0.0283218605352761,0.00435734106063695,-0.0368622490141245,-0.0197814720564277,8.32527681317348e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,40260,-0.0183027161482625,0.00281892594809821,-0.023827811006535,-0.01277762128999,8.67684112367736e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,39980,-0.0325302252988683,0.00501338385304778,-0.042356457650842,-0.0227039929468947,8.92156264933233e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,-0.0266681528413546,0.00411217383965895,-0.0347280135670861,-0.0186082921156231,9.18078184836516e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,-0.0526632385327647,0.00813433501756774,-0.0686065351671975,-0.036719941898332,9.81819260533042e-11
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,40411,0.0168401247903161,0.00260530470905747,0.0117337275605635,0.0219465220200688,1.05079001245878e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,40332,0.0194428662862158,0.00300823319657956,0.0135467292209199,0.0253390033515118,1.05486490202369e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,40433,-0.036567930916769,0.00565814324198528,-0.0476578916710601,-0.0254779701624779,1.05698832942256e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPTC,Opticin,40305,0.0276691821807029,0.00428225069392288,0.019275970820614,0.0360623935407917,1.06788588546579e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,-0.0193162904919086,0.00298987556694162,-0.0251764466031142,-0.013456134380703,1.07987160564279e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,40453,-0.019095595838592,0.00295698613114532,-0.0248912886556368,-0.0132999030215471,1.09304987589364e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,37402,-0.0485795833446706,0.00752411699329919,-0.063326852651537,-0.0338323140378042,1.10964428292781e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.0366217079442708,0.00567648732769736,-0.0477476231065576,-0.0254957927819839,1.13993805896529e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,37562,-0.0489253956295511,0.00758501335785042,-0.063792021810938,-0.0340587694481643,1.15570109991466e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,-0.0544097125598095,0.00843921050459361,-0.070950565148813,-0.0378688599708061,1.17192788324102e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,-0.0254502018313895,0.00394827509394285,-0.0331888210155175,-0.0177115826472615,1.1890369364946e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,-0.0660628270325126,0.0102498797259971,-0.0861525912954668,-0.0459730627695583,1.19345299759109e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,-0.0340640982207926,0.00528954517033378,-0.0444316067546468,-0.0236965896869384,1.22999111703673e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,-0.0439352112651743,0.00682987295817161,-0.0573217622631906,-0.0305486602671579,1.28923855269693e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,0.0472050025041815,0.00734372441869834,0.0328113026435328,0.0615987023648303,1.33028811832953e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,-0.0226221485171786,0.00352319753276624,-0.0295276156814004,-0.0157166813529568,1.40074888249007e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,-0.0299450554934585,0.00466515996704846,-0.0390887690288734,-0.0208013419580435,1.41272456715593e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,-0.0569072145791159,0.008889185347889,-0.0743300178609783,-0.0394844112972535,1.58711646519334e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,-0.0173872814794036,0.00271743460702249,-0.0227134533091677,-0.0120611096496395,1.62332973293048e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,-0.0153022878655698,0.00239298851937549,-0.0199925453635458,-0.0106120303675938,1.66215783449596e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,37572,-0.0484717975834299,0.00761192243675948,-0.0633911655594784,-0.0335524296073813,1.98050186233494e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,40341,-0.0399429536845821,0.00627463781944271,-0.0522412438106898,-0.0276446635584743,1.9963023720721e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,-0.0517684183949056,0.00813222725249434,-0.0677075838097945,-0.0358292529800167,2.00509044120185e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GH1,Somatotropin,40330,0.105747483307221,0.0166260665080971,0.0731603929513502,0.138334573663091,2.0680956027396e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,40536,0.0183595644351866,0.0028874621547694,0.0127001386118385,0.0240189902585346,2.09398137072535e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,-0.0665797979643154,0.0104950977126519,-0.087150189481113,-0.0460094064475178,2.30205598911757e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,37671,-0.0527258092167056,0.00831132832964082,-0.0690160127428016,-0.0364356056906096,2.31398745029226e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,-0.0620264819376612,0.00978713229988827,-0.0812092612454422,-0.0428437026298802,2.39735593739877e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,-0.0153310998936874,0.00243097525123283,-0.0200958113861037,-0.010566388401271,2.92893407815496e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,-0.0194149711564968,0.00308032232416259,-0.0254524029118554,-0.0133775394011381,3.01180820527584e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,40228,-0.0604241115388647,0.00958956146187871,-0.079219652004147,-0.0416285710735824,3.03518189576031e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,-0.0624689940683345,0.00992045432539145,-0.0819130845461017,-0.0430249035905672,3.11512532142642e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,39961,-0.0314873888129119,0.00500434755172072,-0.0412959100142845,-0.0216788676115393,3.21798088777586e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,37598,-0.0202310771288224,0.00321555707454199,-0.0265335689949247,-0.0139285852627201,3.24125976346682e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,40442,-0.0417153553951332,0.00663225786247192,-0.0547145808055782,-0.0287161299846883,3.26204594643037e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,40332,-0.0158338340630433,0.00251869084215429,-0.0207704681136657,-0.0108972000124209,3.33110302042889e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,-0.0706950345798578,0.0112625885533953,-0.0927697081445126,-0.048620361015203,3.55769628443225e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,-0.033057352344065,0.00527044357458765,-0.0433874217502568,-0.0227272829378732,3.65333569998763e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,-0.0550571770857537,0.00879031558088049,-0.0722861956242795,-0.037828158547228,3.88433734599368e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,40044,-0.0393732941021814,0.00628805786076842,-0.0516978875092875,-0.0270487006950753,3.91029037363886e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,-0.0534487617111896,0.00854162015935401,-0.0701903372235235,-0.0367071861988558,4.03114048892227e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,-0.0514468757739447,0.00823997250813188,-0.0675972218898832,-0.0352965296580063,4.4054526563629e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,37482,-0.0308032965381226,0.00493490219318336,-0.040475704836762,-0.0211308882394832,4.45619553982372e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0172193771528314,0.002759682590008,0.0118103992764158,0.0226283550292471,4.49619616859977e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,-0.030306444329211,0.00486000776955946,-0.0398320595575475,-0.0207808291008745,4.6267604236685e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,-0.0401482088298457,0.00644760063466521,-0.0527855060737895,-0.0275109115859019,4.8786938201831e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,40260,-0.0334692775027103,0.00537734238374924,-0.0440088685748588,-0.0229296864305618,4.9644778293878e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,37562,-0.0233529961703652,0.00375331842633188,-0.0307095002859757,-0.0159964920547547,5.059262162114e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SELL,L-selectin,38013,0.0137528541063457,0.00221077997058867,0.00941972536399187,0.0180859828486995,5.0911284088823e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,37671,0.0192481616278662,0.00309737457834412,0.0131773074543117,0.0253190158014207,5.30863597012887e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,37942,-0.0413845129320335,0.00666687150452088,-0.0544515810808944,-0.0283174447831725,5.54160853166975e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,-0.0216396733229439,0.00348852877241291,-0.0284771897168732,-0.0148021569290145,5.70200329357133e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,37900,-0.0235093381003333,0.00379377337951208,-0.030945133924177,-0.0160735422764897,5.92963467413206e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,37622,-0.0390860472498961,0.00631129829350341,-0.0514561919051628,-0.0267159025946294,6.07745285731233e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,-0.0492503037963797,0.00796974471718204,-0.0648710034420566,-0.0336296041507029,6.58052119113804e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,37598,-0.0256493725287707,0.00415140819343654,-0.0337861325879063,-0.0175126124696351,6.66343084429342e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,37900,-0.022244075870516,0.00360079593652875,-0.0293016359061124,-0.0151865158349197,6.69835071543176e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,-0.0328998987039761,0.00532776288291522,-0.0433423139544899,-0.0224574834534623,6.76987233165453e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,-0.0133145259715198,0.00215625975028411,-0.0175407950820767,-0.00908825686096296,6.78371103133513e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,40044,-0.0257251331421976,0.00416762471894494,-0.0338936775913297,-0.0175565886930655,6.88328862093345e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,-0.0297393700065686,0.0048209313869762,-0.0391883955250419,-0.0202903444880952,7.0782254693804e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,-0.0879999912917235,0.0142682475808343,-0.115965756550159,-0.0600342260332882,7.10390361755945e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,37987,0.0152013740323022,0.00246467987786009,0.0103706014716964,0.020032146592908,7.1268581520772e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,0.028588858094713,0.00464211795925819,0.019490306894567,0.0376874092948591,7.55330075463066e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,40329,-0.0567962565289415,0.00922481050186843,-0.0748768851126036,-0.0387156279452793,7.59660310272433e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,37942,-0.0625111721331929,0.0101629474755784,-0.0824305491853265,-0.0425917950810593,7.92262774303552e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,-0.0344428613614316,0.00560212886253706,-0.0454230339320042,-0.023462688790859,8.05976680694081e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,40411,-0.0177978821503689,0.00290112338042688,-0.0234840839760055,-0.0121116803247322,8.72647846717081e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,37987,-0.0529855290457962,0.00863927997518315,-0.0699185177971552,-0.0360525402944372,8.85846270709852e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,-0.0563668811225991,0.00919240793362915,-0.0743840006725122,-0.038349761572686,8.92620708350416e-10
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFB,Complement factor B,37770,-0.0191168826627763,0.00313353651891261,-0.025258614239845,-0.0129751510857076,1.0850625307743e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,-0.0391682162503353,0.00642603168081527,-0.0517632383447333,-0.0265731941559374,1.12338067918931e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,-0.0670438443142328,0.0110019284412676,-0.0886076240591174,-0.0454800645693483,1.1279331724521e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,0.0108129653262744,0.00177490837910205,0.00733414490323439,0.0142917857493144,1.1444307105433e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,-0.0330765948245882,0.00543109605473378,-0.0437215430918664,-0.02243164655731,1.15327384422519e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLG,Plasminogen,37705,-0.013036577410049,0.00214049991787307,-0.0172319572490802,-0.00884119757101776,1.15718810214212e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,37541,-0.0318646667387049,0.00523621883566175,-0.0421276556566019,-0.0216016778208078,1.19419945122889e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,-0.0324833053323754,0.00534199591596044,-0.0429536173276578,-0.0220129933370929,1.22894193147466e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,37942,0.021257851696236,0.00349771321901619,0.0144023337869643,0.0281133696055077,1.25248656964027e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,40028,-0.0245858716914009,0.00405416156362725,-0.0325320283561103,-0.0166397150266915,1.35545678677055e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,-0.0683857616793401,0.0113001575406224,-0.0905340704589601,-0.0462374528997202,1.47153365675259e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,37959,0.0256132229090134,0.00424106389446151,0.0173007376758688,0.033925708142158,1.58808928734808e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,-0.0438706540183425,0.00727395476580076,-0.058127605359312,-0.029613702677373,1.6634357244726e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,40359,-0.0377492267715827,0.00626857758215992,-0.0500356388326162,-0.0254628147105493,1.76090768810282e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,40042,-0.0204962975091805,0.0034103420810962,-0.0271805679881291,-0.0138120270302319,1.89607905767384e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,37572,-0.0390982369471129,0.0065255241788979,-0.0518882643377528,-0.026308209556473,2.13249377784243e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,40305,-0.0165881602015309,0.00277863381261586,-0.022034282474258,-0.0111420379288038,2.42467077428878e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,-0.0527351753019257,0.00883571016751233,-0.0700531672302499,-0.0354171833736016,2.44764231958733e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,37482,-0.0321702557532142,0.00539003204898201,-0.0427347185692189,-0.0216057929372094,2.45708460733749e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,40305,-0.0466337305237205,0.00781839864142919,-0.0619577918609217,-0.0313096691865193,2.50426365231037e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,-0.0410278066342672,0.0068790915028477,-0.0545108259798487,-0.0275447872886858,2.51147857903044e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,40411,-0.0360747437229763,0.00605070127403765,-0.0479341182200901,-0.0242153692258625,2.54303327160786e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,-0.0497533188962037,0.00834446727767596,-0.0661084747604486,-0.0333981630319589,2.54740165449184e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,37901,-0.0199643019803763,0.00334888712123388,-0.0265281207379947,-0.0134004832227579,2.56235193797614e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,37643,-0.0802108966996249,0.0134707593003981,-0.106613584928405,-0.0538082084708447,2.67590940462508e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,-0.0216137583593843,0.00363058184585665,-0.0287296987772633,-0.0144978179415052,2.695349460076e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,37598,-0.0285095417138584,0.00479232515631319,-0.0379024990202322,-0.0191165844074845,2.7664457658034e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,40490,-0.0151965651966332,0.00255662323154618,-0.0202075467304638,-0.0101855836628027,2.83917667941825e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,37942,-0.0378501515415456,0.00636943378471642,-0.0503342417595898,-0.0253660613235014,2.87687633808951e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,-0.0279147838857153,0.00469923702165694,-0.0371252884481629,-0.0187042793232677,2.91664027997688e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,37990,-0.0365749778098271,0.00616649159375601,-0.0486613013335889,-0.0244886542860653,3.079773700514e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,40411,-0.0325245734783243,0.00548697156058986,-0.0432790377370804,-0.0217701092195682,3.13728553380558e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,37990,-0.0316693344779376,0.00534625406609967,-0.042147992447493,-0.0211906765083823,3.22515643285912e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,-0.0531094703859084,0.00897269794477568,-0.0706959583576687,-0.035522982414148,3.31778024787903e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,-0.0119875357561279,0.00202644057740579,-0.0159593592878432,-0.0080157122244125,3.38921296345382e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,39980,-0.0273275252758245,0.00462215590211156,-0.0363869508439632,-0.0182680997076859,3.44459351017399e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,-0.0358651580499799,0.00607699526384655,-0.0477760687671191,-0.0239542473328406,3.67073002699135e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,40489,0.0250863010673119,0.00425447774379582,0.0167475246894721,0.0334250774451517,3.78873052084016e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DMD,Dystrophin,37628,-0.02923766797166,0.00496125415238711,-0.0389617261103388,-0.0195136098329813,3.88042711626945e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,-0.0383460983006794,0.00650712226570856,-0.0511000579414682,-0.0255921386598906,3.88419072680277e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,-0.0406468064692229,0.00689896280250519,-0.0541687735621331,-0.0271248393763128,3.89870018699169e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,40042,-0.0417808012971331,0.00709226646642484,-0.0556816435713258,-0.0278799590229404,3.91683672213364e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,-0.0554551560570802,0.00942609180197231,-0.073930295988946,-0.0369800161252145,4.12049312393482e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,37671,-0.031942990999892,0.00543614104481986,-0.0425978274477389,-0.021288154552045,4.30311719097952e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,37884,-0.0494547272513719,0.0084224898547372,-0.0659628073666568,-0.032946647136087,4.41416225725148e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,40359,-0.0377400601925596,0.00643635924166293,-0.0503553243062189,-0.0251247960789002,4.61987450433628e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRN,Progranulin,40262,-0.0135170205728974,0.00230546519604744,-0.0180357323571504,-0.00899830878864445,4.63542067795916e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,-0.0221025929437653,0.00378122018518068,-0.0295137845067195,-0.0146914013808112,5.17141908076368e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,-0.0270114440072095,0.00462381345956652,-0.0360741183879598,-0.0179487696264591,5.26706685661864e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,-0.0314968612650385,0.00539409824605491,-0.0420692938273061,-0.0209244287027709,5.37125363756445e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,37477,0.0345160442932135,0.00591579117842957,0.0229210935834915,0.0461109950029355,5.52144741612321e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOST,Sclerostin,40330,-0.0213974658735425,0.00367049315477276,-0.0285916324568971,-0.0142032992901879,5.6642084024941e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,37942,-0.0464274084931215,0.0079644218830009,-0.0620376753838032,-0.0308171416024397,5.69156939974997e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,40341,-0.0393155726105516,0.00674565002756954,-0.0525370466645879,-0.0260940985565153,5.70845071665472e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,-0.0270204530248836,0.00463678527358522,-0.0361085521611106,-0.0179323538886566,5.74045854397437e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,40442,-0.0269164742367866,0.0046216298327337,-0.0359748687089446,-0.0178580797646285,5.85504823249165e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,37942,-0.0753656273644639,0.0129649650141032,-0.100776958792106,-0.0499542959368217,6.27424334648794e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,39961,-0.0250174930065709,0.00431134515732496,-0.0334677295149278,-0.0165672564982139,6.6523894392253e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,39877,-0.0468845270416973,0.00808014996552362,-0.0627216209741236,-0.031047433109271,6.6641444005589e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,40305,-0.0751059215659327,0.0129475533672826,-0.100483126165807,-0.0497287169660588,6.72646601218385e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,-0.0144699522453531,0.00249700281073288,-0.0193640777543896,-0.00957582673631669,6.96382087789365e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,40359,-0.0372571750365577,0.00643981974774945,-0.0498792217421466,-0.0246351283309687,7.36831907156871e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0326879613090734,0.00565229271540074,-0.0437664550312588,-0.0216094675868879,7.47259866239754e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,37572,0.0172158635155238,0.00298732370394516,0.0113607090557913,0.0230710179752563,8.45033023549065e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,37628,-0.0510284567710575,0.00887657486198282,-0.0684265435005438,-0.0336303700415711,9.19446327173009e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,-0.034436327738941,0.00599188337259774,-0.0461804191492326,-0.0226922363286495,9.27733023700915e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,-0.0334528583098778,0.00582234868154558,-0.0448646617257071,-0.0220410548940484,9.32795932021532e-09
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,37900,-0.0224645032923204,0.00391904720208881,-0.0301458358084145,-0.0147831707762263,1.0130420415881e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,37905,-0.052416306708488,0.00916241285957166,-0.0703746359132485,-0.0344579775037275,1.08283209389415e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,40341,-0.036626169423756,0.00640510147231654,-0.0491801683094964,-0.0240721705380156,1.09541385281728e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,37990,-0.0389722881280352,0.00682392642712219,-0.0523471839251947,-0.0255973923308757,1.14591815968804e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,-0.0317552362048216,0.00556269020966581,-0.0426581090157666,-0.0208523633938766,1.15950204984179e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,-0.0586011413674873,0.0102654190936067,-0.0787213627909565,-0.0384809199440182,1.16317680091639e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,40359,-0.0150282230137948,0.00263691262826598,-0.0201965717651961,-0.00985987426239342,1.2252290379653e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,37987,0.0134025833330366,0.00235286155687235,0.00879097468156678,0.0180141919845064,1.24990314774145e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,40042,-0.0457212702537443,0.00802938295857149,-0.0614588608525444,-0.0299836796549442,1.26152676934702e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,-0.0431896915515376,0.00758469933007491,-0.0580557022384844,-0.0283236808645907,1.26517127442147e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.0202080970789026,0.00355303473405705,0.0132441490001508,0.0271720451576544,1.31230417794913e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,37810,0.016436660669502,0.00289116477462201,0.0107699777112429,0.0221033436277611,1.33445294479407e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,-0.0339349450588955,0.00597201603122108,-0.0456400964800888,-0.0222297936377022,1.35703131008705e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,-0.0507015736932914,0.00892784274012325,-0.0682001454639329,-0.0332030019226498,1.37823416033119e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,-0.0140130213091667,0.00246747800507234,-0.0188492781991085,-0.00917676441922487,1.38200922007895e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,-0.0533152749687702,0.0093905587607638,-0.0717207701398672,-0.0349097797976731,1.39089698910992e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,37598,-0.0311038151485997,0.00548346915593834,-0.0418514146942389,-0.0203562156029606,1.43873400380817e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,40044,-0.0302000870116942,0.00532746363813183,-0.0406419157424326,-0.0197582582809558,1.46385559624332e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,-0.0277534022432874,0.00489584864287481,-0.037349265583322,-0.0181575389032528,1.46390046457999e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,37942,-0.0384075691490093,0.00677788809731232,-0.0516922298197414,-0.0251229084782771,1.48640237061943e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",39961,-0.026850127169833,0.00474364499269893,-0.0361476713555229,-0.0175525829841431,1.53844473834916e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,-0.0145742831646573,0.0025795984305202,-0.0196302960884769,-0.00951827024083776,1.63846221406879e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,-0.0413200416807462,0.00732660579956074,-0.0556801890478852,-0.0269598943136071,1.73752649295773e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,40360,0.0336387285896839,0.00596593656054404,0.0219454929310175,0.0453319642483502,1.74487288977095e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,-0.0263471476424573,0.00467380173635283,-0.0355077990457088,-0.0171864962392057,1.76314460020555e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,40291,-0.0377249701375459,0.00670990667510705,-0.0508763872207557,-0.0245735530543361,1.91634339386529e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,-0.0134589681777222,0.00239529760440557,-0.0181537514823571,-0.00876418487308728,1.95373599982508e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,-0.0346415226448559,0.0061658363301735,-0.046726561851996,-0.0225564834377158,1.96659732391575e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,0.0181446955022829,0.00323001792149406,0.0118138603761546,0.0244755306284113,1.96963809560078e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,0.0156150331920438,0.0027861888702555,0.010154103006343,0.0210759633777446,2.13033273102496e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,-0.0362224917925917,0.00646454128041145,-0.0488929927021981,-0.0235519908829853,2.144752360082e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,37900,-0.0348209067069744,0.00621555523647273,-0.047003394970461,-0.0226384184434879,2.15776816836896e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,-0.0257414430592447,0.00460115709582857,-0.0347597109670687,-0.0167231751514207,2.25475910315188e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,-0.0429142916057149,0.00767602897850131,-0.0579593084035775,-0.0278692748078523,2.2989184043699e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,40536,-0.046689450903089,0.00836475934954531,-0.0630843792281978,-0.0302945225779802,2.42047045125774e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,40271,-0.0287384462132562,0.00514902202648524,-0.0388305293851673,-0.0186463630413452,2.42590689511558e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,-0.0241843787226798,0.00433625947414167,-0.0326834472919975,-0.0156853101533621,2.4907020303026e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.0630790365202085,0.0113181332617732,-0.085262577713284,-0.040895495327133,2.54064755238043e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,40332,-0.0479487047356031,0.00860950104672559,-0.0648233267871852,-0.0310740826840209,2.59945892931554e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,-0.0387023984839357,0.00695762047798335,-0.0523393346207831,-0.0250654623470884,2.70039371835684e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,-0.0347578101293246,0.00625332520700606,-0.0470143275350565,-0.0225012927235927,2.77610455189942e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,40355,-0.0209200692753398,0.00376534530967008,-0.0283001460822932,-0.0135399924683865,2.80536318284764e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,-0.0203759026358638,0.00366797780053835,-0.0275651391249189,-0.0131866661468086,2.82051128139269e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,-0.0440433040366566,0.00793695475141601,-0.059599735349432,-0.0284868727238812,2.91639549121941e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,-0.022921035047265,0.00414076622566608,-0.0310369368495706,-0.0148051332449595,3.16229420905025e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,-0.016089918364089,0.00290768338846276,-0.021788977805476,-0.010390858922702,3.19575171494927e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,40042,-0.0263790972119957,0.00477158789091489,-0.0357314094781889,-0.0170267849458025,3.28411014612005e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,39961,0.0386405509504293,0.00699048529433303,0.0249391997735366,0.0523419021273221,3.29892277025331e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,40267,-0.0181346733576974,0.00328114355442399,-0.0245657147243684,-0.0117036319910263,3.31021329489689e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,37572,-0.0256476147874797,0.00464094250932593,-0.0347438621057585,-0.0165513674692008,3.33139523068519e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,37998,-0.0434500506113355,0.00786565934199222,-0.0588667429216402,-0.0280333583010308,3.37440834696799e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,40228,0.0179188374626426,0.00324570116440169,0.0115572631804153,0.0242804117448699,3.42801950320589e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,40341,-0.0302242083330023,0.00547466296786922,-0.040954547750026,-0.0194938689159787,3.42856738078443e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,-0.0223779225311478,0.00405364286785431,-0.0303230625521422,-0.0144327825101533,3.43412454457909e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,-0.0201992603290896,0.0036599132773377,-0.0273726903526715,-0.0130258303055077,3.47300671530049e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SORT1,Sortilin,40330,-0.0190303191288364,0.00344909899529758,-0.0257905531596197,-0.0122700850980532,3.49282502832557e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,-0.02420396975977,0.00439107930576211,-0.0328104851990638,-0.0155974543204763,3.61132953199605e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,-0.0246130925415181,0.00447330580823534,-0.0333807719256594,-0.0158454131573769,3.8100341833261e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,-0.0388863021370862,0.00707093175344797,-0.0527453283738442,-0.0250272759003282,3.87864100345866e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,40332,-0.0630836603485133,0.0114819883008237,-0.0855883574181278,-0.0405789632788989,3.98655878591294e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,40310,-0.0243304641101162,0.00443056214361999,-0.0330143659116114,-0.015646562308621,4.0464451364262e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,40015,-0.0251251726025794,0.00458565682938565,-0.0341130599881753,-0.0161372852169836,4.34186460077497e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,39980,-0.0307356492736418,0.00561893241794262,-0.0417487568128093,-0.0197225417344743,4.56953898118249e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,40516,-0.0137948344431579,0.00252661769103411,-0.0187470051175848,-0.00884266376873105,4.83735276067021e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.0329359361358048,0.00603311516546375,-0.0447608418601138,-0.0211110304114959,4.86731385830435e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,-0.0427505995045466,0.00784866367485532,-0.0581339803072631,-0.0273672187018302,5.21827184868348e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,40044,-0.026803006346871,0.00492489300939886,-0.0364557966452928,-0.0171502160484492,5.33752058590787e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,39961,-0.0254957643707868,0.0046874480954345,-0.0346831626378384,-0.0163083661037352,5.43441077042508e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,-0.0179842680051395,0.0033148706749902,-0.0244814145281203,-0.0114871214821587,5.88629364540251e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,37942,-0.0514150262181964,0.00949220115439234,-0.0700197404808054,-0.0328103119555874,6.18002034524926e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,40194,0.0146839929862607,0.00271153413325397,0.00936938608508287,0.0199985998874384,6.2054958021239e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,40042,-0.0156886636117255,0.00290245024290228,-0.021377466087814,-0.00999986113563707,6.56450572814926e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,40350,-0.0477495691824133,0.00883413764199293,-0.0650644789607194,-0.0304346594041071,6.5698756500783e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,-0.0364350374435633,0.00674258776549481,-0.0496505094639332,-0.0232195654231935,6.63787466293704e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,-0.027052531072549,0.00500681496059656,-0.0368658883953182,-0.0172391737497797,6.64499946740814e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,-0.0423694652801556,0.00785124877663775,-0.0577579128823656,-0.0269810176779456,6.91195124279433e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0312732297712508,0.0057971178221058,-0.0426355807025782,-0.0199108788399234,6.96408240447918e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,37998,-0.0463449221756175,0.00859682910739221,-0.0631947072261062,-0.0294951371251288,7.12680219599409e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,40471,0.0152006914265714,0.00282067601900199,0.00967216642932746,0.0207292164238153,7.18428988245656e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,40471,-0.0152440365878858,0.00282917640449685,-0.0207892223406996,-0.00969885083507198,7.2191141303372e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,40536,0.0150691648660548,0.00280052805690902,0.0095801298745131,0.0205581998575965,7.51811603400945e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,-0.0446937806136567,0.00831190261691905,-0.060985109742818,-0.0284024514844953,7.69681133565065e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,-0.0138305874592352,0.00257400468906069,-0.0188756366497941,-0.0087855382686762,7.84486458257097e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,-0.0313023204810721,0.00583050262976363,-0.0427301056354088,-0.0198745353267354,8.06390957500473e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,-0.0229740422944408,0.00428292941871522,-0.0313685839551226,-0.014579500633759,8.24948746034072e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,40207,-0.0228677226128338,0.00427238825759507,-0.0312416035977201,-0.0144938416279474,8.79886568668708e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,40042,-0.0250332527500841,0.00467726389752018,-0.0342006899892236,-0.0158658155109445,8.81620686352798e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,40116,-0.0343982251560909,0.00643415464557061,-0.0470091682614093,-0.0217872820507725,9.10832156336268e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,39980,-0.0350117137251138,0.00654950311414979,-0.0478487398288473,-0.0221746876213802,9.13389064765691e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,40314,-0.0205413353335644,0.00384266578155046,-0.0280729602654033,-0.0130097104017255,9.13674414350851e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,-0.0343834675405254,0.00643285603922573,-0.0469918653774078,-0.0217750697036429,9.19435543837076e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,37562,-0.0203818502308043,0.00382061373725603,-0.0278702531558261,-0.0128934473057825,9.72909370601557e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,40172,-0.0356404504650719,0.00668325167268591,-0.0487396237435362,-0.0225412771866075,9.80470837280102e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,-0.0295303537326303,0.00554009807218567,-0.0403889459541142,-0.0186717615111464,9.94029708841079e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,-0.0539529148145069,0.010121949043534,-0.0737919349398335,-0.0341138946891803,9.96630571851252e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,40516,-0.038703630982547,0.00726218405098298,-0.0529375117224736,-0.0244697502426203,9.9826780483045e-08
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,40359,-0.0202666551688435,0.00380366199632949,-0.0277218326816493,-0.0128114776560377,1.00544591496736e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,40192,-0.0157841578097164,0.002963771964751,-0.0215931508606283,-0.0099751647588044,1.0194758579702e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,-0.0356594443991506,0.00670609805458148,-0.0488033965861303,-0.0225154922121709,1.06909367527964e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,40311,-0.0443384158444241,0.00834646168658471,-0.0606974807501301,-0.0279793509387181,1.09747776029181e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,37812,-0.0505941165933181,0.00953631016878094,-0.0692852845241287,-0.0319029486625074,1.14209896574407e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,39961,-0.0356426781229146,0.00672265175896141,-0.0488190755704789,-0.0224662806753502,1.16188719953704e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,39961,-0.0338974150168323,0.00639459556679545,-0.0464308223277514,-0.0213640077059133,1.16781366282449e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,-0.0180193863396751,0.00339941800744597,-0.0246822456342692,-0.011356527045081,1.17213313023593e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,37990,-0.0270646000765136,0.00510787981520363,-0.0370760445143127,-0.0170531556387144,1.18525074587872e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,37628,-0.015137313321315,0.00286106730786358,-0.0207450052447276,-0.00952962139790236,1.23738532432293e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,40305,-0.0375349417325837,0.00709838795788956,-0.0514477821300472,-0.0236221013351201,1.25430807263852e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,40497,0.0239134869232365,0.00452863997449997,0.0150373525732165,0.0327896212732564,1.30511330973204e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,-0.0350132859690819,0.00663087030045322,-0.0480097917579702,-0.0220167801801936,1.30939745518342e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0275082782908781,0.00523056477271368,-0.0377601852453969,-0.0172563713363593,1.46605975085941e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,-0.0166318991310659,0.00316329220542745,-0.0228319518537037,-0.0104318464084281,1.48036723066641e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,39934,-0.0347036742038886,0.00660629448002194,-0.0476520113847316,-0.0217553370230456,1.51522959895011e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,40435,-0.0220515607758903,0.00420292393637691,-0.030289291691189,-0.0138138298605915,1.56808796992476e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,40305,0.0379509596577955,0.00723356980902145,0.0237731628321135,0.0521287564834775,1.57007002806539e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,-0.0193007256616855,0.00369092492425549,-0.0265349385132262,-0.0120665128101447,1.72372948479538e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,-0.0277493668766237,0.00530770569999939,-0.0381524700486225,-0.0173462637046249,1.73829943218811e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,-0.0127706969813203,0.00244864810185391,-0.017570047260954,-0.00797134670168662,1.86118239771262e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,40332,-0.0328409803318126,0.00630244138083063,-0.0451937654382407,-0.0204881952253846,1.90345328280601e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,-0.0397125543433201,0.00762507378528345,-0.0546576989624757,-0.0247674097241646,1.93532060018873e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,-0.0154214300001879,0.00296439668542448,-0.0212316475036199,-0.0096112124967559,1.99344044424154e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,-0.0222041308372923,0.00426879498384435,-0.0305709690056272,-0.0138372926689574,2.00148820649057e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,37901,-0.0172815915509042,0.00332218918889824,-0.0237930823611448,-0.0107701007406637,2.0019303430624e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,-0.0326194731718261,0.00628298834455769,-0.0449341303271592,-0.020304816016493,2.10985998085268e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,40359,-0.033827511805648,0.00652416013433993,-0.0466148656689543,-0.0210401579423417,2.18708131229216e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,-0.0241168368130842,0.00465161500694839,-0.033234002226703,-0.0149996713994653,2.19672389699287e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,37959,-0.0283875177613999,0.00548600267399648,-0.039140083002433,-0.0176349525203668,2.31752290884868e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,-0.0443411969873253,0.00859725159154351,-0.0611918101067506,-0.0274905838679,2.53672400484319e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,40032,-0.0212700485904413,0.00412448404528161,-0.0293540373191933,-0.0131860598616894,2.53984376370939e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,39903,-0.0560953483018762,0.010890190291871,-0.0774401212739434,-0.034750575329809,2.62290461060725e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,40354,-0.0376995062459087,0.00732474351574458,-0.052056003536768,-0.0233430089550493,2.68022770220258e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,-0.0157296751639874,0.00305660344015514,-0.0217206179066915,-0.00973873242128332,2.69740952015353e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,-0.0448094118120333,0.0087141464265721,-0.0618891388081146,-0.027729684815952,2.75512536933015e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.0132410346487733,0.0025803961860925,-0.0182986111735146,-0.00818345812403203,2.9097463530862e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,40044,-0.0144476725454712,0.00281593299959534,-0.0199669012246781,-0.00892844386626438,2.92150132153364e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,-0.0357252112792893,0.00698092264667083,-0.0494078196667641,-0.0220426028918145,3.13859889493535e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,-0.0463866330485531,0.00907015259301961,-0.0641641321308715,-0.0286091339662347,3.19394976378692e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,-0.0371573374554716,0.00727500792489794,-0.0514163529882716,-0.0228983219226716,3.30258175529709e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,37942,-0.0289117159736847,0.00566203938856276,-0.0400093131752677,-0.0178141187721017,3.33115191766046e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,-0.0211585049570452,0.00414665982969016,-0.0292859582232379,-0.0130310516908525,3.39058519881113e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,-0.0135856546105742,0.00266401991015651,-0.018807133634481,-0.00836417558666748,3.44971725762309e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2,Complement C2,40372,-0.0116254630411605,0.00228185445648254,-0.0160978977758663,-0.00715302830645472,3.53207443229807e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,37671,0.0106110697729491,0.00208388238688071,0.00652666029466295,0.0146954792512353,3.59234116814784e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,-0.0533726875919317,0.0104918753340767,-0.073936763246722,-0.0328086119371415,3.67798923379462e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,37598,-0.030864369556275,0.00606979273018622,-0.04276116330744,-0.01896757580511,3.72854625441515e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,-0.0137849991475322,0.00271849592019202,-0.0191132511511086,-0.00845674714395586,4.00510976354367e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,-0.0107562273763449,0.00212186416921804,-0.0149150811480123,-0.00659737360467758,4.0391781206606e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,37714,-0.0162537046439055,0.00320637579301992,-0.0225382011982246,-0.00996920808958646,4.04911250123187e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,-0.0372945220599511,0.00737274137750245,-0.0517450951598559,-0.0228439489600463,4.28400984109468e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,-0.0250339341314556,0.00494998246136662,-0.0347358997557341,-0.015331968507177,4.2977522107318e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,-0.0218257003342888,0.00431710191980881,-0.0302872200971141,-0.0133641805714636,4.34714486671373e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,-0.0245739296120213,0.00486735052302357,-0.0341139366371475,-0.0150339225868951,4.4979603021641e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,40396,-0.0413612678907829,0.00819351540715634,-0.0574205580888093,-0.0253019776927565,4.5126238058881e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,-0.00991816383224703,0.00196998259356929,-0.0137793297156429,-0.00605699794885121,4.84050939602412e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,-0.0320186638277004,0.00635925790973587,-0.0444828093307827,-0.0195545183246181,4.84085812607959e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,37990,-0.0250715922807336,0.00498043705657376,-0.0348332489116182,-0.0153099356498491,4.86483938575414e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,-0.0273704935496622,0.00543782421251034,-0.0380286290061824,-0.0167123580931419,4.8833191440484e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,-0.00904805056340048,0.00179976465465085,-0.0125755892865161,-0.00552051184028481,5.02720593385638e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,0.0128009770909508,0.00254630677509163,0.00781021581177119,0.0177917383701304,5.03887163569569e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,-0.0227920824091234,0.00453561080188772,-0.0316818795808234,-0.0139022852374235,5.09497175427497e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,37671,-0.0452870167081448,0.00901466545132481,-0.0629557609927414,-0.0276182724235481,5.13458148351734e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,-0.0418193683757341,0.00832665166932649,-0.0581396056476141,-0.0254991311038542,5.15971058925739e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,40453,-0.0247030852550448,0.00492208699056025,-0.0343503757565429,-0.0150557947535468,5.25469889884565e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,37900,-0.0212917279230694,0.00425131627031599,-0.0296243078128887,-0.0129591480332501,5.56185909312173e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,37608,-0.0198339723698707,0.00396297514526402,-0.0276014036545882,-0.0120665410851532,5.66374217254419e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.0136536573086907,0.00273253741453291,0.00829788397620614,0.0190094306411752,5.90740955550732e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,-0.0136169847109059,0.0027256143374539,-0.0189591888123155,-0.00827478060949627,5.91803709596115e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,-0.0446714785975226,0.00897183353501533,-0.0622562723261527,-0.0270866848688926,6.45583952510836e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,-0.0329377898527492,0.0066169698698479,-0.0459070507976511,-0.0199685289078473,6.51362706269845e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,40042,-0.0224227160899317,0.00450528340291272,-0.0312530715596406,-0.0135923606202227,6.52721073605859e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,37714,-0.0258902934484849,0.00521076348883503,-0.0361033898866015,-0.0156771970103682,6.8272441407839e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,0.0118638253836267,0.00238986651253094,0.00717968701906605,0.0165479637481873,6.98372047519609e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,40332,0.00915628186047898,0.0018453690432973,0.00553935853561628,0.0127732051853417,7.05794565086783e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,-0.0253445937119945,0.00511989513872343,-0.0353795881838924,-0.0153095992400966,7.49081656149982e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,40514,0.019715636923983,0.00398795446819194,0.0118992461663268,0.0275320276816392,7.73883873942831e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,-0.0310225595955332,0.00627870368020967,-0.0433288188087441,-0.0187163003823222,7.85681473011e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,40258,-0.0196928852890875,0.00398937241501928,-0.0275120552225253,-0.0118737153556497,8.04149589590663e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,37990,-0.0129040554725356,0.00261397530407378,-0.0180274470685202,-0.00778066387655103,8.04580343247648e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0154500847459646,0.00313784076460355,-0.0216002526445875,-0.00929991684734161,8.58892157921697e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,40305,-0.0400537802358766,0.00815198468896386,-0.0560316702262457,-0.0240758902455074,9.04139636809006e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,-0.0351085819426195,0.00715702465994854,-0.0491363502761187,-0.0210808136091204,9.41480457941216e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,-0.0300284093128875,0.00612875903798694,-0.0420407770273419,-0.0180160415984331,9.70058159854819e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,0.0131475010408923,0.002684826055968,0.00788524197119502,0.0184097601105896,9.82796129457538e-07
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,-0.0391473157063853,0.00803843610190551,-0.0549026504661201,-0.0233919809466505,1.12687717897987e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,-0.040582557895332,0.00833335391025196,-0.0569159315594259,-0.0242491842312382,1.12949814337964e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,-0.0259826390398281,0.00533555901423558,-0.0364403347077298,-0.0155249433719263,1.13058122005818e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,-0.0393610906634032,0.00808490766829179,-0.0552075096932551,-0.0235146716335513,1.13549197488152e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,37541,-0.0297397146776362,0.0061094216478087,-0.0417141811073412,-0.0177652482479311,1.14138598467551e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,37901,-0.0142440698812,0.002933540693903,-0.0199938096412499,-0.00849433012115014,1.21378803436625e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,40522,-0.0155769934732385,0.00321121096934044,-0.0218709669731458,-0.00928301997333128,1.24106525328172e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,37911,-0.0264260876174053,0.00545551548067272,-0.0371188979595239,-0.0157332772752868,1.28718621097716e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,-0.0460756685146486,0.00951788420148768,-0.0647307215495644,-0.0274206154797328,1.30691213928779e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,0.0302693084099879,0.00625347756823969,0.0180124923762381,0.0425261244437377,1.31015838789874e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,37562,-0.0282505340078027,0.00584519833755779,-0.039707122749416,-0.0167939452661894,1.35934187062921e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,40216,-0.0222228507520438,0.00460147452411623,-0.0312417408193116,-0.013203960684776,1.38157170381107e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.0213110315076375,0.00441522705485017,-0.0299648765351439,-0.0126571864801312,1.40127269475294e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,-0.0339393846861277,0.00703369403990426,-0.04772542500434,-0.0201533443679153,1.41133043908102e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,-0.0321707938670421,0.00666738507582171,-0.0452388686156527,-0.0191027191184316,1.41491164842845e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,-0.0308744808508334,0.0064085325882961,-0.0434352047238938,-0.0183137569777731,1.46818611820371e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.00927397138525341,0.00192616640306847,0.00549868523523921,0.0130492575352676,1.49044926721328e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,40471,-0.0134506601363277,0.00279543524596693,-0.0189297132184228,-0.00797160705423248,1.51051736511334e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,-0.0240722621138703,0.00500337357566604,-0.0338788743221757,-0.0142656499055649,1.51431547218983e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,-0.0150455969860891,0.00312750166359425,-0.0211755002467338,-0.00891569372544434,1.51737512821791e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,-0.0278012107497902,0.00577902864061834,-0.0391281068854022,-0.0164743146141783,1.52070466646946e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,37748,-0.0129823061826185,0.00269938761725706,-0.0182731059124423,-0.00769150645279465,1.53080019618675e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,-0.0334437073819702,0.00695823632776279,-0.0470818505843852,-0.0198055641795551,1.55152253719996e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,37942,-0.0171344061766571,0.00356572569563557,-0.0241232285401029,-0.0101455838132114,1.5617829423795e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,-0.0252733416564679,0.00527042480571194,-0.0356033742756633,-0.0149433090372725,1.64160651945982e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,40192,-0.034817787849745,0.00726447283072937,-0.0490561545979745,-0.0205794211015154,1.65900654042879e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,39923,-0.0344779855705849,0.00720402529075204,-0.0485978751404589,-0.020358096000711,1.71767010766254e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,-0.0335155668132812,0.00700369276753661,-0.0472428046376529,-0.0197883289889094,1.72487201221321e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,0.0214062387911774,0.00447489825778983,0.0126354382059093,0.0301770393764454,1.73706903300943e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,-0.0174075682714218,0.00364037156982596,-0.0245426965482807,-0.0102724399945629,1.75319002573116e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,-0.010713442761794,0.00224319800666595,-0.0151101108548592,-0.00631677466872871,1.80770464983369e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,0.0108403391763509,0.00227220354246232,0.00638682023312479,0.0152938581195771,1.85074501854294e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,-0.0243202947204431,0.00511192595622874,-0.0343396695946514,-0.0143009198462347,1.97673629188517e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,37987,0.0215854132883762,0.00454155408005252,0.0126839672914733,0.0304868592852792,2.02613151708298e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0169916745080649,0.0035756821305173,0.00998333753225104,0.0240000114838789,2.03209058203637e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,-0.0182161567903874,0.0038435940572481,-0.0257496011425937,-0.0106827124381811,2.1659534823846e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,-0.0101934763929573,0.00215232663237764,-0.0144120365924175,-0.00597491619349714,2.19845361009944e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,40516,-0.0273774861233541,0.00578101615883947,-0.0387082777946795,-0.0160466944520288,2.20103682864037e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,-0.0278670049314162,0.00589321337433812,-0.0394177031451189,-0.0163163067177135,2.28358153654411e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,-0.00966406376381733,0.00204768637651328,-0.0136775290617833,-0.0056505984658513,2.38802793942581e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,-0.0186911852434078,0.00396222237698596,-0.0264571411023003,-0.0109252293845153,2.41391131885196e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,40489,-0.027166506948918,0.00576295401186856,-0.0384618968121804,-0.0158711170856556,2.44954855996828e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,-0.0276124357822077,0.0058597624743266,-0.0390975702318879,-0.0161273013325276,2.47577437167613e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,-0.0471269584814956,0.0100422583666955,-0.0668097848802187,-0.0274441320827725,2.72053745472004e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,40341,-0.0236289587193977,0.00504009705884175,-0.0335075489547275,-0.0137503684840678,2.77914959285265e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,-0.0558208644704873,0.0119488666923355,-0.079240643187465,-0.0324010857535097,3.01742232949927e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,37901,-0.0315896127191092,0.0067777042784099,-0.0448739131047926,-0.0183053123334258,3.17986877856351e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,39961,-0.032091969531129,0.00688700839352268,-0.0455905059824334,-0.0185934330798245,3.19173937613638e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,-0.0155367339835427,0.0033398280095846,-0.0220827968823285,-0.00899067108475692,3.31448987662643e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,-0.0209978226574935,0.00451699151500478,-0.0298511260269028,-0.0121445192880841,3.37389135570811e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,40341,-0.0135689110712385,0.00292076896270037,-0.0192936182381312,-0.00784420390434576,3.4170359307874e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,-0.0146016006749544,0.00314391502755934,-0.0207636741289707,-0.00843952722093805,3.43850862321255e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,40171,-0.025786515881222,0.00555535008745887,-0.0366750020526414,-0.0148980297098026,3.48272087589945e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,-0.0526875163551767,0.0113540035772132,-0.0749413633665145,-0.0304336693438388,3.50445540117523e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,-0.015294452413503,0.00330036286715707,-0.0217631636331309,-0.00882574119387516,3.61235082847385e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,-0.0340858795904618,0.00736090035190235,-0.0485132442801904,-0.0196585149007332,3.6795105371995e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,-0.017401960573512,0.00376328923306158,-0.0247780074703127,-0.0100259136767113,3.79644596490289e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,-0.015505227634795,0.00335345445986148,-0.0220779983761235,-0.00893245689346653,3.80622218331086e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,39961,-0.0270111136345394,0.0058436606392194,-0.0384646884874095,-0.0155575387816694,3.82580033290138e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,-0.0192099359863747,0.00416256604910808,-0.0273685654426266,-0.0110513065301229,3.96392335121688e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,-0.0230578448142782,0.00500270639134707,-0.0328631493413185,-0.013252540287238,4.07673783616322e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,39961,-0.0162981623483979,0.00354061982769971,-0.0232377772106893,-0.00935854748610643,4.19359712055743e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,-0.0268609627756481,0.00583570556001043,-0.0382989456732685,-0.0154229798780276,4.20628133818765e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,37562,-0.053513615973794,0.0116385580184872,-0.0763251896900289,-0.0307020422575592,4.30638198781532e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,-0.0176862846120623,0.00386925443713354,-0.0252700233088441,-0.0101025459152806,4.898734588948e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.0120788053046738,0.00264531597486765,-0.0172636246154144,-0.00689398599393324,5.01233345658192e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,40042,-0.0193428528009214,0.0042598515513441,-0.0276921618415559,-0.010993543760287,5.64785060059963e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,-0.0206788641103304,0.00455725474064991,-0.0296110834020042,-0.0117466448186566,5.73974117567308e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,-0.0155369950499767,0.00343747045795574,-0.0222744371475699,-0.00879955295238342,6.24065688786861e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0158958242402259,0.00352291369875435,0.00899091339066742,0.0228007350897845,6.4736893271565e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,-0.0216025374175864,0.00479285526066396,-0.0309965337284877,-0.012208541106685,6.62429721320693e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,40429,0.0109950365583472,0.00244275793882449,0.00620723099825119,0.0157828421184432,6.80882931257165e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,0.0296393922945273,0.00659081296987306,0.0167213988735761,0.0425573857154785,6.9470606633956e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBN1,Drebrin,37598,-0.0221097434580161,0.00492777366220081,-0.0317681798359297,-0.0124513070801025,7.29277485444159e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,37900,-0.0167583792772171,0.00374088816142569,-0.0240905200736115,-0.00942623848082278,7.53339426719793e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,-0.0377007512559874,0.0084303988911642,-0.0542243330826692,-0.0211771694293055,7.81216037404828e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,40312,-0.0285451730004754,0.00638413269171602,-0.0410580730762388,-0.016032272924712,7.829635936513e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,39896,-0.013011954963552,0.00291172836196026,-0.0187189425529941,-0.00730496737410988,7.92159458253497e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,0.0250335285949668,0.00560906910704539,0.0140397531451579,0.0360273040447758,8.13535033903922e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,37819,-0.0189236397626853,0.00425295777073392,-0.0272594369933237,-0.0105878425320468,8.67562446612505e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,-0.0383355588228952,0.00865227496434365,-0.0552940177530087,-0.0213770998927816,9.46707404174765e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,-0.0218285848800176,0.00492898631467617,-0.0314893980567829,-0.0121677717032523,9.55882768538493e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,40341,-0.0328828705143634,0.00742929820586011,-0.0474442949978492,-0.0183214460308775,9.65879239172084e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,37628,-0.0122983678537315,0.00277907987005102,-0.0177453643990315,-0.0068513713084315,9.70646895172438e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,-0.0323050484821862,0.00730297382069425,-0.0466188771707469,-0.0179912197936255,9.77537785788472e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,40359,-0.032078567909229,0.00725376356611016,-0.0462959444988049,-0.0178611913196531,9.82876874526419e-06
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00733911787352854,0.00166162441978192,0.00408233401075597,0.0105959017363011,1.00818492590912e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,0.0137443053111765,0.00311495712110931,0.00763898935380226,0.0198496212685508,1.03041158749657e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,37598,0.0180711652131399,0.00409781698505395,0.0100394439224342,0.0261028865038456,1.04216035663316e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,-0.0496380386791455,0.0112786182203441,-0.07174413039102,-0.027531946967271,1.08414619630475e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,-0.0323484866842143,0.00736765778220494,-0.046789095937336,-0.0179078774310926,1.13921547118463e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,-0.0472494918826167,0.0107930218814867,-0.0684038147703306,-0.0260951689949027,1.20798444488873e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,40489,0.018896203158489,0.00432127467623325,0.0104265047930718,0.0273659015239062,1.23418431260744e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,-0.0112326694343404,0.0025709626613043,-0.0162717562504968,-0.00619358261818399,1.25581372742638e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,-0.0221483697145555,0.00507086020051268,-0.0320872557075603,-0.0122094837215506,1.26478185275486e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,-0.0339811867167073,0.00781071572448123,-0.0492901895366905,-0.0186721838967241,1.36621178993607e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENG,Endoglin,40536,0.0070548131913181,0.00162191503582101,0.00387585972110892,0.0102337666615273,1.37174837072951e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,0.0209813490013311,0.00482534180431973,0.0115236790648644,0.0304390189377978,1.38295339629847e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,-0.0105964815073594,0.00244060766136865,-0.015380072523642,-0.00581289049107687,1.42411230468883e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,-0.0301900928188679,0.00697062542643851,-0.0438525186546874,-0.0165276669830484,1.49315025898442e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,40341,-0.0258419851580324,0.00597185743344775,-0.03754682572759,-0.0141371445884748,1.51874361474637e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,39934,-0.0256047803220764,0.00591780816357029,-0.0372036843226741,-0.0140058763214786,1.52285161382665e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,40489,0.0129250094754879,0.00298876966723513,0.00706702092770709,0.0187829980232688,1.53783767816596e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,-0.0280050954703035,0.00647674829917537,-0.0406995221366872,-0.0153106688039198,1.54215770773113e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSPN,Persephin,40341,-0.0407776054880021,0.0094326106106132,-0.059265522284804,-0.0222896886912003,1.54826571321056e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,39990,-0.0368676683543378,0.00854047146141509,-0.0536069924187114,-0.0201283442899643,1.59273792004177e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,40305,-0.0132227310609316,0.00307094880217028,-0.0192417907131854,-0.00720367140867786,1.67422358618034e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,37942,-0.0109218981646122,0.00253738866580009,-0.0158951799495804,-0.00594861637964399,1.68631312190332e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,40434,-0.0252424422257078,0.00586662928714487,-0.0367410356285118,-0.0137438488229039,1.69719394628473e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,40359,-0.0351060520577267,0.00816847826477319,-0.0511162694566822,-0.0190958346587713,1.73568740784136e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,-0.0260884256017099,0.00607640394698907,-0.0379981773378085,-0.0141786738656114,1.77000492028968e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,37990,-0.0397273987473305,0.00925971911774909,-0.0578764482181187,-0.0215783492765423,1.79633344718213e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,40305,0.0116879585997612,0.00272742387746272,0.00634220779993426,0.0170337093995881,1.83530306462974e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,-0.0244996148525569,0.00572296692176245,-0.0357166300192113,-0.0132825996859025,1.87226781083906e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.0128263787739938,0.00299737290098181,0.00695152788806945,0.0187012296599181,1.88657185487897e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,-0.0281312742205818,0.00657470497808219,-0.0410176959776229,-0.0152448524635408,1.89309917072036e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,39961,-0.0213030826614469,0.00498628976406021,-0.0310762105990049,-0.0115299547238889,1.94592839876142e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,-0.0295677936911182,0.00692680496639828,-0.0431443314252588,-0.0159912559569775,1.9804158740522e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,-0.0222759528623555,0.00522116631598543,-0.032509438841687,-0.0120424668830241,1.99741601452298e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,40341,-0.0260512938352699,0.00610879058811954,-0.0380245233879842,-0.0140780642825556,2.0145529514105e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,-0.0351846139312416,0.00826773914559945,-0.0513893826566166,-0.0189798452058667,2.09630147707618e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,-0.0233611770676115,0.00550748771880608,-0.0341558529964714,-0.0125665011387516,2.2310605734087e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,-0.0220982740462974,0.00521066730572053,-0.0323111819655097,-0.0118853661270852,2.24045775296201e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0164722748631369,0.00388989899299095,0.00884807283687468,0.0240964768893992,2.30231132169525e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,-0.0352010688174865,0.00834302712209946,-0.0515534019768014,-0.0188487356581715,2.46792985850028e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,0.0107672302525297,0.00255331068097244,0.00576274131782373,0.0157717191872357,2.49256957813618e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),37735,0.0707913222292779,0.0168191298139938,0.0378258277938502,0.103756816664706,2.58217156830255e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,-0.0265500654459982,0.0063148684751417,-0.0389272076572759,-0.0141729232347205,2.63237570274327e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,40257,-0.0266233091205967,0.00633835034894845,-0.0390464758045357,-0.0142001424366578,2.67960066710208e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,40471,-0.0380284369919188,0.00905837935985808,-0.0557828605372406,-0.020274013446597,2.7055673006055e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,-0.0154252379306369,0.00367469857664894,-0.0226276471408688,-0.00822282872040492,2.71427518306824e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,38013,-0.0147154707021533,0.00351465941565884,-0.0216042031568446,-0.00782673824746197,2.84595999610306e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,-0.0209511205499687,0.00500682595137372,-0.0307644994146612,-0.0111377416852762,2.87301055637358e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,-0.016599094583001,0.00396900109693356,-0.0243783367329908,-0.00881985243301124,2.90554826356015e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,-0.0189457302889056,0.00453195447274106,-0.0278283610554781,-0.0100630995223331,2.92492704226707e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,40489,-0.0180235367054329,0.00431496021590615,-0.0264808587286089,-0.0095662146822568,2.96957032882998e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,-0.0464866133312373,0.0111444946420134,-0.0683298228295835,-0.0246434038328911,3.0486700680951e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,-0.0149157101343685,0.00357757627870073,-0.0219277596406219,-0.00790366062811504,3.07549866288105e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,-0.014905616351436,0.00358219608863631,-0.0219267206851632,-0.00788451201770885,3.18782844098388e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,-0.00869351643154033,0.00209066786312342,-0.0127912254432622,-0.00459580741981844,3.22679971646001e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,37855,-0.0190096681869032,0.0045808567516191,-0.0279881474200766,-0.0100311889537297,3.34811600488117e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,-0.0127039672772877,0.0030619968090189,-0.0187054810229647,-0.00670245353161064,3.3581083772821e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,40288,-0.0428226981685984,0.0103228752505248,-0.063055533659627,-0.0225898626775697,3.3665611237551e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,-0.0405090631208099,0.00977284884853541,-0.0596638468639393,-0.0213542793776805,3.4184678581866e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,-0.0207664642356186,0.00501517037993079,-0.0305961981802829,-0.0109367302909542,3.48032382170794e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCN,Decorin,40042,0.00897062594240476,0.00216891094650592,0.00471956048725316,0.0132216913975564,3.5525689391898e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,40309,-0.0106706764162475,0.00258039766977635,-0.0157282558490091,-0.00561309698348582,3.56341663829202e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,39980,0.0332075269583173,0.00804832235062005,0.017432815151102,0.0489822387655326,3.71021765100903e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,37598,-0.0130027052968519,0.00315234417754404,-0.0191812998848383,-0.00682411070886562,3.73383321600209e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,-0.0314747651992727,0.0076332210903569,-0.0464358785363722,-0.0165136518621732,3.7527458764032e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,0.0178114078127488,0.00433717822527582,0.00931053849120818,0.0263122771342894,4.03386515643647e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,-0.0200634155621763,0.0048871708372284,-0.0296422704031439,-0.0104845607212086,4.06196727739333e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLU,Clusterin,38013,0.0129500221281201,0.00316000026076656,0.00675642161701769,0.0191436226392226,4.1896482654147e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,-0.0163659967850415,0.00399382103146386,-0.0241938860067107,-0.00853810756337238,4.19152129870505e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,37987,0.00873913120755267,0.00213391474596625,0.00455665830545882,0.0129216041096465,4.23979365264164e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,39946,-0.0219404904462859,0.00535785247715604,-0.0324418813015117,-0.01143909959106,4.24282808815367e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.0191209508819599,0.004669247905347,-0.02827267677644,-0.00996922498747979,4.24540305597339e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,-0.0435952361751522,0.0106682443293393,-0.0645049950606571,-0.0226854772896472,4.40229809010667e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,40379,0.0129575695604257,0.00317343495186603,0.00673763705476831,0.0191775020660832,4.46488418186745e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,37598,-0.0203468608840064,0.00499032424881143,-0.0301278964116768,-0.010565825356336,4.58373710721606e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,0.0152301881480018,0.00373586964809827,0.00790788363772924,0.0225524926582745,4.59386654984919e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,40024,-0.0163863477986355,0.0040224917347555,-0.0242704315987562,-0.00850226399851469,4.65050393337642e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,37562,0.0143081241392978,0.00352350197417409,0.00740206026991655,0.021214188008679,4.91959018610939e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALB1,Calbindin,40305,-0.016365474054049,0.00403254807603369,-0.0242692682830751,-0.00846167982502301,4.96585542626617e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,-0.0485445762461989,0.0119618524433507,-0.0719898070351663,-0.0250993454572315,4.97132289386026e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,-0.0188227034605541,0.00464070611682861,-0.0279184874495382,-0.00972691947157005,5.01583170011606e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,-0.0313217554219876,0.00772296139457941,-0.0464587597553633,-0.016184751088612,5.02286901853754e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,-0.0293511631651124,0.00723727416614581,-0.0435362205307582,-0.0151661057994666,5.03014376845458e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,40228,-0.0128635144596363,0.00318604235463422,-0.0191081574747193,-0.00661887144455318,5.42886584944899e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,40305,-0.0107901039141532,0.00267527633743645,-0.0160336455355287,-0.0055465622927778,5.5264331116102e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,-0.0277631608714513,0.0068862609518536,-0.0412602323370844,-0.0142660894058183,5.56843454701906e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,39980,-0.0283659697727475,0.00704038500587698,-0.0421651243842664,-0.0145668151612286,5.62726075094833e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",38013,-0.00628165272690918,0.00156019953479919,-0.0093396438151156,-0.00322366163870277,5.69973768644378e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,-0.0238251106047984,0.00591963047709555,-0.0354275863399056,-0.0122226348696911,5.73516139000682e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.0181430349855483,0.00450962647031604,0.00930416710372885,0.0269819028673677,5.77305268707727e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,0.0173533926222376,0.00431548902614063,0.008895034131002,0.0258117511134733,5.82201627018965e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,-0.0116788222841284,0.00290506329444998,-0.0173727463412503,-0.00598489822700638,5.84829238336832e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,-0.0157871799935793,0.00392793077171071,-0.0234859243061323,-0.00808843568102633,5.87205645162984e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,0.0154235470003361,0.00384303815934196,0.00789119220802582,0.0229559017926463,6.01899304710795e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,37598,0.0102250877924813,0.00255279584381227,0.00522160793860922,0.0152285676463533,6.22410415087886e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,-0.011822811376833,0.00295553018474517,-0.0176156505389336,-0.00602997221473248,6.3617224758674e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,-0.0318014572315564,0.00796288829562604,-0.0474087182909835,-0.0161941961721294,6.53477297306377e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0262697369006162,0.00658605541867288,-0.0391784055212151,-0.0133610682800174,6.67373319711331e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,37942,-0.0275588365690954,0.00691069468067629,-0.0411037981432209,-0.0140138749949699,6.70255064269751e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,37714,-0.0282340964251568,0.0070824820436709,-0.0421157612307518,-0.0143524316195619,6.74231448654288e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,-0.0152748215173297,0.00383184701150282,-0.0227852416598752,-0.00776440137478419,6.74688087414502e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,37967,0.0401980041333899,0.0100922593688239,0.020417175770495,0.0599788324962849,6.83920911463573e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNC,Tenascin,40403,0.0178759769534579,0.00450178018431265,0.0090524877922051,0.0266994661147107,7.19253011722908e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPL,Periplakin,37598,-0.0124842759940794,0.00314546505482873,-0.0186493875015437,-0.00631916448661507,7.25657872864036e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,37604,0.0129960461507401,0.00327454141710633,0.00657794497321167,0.0194141473282685,7.2614930778313e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,37598,-0.0107799716935206,0.00272021578303163,-0.0161115946282626,-0.00544834875877864,7.44328559311138e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,-0.0152820706056923,0.00386701037164334,-0.0228614109341132,-0.00770273027727135,7.78735961990924e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,-0.0367888057208789,0.00931809131439966,-0.0550522646971023,-0.0185253467446556,7.91733442049107e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,-0.0232643970818266,0.0058952535593545,-0.0348190940581614,-0.0117097001054918,7.97824304620445e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,-0.0254487138185436,0.006454460657228,-0.0380994567067105,-0.0127979709303767,8.0885713767368e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,40471,-0.00969750649085955,0.00246398967206928,-0.0145269262481153,-0.00486808673360377,8.33074359989919e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.0184572571855157,0.00470163144777749,-0.0276724548231596,-0.00924205954787184,8.68372825792234e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,37598,-0.044165785188866,0.0112502816927899,-0.0662163373067341,-0.0221152330709979,8.69011054267275e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,37598,0.01297881405354,0.00330794551696535,0.00649524084028794,0.0194623872667921,8.77059876131982e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,-0.0349767147177581,0.00895025352852554,-0.0525192116336681,-0.017434217801848,9.34900914692981e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,37959,-0.0307744868947428,0.00787690743543624,-0.0462132254681978,-0.0153357483212878,9.39337273139402e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,37671,-0.0133904941078033,0.00342826907487255,-0.0201099014945535,-0.00667108672105306,9.4340339161831e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,37901,-0.0208149209283157,0.00533353897604123,-0.0312686573213565,-0.0103611845352749,9.56101370356667e-05
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,39980,-0.0278671516587695,0.00716822341068974,-0.0419168695437213,-0.0138174337738176,0.00010166338300665
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,0.0146298223240569,0.00376499915806585,0.00725042397424786,0.022009220673866,0.000102430525087496
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,40332,0.0123293620683638,0.00317631586444823,0.00610378297404525,0.0185549411626823,0.000104167584208508
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,37541,0.0134817973061968,0.0034763363109069,0.00666817813681927,0.0202954164755743,0.000105763161977021
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,-0.0118891118158445,0.00306626851642133,-0.0178989981080303,-0.00587922552365869,0.000106010562367182
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,-0.0161248458540837,0.00416957511499725,-0.0242972130794783,-0.00795247862868912,0.000110579581342887
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,37714,0.0108056683847974,0.00281868647369868,0.00528104289634795,0.0163302938732468,0.00012687375803191
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,37628,-0.0153488545872586,0.00400468971938257,-0.0231980464372485,-0.0074996627372688,0.00012732309394299
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,37628,-0.0427830859228802,0.0111756245422093,-0.0646873100256105,-0.02087886182015,0.000129654678564646
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,-0.0349212058835363,0.00912290682294506,-0.0528021032565086,-0.017040308510564,0.000129860309691761
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAT,Catalase,37786,-0.0198943487003696,0.00520312718562322,-0.0300924779841911,-0.00969621941654808,0.000132149532068642
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,-0.0141284137693906,0.00369656529792812,-0.0213736817533297,-0.00688314578545148,0.000132945495205965
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,39903,-0.0154869026330854,0.00406104093230215,-0.0234465428603976,-0.00752726240577322,0.00013752830697614
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,40536,-0.00702766626412658,0.0018452264166366,-0.0106443100407343,-0.00341102248751884,0.000140294559600334
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,-0.0135540931615997,0.00358238487725833,-0.020575567521026,-0.00653261880217333,0.000155301827069535
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,-0.0125989902563066,0.00333012336989279,-0.0191260320612964,-0.00607194845131671,0.000155316151625629
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0101495368999599,0.00268554710791015,0.004885864568456,0.0154132092314638,0.000157832372461965
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",40489,-0.0265088192896564,0.00701604596768843,-0.0402602693863257,-0.012757369192987,0.000158465250356967
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,40044,-0.0298741143534794,0.00791837350694955,-0.0453941264271005,-0.0143541022798583,0.000162049549778871
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,40305,0.00545270690981952,0.0014453453022122,0.0026198301174836,0.00828558370215543,0.000162144144718384
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,37714,-0.0192562089771973,0.00510817978420185,-0.0292682413542329,-0.00924417660016166,0.000164165147393704
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.012470618919627,0.00331043406007701,0.0059821681618761,0.018959069677378,0.000165776652315377
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,-0.0357399157964268,0.00949131139328688,-0.0543428861272691,-0.0171369454655846,0.000166787616813609
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,-0.0358499859617081,0.00953844572493905,-0.0545453395825886,-0.0171546323408275,0.000171565610773532
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,-0.0193648740625036,0.00515482797498773,-0.0294683368934795,-0.00926141123152763,0.000172931365077556
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,-0.0226621215179005,0.00603463215236518,-0.0344900005365363,-0.0108342424992648,0.00017384579532566
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,40070,-0.0196430190026936,0.00523703351530573,-0.0299076046926928,-0.00937843331269436,0.00017691435423604
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,40044,-0.0168462985075251,0.00449211233076349,-0.0256508386758215,-0.00804175833922863,0.000177335977061926
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,-0.0147706246872416,0.00394494554216157,-0.0225027179498783,-0.00703853142460497,0.000181755571635751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,40497,-0.0106287549698058,0.00284074623850524,-0.0161966175972761,-0.00506089234233552,0.000183536041147747
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,37562,-0.0136236397548382,0.00364340218278911,-0.0207647080331049,-0.00648257147657156,0.000185345792638163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,-0.0250283396791326,0.00670453116747421,-0.038169220767382,-0.0118874585908832,0.000189976197038262
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,37959,-0.0213131974004208,0.00571008584722899,-0.0325049656609896,-0.0101214291398519,0.000190326487221314
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,-0.0847731087833253,0.0227464819269148,-0.129356213360078,-0.0401900042065722,0.000194666631856009
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,-0.0148022128193393,0.00397679664333007,-0.0225967342402662,-0.00700769139841235,0.000198232253567921
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,-0.0219523800195733,0.0059093045087026,-0.0335346168566304,-0.0103701431825162,0.000204113919350625
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,-0.0126553762194227,0.00341143413806055,-0.0193417871300214,-0.00596896530882405,0.000208218626348693
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,-0.0122024499056718,0.00329171460364656,-0.0186542105288191,-0.00575068928252458,0.000210420537925573
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,-0.0161258945834808,0.00435004787883508,-0.0246519884259976,-0.00759980074096403,0.000210541828733562
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",37714,-0.0158187608706094,0.00427263859267898,-0.0241931325122602,-0.00744438922895858,0.000214485746771593
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MB,Myoglobin,40536,-0.0172137291204843,0.00467522517419614,-0.0263771704619087,-0.00805028777905985,0.000232256248333396
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,40536,0.00817859420060463,0.00222239778545973,0.00382269454110357,0.0125344938601057,0.000233925321030549
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0098692922448889,0.00268490241451863,-0.0151317009773454,-0.00460688351243238,0.000237842621940437
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,-0.0103642216410211,0.00281996081838448,-0.0158913448450547,-0.0048370984369875,0.000238344367433726
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,-0.0311644316757334,0.00849331296082867,-0.0478113250789576,-0.0145175382725093,0.00024418077053795
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,37598,-0.0218388524330014,0.00595237737682627,-0.0335055120915809,-0.0101721927744219,0.000244530735241876
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,-0.0306170286100799,0.00834888178872839,-0.0469808369159876,-0.0142532203041723,0.000246035360292088
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,0.0120059504163084,0.00328064498443331,0.00557588624681909,0.0184360145857976,0.000253571467423573
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,40341,-0.019505284555722,0.00533433078202612,-0.0299605728884932,-0.0090499962229508,0.000256450566240003
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,40359,0.0117983451670381,0.00322920433518966,0.00546910467006634,0.0181275856640098,0.000259381231930482
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,-0.0210831489631154,0.00577569472951796,-0.0324035106329706,-0.00976278729326023,0.000262903660015447
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,37901,-0.0147906749844684,0.00405444232309,-0.0227373819377248,-0.00684396803121201,0.000265271040821028
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,-0.0217367101338921,0.00596277540421447,-0.0334237499261525,-0.0100496703416318,0.000267842839042198
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,38013,0.0260812474871231,0.00715872971299357,0.0120501372496557,0.0401123577245905,0.000270191353582099
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,40278,-0.020584321842287,0.00566170413912481,-0.0316812619549716,-0.00948738172960234,0.000278093785419855
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,-0.0118933612272742,0.00327700201300089,-0.018316285172756,-0.00547043728179245,0.000285039008193956
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,-0.012172826182016,0.00335762144380427,-0.0187537642118724,-0.00559188815215964,0.000289540295967362
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,0.0113696155227479,0.00314429941765583,0.00520678866414243,0.0175324423813533,0.000300168177569302
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,37541,0.00963017585481704,0.00266451483127055,0.00440772678552676,0.0148526249241073,0.000302368727423636
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,37598,-0.01301577778386,0.00360365486060653,-0.0200789413106488,-0.0059526142570712,0.000305180150376587
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00882319587968922,0.00244816998924925,0.0040247827007607,0.0136216090586177,0.000314522518931026
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,40044,-0.0203393802664279,0.00565429971994081,-0.0314218077175119,-0.00925695281534389,0.0003227145130714
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0250086321401602,0.00697729949996661,-0.0386841391600947,-0.0113331251202256,0.000339008724789736
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,0.0197128144863634,0.00550419247055489,0.00892459724407585,0.030501031728651,0.000342978699829258
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,0.0105442481288416,0.00294741024639268,0.00476732404591192,0.0163211722117712,0.00034800222804151
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,-0.0101448429953527,0.00283791019299615,-0.0157071469736252,-0.00458253901708028,0.000351583786942148
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,40209,0.0432503081706884,0.0121068025972285,0.0195209750801206,0.0669796412612563,0.000354783248748926
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,37942,-0.0325754679178901,0.00913988886856875,-0.0504896501002849,-0.0146612857354954,0.000366369330289225
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.0175975931132918,0.00493843318293213,-0.0272769221518388,-0.00791826407474484,0.000367355116025229
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,39980,-0.0275807701531177,0.00774125448962065,-0.0427536289527742,-0.0124079113534613,0.000367978154801766
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,37987,-0.0179276092337909,0.00503724119373925,-0.0278006019735198,-0.00805461649406194,0.000373525063842572
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,-0.0201565033787392,0.005671246796809,-0.0312721471004848,-0.00904085965699354,0.000380525481175443
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,37900,-0.0183192564954118,0.00516200000769018,-0.0284367765104845,-0.00820173648033901,0.000388210175379393
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,0.00952838333984419,0.00268521613085205,0.00426535972337418,0.0147914069563142,0.00038863539662945
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,-0.0222436542697415,0.00627799088014876,-0.0345485163948331,-0.00993879214464996,0.000396553790067311
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,40379,-0.00810060549430941,0.00228998194068728,-0.0125889700980565,-0.00361224089056234,0.000405220675418801
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,-0.00689671040175524,0.00195326041057421,-0.0107251008064807,-0.00306831999702979,0.000415611336274287
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,37562,-0.0269700308490502,0.00764596742211753,-0.0419561269964005,-0.0119839347016998,0.000421170866083742
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,-0.0292965323504579,0.00832451106333116,-0.045612574034587,-0.0129804906663289,0.000434121264799537
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,37541,-0.0152778732689192,0.004347976127761,-0.0237999064793308,-0.00675584005850767,0.000443253783311416
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,-0.0121983945320296,0.00347920806062883,-0.0190176423308621,-0.0053791467331971,0.000456259781595564
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,0.00953335490872784,0.00272825383017004,0.00418597740159456,0.0148807324158611,0.000476864033762335
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,-0.012272415395254,0.00352372602310641,-0.0191789184005426,-0.00536591238996549,0.000497543600537736
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,0.0172893111735304,0.00496837918610793,0.0075512879687589,0.027027334378302,0.000503288614896057
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,37628,-0.0098050056098814,0.00281776148263495,-0.0153278181158459,-0.0042821931039169,0.000503571318956577
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,0.00681151206664066,0.00195840418463113,0.00297303986476365,0.0106499842685177,0.000506339128776361
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.010523897159117,0.00302844611402948,-0.0164596515426148,-0.00458814277561926,0.000512212401870503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,37901,-0.0193525722998549,0.00557220846057362,-0.0302741008825792,-0.00843104371713065,0.000516193198065764
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,39961,-0.0151570159225232,0.00437548603141871,-0.0237329685441038,-0.00658106330094252,0.00053349328751504
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,37959,-0.0143763385009187,0.00416184911350335,-0.0225335627633852,-0.00621911423845209,0.000553385460299311
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,40341,0.0135797808084611,0.00394677728328356,0.00584409733322533,0.0213154642836969,0.000581646197941637
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,-0.0126368166766204,0.00367965591612485,-0.0198489422722251,-0.00542469108101568,0.000596010314468372
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,0.00989663489014284,0.00288710755412863,0.00423790408405072,0.015555365696235,0.000610213253496559
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',37562,-0.0141003327023841,0.00411568731435292,-0.0221670798385159,-0.00603358556625242,0.00061442545194237
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,40341,-0.0223962345692128,0.00653795546550921,-0.0352106272816109,-0.00958184185681477,0.000615058586095113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,37572,-0.0229720161083651,0.00670737200540527,-0.0361184652389594,-0.00982556697777073,0.000616929203526819
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,0.0215885114527147,0.00630433725625522,0.00923201043045445,0.0339450124749749,0.000618065401046501
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,-0.033037728344291,0.00965219542456602,-0.0519560313764404,-0.0141194253121416,0.000621644845526593
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,39951,-0.0359978136426696,0.0105258453326323,-0.056628470494629,-0.0153671567907102,0.000627951449558157
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,0.0108489343797064,0.00318438356868437,0.00460754258508503,0.0170903261743278,0.000658984653553376
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,37655,0.0120516559506145,0.00354099753559635,0.00511130078084561,0.0189920111203833,0.000667349901785015
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.0206961398533404,0.0060819561785056,0.00877550574346939,0.0326167739632113,0.000668445377909014
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,40250,0.0164618371858672,0.00484130551835025,0.00697287836990076,0.0259507960018337,0.000674812482726241
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,-0.0177855330180567,0.00523051886419267,-0.0280373499918743,-0.00753371604423905,0.000674982085387752
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,-0.02570467862302,0.00756312444408151,-0.0405284025334198,-0.0108809547126202,0.000679070856920041
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,-0.0185280857459316,0.00545254786802745,-0.0292150795672654,-0.0078410919245978,0.000680368226647286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,-0.0132388719055867,0.00389737210232721,-0.0208777212261481,-0.00560002258502537,0.000683321302731129
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FST,Follistatin,40396,-0.0166927365297608,0.00493959844461904,-0.0263743494812141,-0.0070111235783075,0.000728259160641057
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,39980,-0.0142058850992616,0.00420496679906423,-0.0224476200254275,-0.00596415017309573,0.000730991550330819
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,-0.0118497462590701,0.00351161146661354,-0.0187325047336326,-0.00496698778450757,0.00074140282545158
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,-0.010088445831512,0.00298999054183554,-0.0159488272935097,-0.00422806436951438,0.000742419009379787
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,-0.0213820851177465,0.00635825082716614,-0.0338442567389921,-0.00891991349650084,0.000773537541894485
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0100639795133011,0.00299791337709892,-0.015939889732415,-0.00418806929418719,0.000790167854649574
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,37986,-0.0116140868284648,0.00347855264825421,-0.018432050019043,-0.00479612363788651,0.00084377361382839
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFD,Complement factor D,38013,-0.00606961565644752,0.001818742609673,-0.00963435117140659,-0.00250488014148845,0.00084836497555353
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.0101764377862223,0.00305227487410614,0.0041939790329743,0.0161588965394704,0.000857906679737291
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F3,Tissue factor,40393,0.00883905612696075,0.00266593074692783,0.00361383186298221,0.0140642803909393,0.000916635620074168
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0218950327622858,0.00662027036110013,0.00891930285452957,0.0348707626700421,0.000944200479110358
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,40044,-0.015688636923656,0.0047449374612358,-0.0249887143476782,-0.00638855949963382,0.000947183246718002
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,37598,-0.00824966361548924,0.00249967114899942,-0.0131490190675281,-0.00335030816345038,0.000968387589482471
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.00975324562733815,0.00295792534868848,0.00395571194390873,0.0155507793107676,0.00097862308862287
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,40173,-0.0324682495906324,0.00985284446743135,-0.0517798247467978,-0.0131566744344669,0.000985281545292787
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,37482,0.00812715365985995,0.00247264098906744,0.00328077732128777,0.0129735299984321,0.0010158954739155
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,37562,0.0128986755133874,0.00392456950240083,0.00520651928868176,0.020590831738093,0.0010165425240048
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,-0.009945946552744,0.00302673867756846,-0.0158783543607782,-0.00401353874470982,0.00101830197189891
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,37671,-0.0349815491358721,0.0106567808121198,-0.055868839527627,-0.0140942587441173,0.00103135102276169
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,37987,0.0452549017526188,0.0137910927379946,0.0182243599861493,0.0722854435190882,0.00103533019358442
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,-0.0187835856069935,0.00572442449273728,-0.0300034576127586,-0.00756371360122847,0.00103555658634361
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,-0.0134815455159227,0.00410921928460408,-0.0215356153137467,-0.00542747571809871,0.00103778622323914
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,39725,0.00983930521020535,0.00300626800003067,0.00394701993014524,0.0157315904902655,0.00106675210521923
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.0132002347763703,0.00403678463985478,0.00528813688225493,0.0211123326704857,0.00107821560264165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,37352,0.0121154857945437,0.00370926055431581,0.00484533510808468,0.0193856364810027,0.00109254686095511
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,-0.00691851871390734,0.00213164363535048,-0.0110965402391943,-0.00274049718862039,0.00117477138478918
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,37900,-0.024081827886421,0.00742847900129105,-0.0386416467289515,-0.00952200904389059,0.0011905624314577
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,37562,-0.0186589323109067,0.00575796542526161,-0.0299445445444195,-0.00737332007739396,0.0011960006167513
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,-0.0117791525711556,0.00363896659483366,-0.0189115270970296,-0.00464677804528164,0.00121106816749278
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,40042,-0.0395266204655139,0.0122125475380447,-0.0634632136400815,-0.0155900272909463,0.00121233184996146
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,37900,-0.0157491719155815,0.00487099295146706,-0.0252963181004569,-0.00620202573070601,0.00122682593070314
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,-0.0211477645794866,0.0065532647608951,-0.033992163510841,-0.00830336564813222,0.00125373882251811
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,0.0126153253000246,0.00391152407462864,0.00494873811375249,0.0202819124862967,0.0012615360412139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,37901,-0.013974497591038,0.00433758597895408,-0.022476166109788,-0.00547282907228797,0.00127725825542322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,38013,-0.00636785384452029,0.00197963858952071,-0.0102479454799809,-0.00248776220905969,0.00129989775551141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,0.0102639641720822,0.00319210734405953,0.00400743377772553,0.0165204945664389,0.00130516790501507
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,-0.0311161872340744,0.00971645288186453,-0.0501604348825288,-0.0120719395856199,0.00136594195412588
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,37572,-0.0183889846421116,0.00575951913502128,-0.0296776421467533,-0.00710032713746991,0.00141233692131579
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,37714,0.0106718340367171,0.00336008394844363,0.00408606949776763,0.0172575985756667,0.00149631024945247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,-0.0125268578921603,0.00395458301356903,-0.0202778405987556,-0.00477587518556497,0.00153957538149329
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,-0.00658051203264174,0.00208832347620101,-0.0106736260459957,-0.00248739801928777,0.00162960505060111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,-0.0118246736563944,0.00375859082486894,-0.0191915116731375,-0.00445783563965125,0.00165858732072838
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,-0.00857986358984208,0.00272928164243958,-0.0139292556090237,-0.0032304715706605,0.00167234109606772
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,37900,-0.0112280480230309,0.00357575361698185,-0.0182365251123153,-0.00421957093374648,0.00169284298050192
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,40305,-0.0123124288585081,0.00392579598051537,-0.0200069889803183,-0.004617868736698,0.00171413657152078
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,37628,-0.0157646735912436,0.0050286756813471,-0.0256208779266839,-0.00590846925580327,0.00172257886322983
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,-0.00723660905732313,0.00231165795733971,-0.011767458653709,-0.00270575946093731,0.00174834871365586
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,-0.0117217703346426,0.00374506425358195,-0.0190620962716632,-0.00438144439762194,0.00175223423896364
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,37959,-0.0082699792013459,0.00264244626667744,-0.0134491738840337,-0.00309078451865812,0.00175376757146948
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,39980,-0.0104197252726086,0.00334566103584986,-0.0169772209028744,-0.00386222964234289,0.00184655052633527
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,40013,-0.0213721892815064,0.00688843432078708,-0.034873520550249,-0.00787085801276368,0.00192159659609804
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,37482,-0.0106218785695881,0.0034247238461678,-0.017334337308077,-0.00390941983109924,0.0019293552432292
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,-0.0228584209087036,0.00739043455079355,-0.0373436726282589,-0.00837316918914821,0.00198580534814144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,-0.0128458817177285,0.00415575766677062,-0.0209911667445989,-0.0047005966908581,0.00199764911391196
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,-0.00874616567896433,0.00283227996225176,-0.0142974344049778,-0.00319489695295088,0.00201838847815317
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,37541,0.0222840035715358,0.00722022636589016,0.00813235989439108,0.0364356472486805,0.00203066705667296
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0102154876601417,0.0033140818973185,0.00371988714139739,0.0167110881788859,0.00205652293863726
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,-0.0155506749825077,0.0050490737744521,-0.0254468595804338,-0.00565449038458153,0.0020749367785642
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,37901,-0.0176957884738404,0.00574922587215574,-0.0289642711832656,-0.00642730576441511,0.00208854277879203
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,37541,0.0129364447017326,0.00421207872327667,0.00468077040411035,0.0211921189993549,0.00213585155672222
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,-0.0139222868577211,0.00453416500207251,-0.0228092502617833,-0.00503532345365901,0.00214050031408237
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,40221,0.00833985453010585,0.00273093422865479,0.00298722344194246,0.0136924856182693,0.00226304137102658
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,39961,-0.00969633483230446,0.00317968027844823,-0.015928508178063,-0.00346416148654593,0.00229633236636149
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,-0.016406142799583,0.00538378133576215,-0.0269583542176768,-0.00585393138148918,0.00231344470095933
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,40332,0.00685526519023567,0.00225190855168705,0.00244152442892906,0.0112690059515423,0.00233679976817177
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,-0.0156181784086963,0.00513733791559447,-0.0256873607232614,-0.00554899609413111,0.00236941683878515
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,0.00852009988453366,0.00280841634632274,0.0030156038457411,0.0140245959233262,0.00241986957286726
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,-0.0343125905915213,0.0113147761391292,-0.0564895518242146,-0.012135629358828,0.00242890398467305
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,39961,0.0101199452694294,0.00335442872124853,0.00354526497578225,0.0166946255630765,0.00255795802081993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,-0.0115307723640495,0.00382199149920871,-0.0190218757024986,-0.00403966902560044,0.00255818373135205
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,37900,0.033758035211053,0.0111986335022163,0.011808713546709,0.055707356875397,0.00257901747663853
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,40359,0.0108308217181154,0.00360682097810372,0.00376145260103209,0.0179001908351987,0.00267860504254252
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,-0.0211987658970485,0.00707870057224346,-0.0350730190186457,-0.00732451277545129,0.00275198823457479
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,37628,-0.00643086517225597,0.00214910656229913,-0.0106431140343623,-0.00221861631014967,0.00277357334978016
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,-0.0172401956655748,0.00576517254412981,-0.0285399338520693,-0.00594045747908042,0.00279038565607127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LXN,Latexin,40183,0.0188484044923505,0.00630855293487477,0.00648364073999595,0.031213168244705,0.00281469185335951
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,-0.0104926343297341,0.00351980827564101,-0.0173914585499905,-0.00359381010947777,0.00287800135352128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,-0.00897910534361263,0.00301708388332097,-0.0148925897549217,-0.00306562093230353,0.00292390741024979
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,-0.00781492300656868,0.0026265006334805,-0.0129628642481905,-0.0026669817649469,0.0029304573205528
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,37562,0.0104395223829677,0.00351241404672259,0.00355519085139143,0.017323853914544,0.00296231555009331
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,0.016991573678538,0.00571779050292744,0.00578470429280017,0.0281984430642757,0.00296690870711796
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,38013,-0.00737485085223624,0.00248200379944853,-0.0122395782991554,-0.00251012340531712,0.00297033668153631
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,40305,0.00600016400627789,0.00201964383601964,0.0020416620876794,0.00995866592487639,0.00297371733912926
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,-0.00737951038567561,0.00248546201099396,-0.0122510159272238,-0.00250800484412745,0.00299143712781693
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,0.00824004357330667,0.00277725515054233,0.0027966234782437,0.0136834636683696,0.00301283028711439
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,40316,-0.0360388603401866,0.0121518593754509,-0.0598565047160703,-0.0122212159643029,0.00302437226189922
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,37598,-0.00476829550660658,0.00161069858611371,-0.00792526473538946,-0.0016113262778237,0.0030779865184589
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,-0.0149245173666743,0.00504760677221805,-0.0248178266402216,-0.0050312080931269,0.0031143902578
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,-0.0149797551054989,0.00507094200260306,-0.0249188014306009,-0.0050407087803969,0.00314190038615657
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,40182,0.0194736676834659,0.00660366332438787,0.0065304875676657,0.0324168477992661,0.00319356702316918
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,37900,-0.0172348047113733,0.0058447890532516,-0.0286905912557464,-0.00577901816700017,0.00319613859571751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,40279,-0.0201168603188524,0.00682331954510104,-0.0334905666272505,-0.0067431540104544,0.00320044042131121
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,-0.0250802179546848,0.00852457363620467,-0.0417883822816459,-0.00837205362772363,0.00326561180701221
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,-0.0162718200560112,0.00553964880299041,-0.0271295317098725,-0.00541410840215004,0.00331517932808138
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,-0.0105500044575481,0.00359740811651091,-0.0176009243659095,-0.00349908454918675,0.00336538024009803
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,-0.00801935819819082,0.00273532493399183,-0.0133805950688148,-0.00265812132756684,0.00337610232450501
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,40077,-0.00953534751063868,0.00325698949394307,-0.0159190469187671,-0.00315164810251025,0.00342019384615674
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,-0.0243515392004251,0.00834051674308077,-0.0406989520168634,-0.00800412638398675,0.00350986876782554
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,40042,-0.0105921287508228,0.00362823358084547,-0.0177034665692799,-0.0034807909323657,0.00351250024041624
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,37714,0.00989238005127246,0.00339321091196152,0.00324168666382788,0.016543073438717,0.00355890316006962
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,40471,-0.0181903232725019,0.00624101827359114,-0.0304227190887406,-0.00595792745626332,0.00356591662137682
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,37998,0.00904767597775981,0.00311226264947432,0.00294764118479014,0.0151477107707295,0.00365381705804478
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,40176,0.00735710764738512,0.00253149682183053,0.00239537387659727,0.012318841418173,0.00366324963886888
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,0.0104342931042443,0.0035997878715264,0.00337870887605259,0.0174898773324361,0.00375471039784752
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,-0.0133931147593649,0.00463327285507117,-0.0224743295553044,-0.0043118999634254,0.00385073184055826
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,37714,0.0101090903227758,0.00350816772365503,0.00323308158441196,0.0169850990611397,0.00396312846139441
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,37628,-0.0188224591593515,0.00653328495876879,-0.0316276976785383,-0.00601722064016466,0.00397042737378877
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,-0.0131735702954776,0.00457612628742238,-0.0221427778188255,-0.00420436277212976,0.00399871121943965
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0110472842480403,0.00386188175618399,0.00347799600591971,0.0186165724901609,0.00423514472285402
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,40422,-0.00891182689918844,0.00311730415206026,-0.0150217430372265,-0.00280191076115033,0.00425763764382949
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,-0.016138300912927,0.00565365080053786,-0.0272194564819812,-0.00505714534387276,0.00431725464928269
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,37457,0.0110517674263886,0.00388375800629118,0.00343960173405784,0.0186639331187193,0.0044391907926186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,-0.00220951150600482,0.000776702501480072,-0.00373184840890576,-0.000687174603103878,0.00445163439520729
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,40305,0.00760664794877922,0.00269429274117452,0.00232583417607717,0.0128874617214813,0.0047599503814148
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,-0.00810114797134199,0.00287683226633071,-0.0137397392133502,-0.0024625567293338,0.00486875775419943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,40471,0.00826701050999686,0.00293792153594919,0.00250868429953645,0.0140253367204573,0.00490044537709198
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,37551,-0.0185256617884826,0.00658748250623354,-0.0314371275007003,-0.00561419607626485,0.00492690873143421
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,-0.0147389213339382,0.00526096007841914,-0.0250504030876397,-0.00442743958023668,0.00509184081002313
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,40228,-0.0161977901006823,0.00578660957666228,-0.0275395448709403,-0.0048560353304242,0.00512939980048898
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,40184,0.0124619573658214,0.00445853753742388,0.00372322379247062,0.0212006909391722,0.00519501392225895
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,37562,0.00853272484548411,0.00305834765314411,0.00253836344532166,0.0145270862456466,0.00527876185222925
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,40359,-0.0119456030565735,0.00428175807265827,-0.0203378488789837,-0.00355335723416327,0.00527898651327507
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,-0.0207586723796,0.00744156437915154,-0.0353441385627371,-0.00617320619646301,0.00528558961483164
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,37572,-0.0138418857285814,0.0049727418126312,-0.0235884596813386,-0.00409531177582427,0.00538441664683742
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,-0.0104396197503604,0.0037679067600152,-0.0178247169999902,-0.00305452250073063,0.00560069500879071
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,-0.0182201217196022,0.0065835791624883,-0.0311239368780792,-0.00531630656112508,0.00565509452716734
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,37998,0.0132053247434358,0.00477437694979483,0.00384754592183796,0.0225631035650337,0.0056847366988721
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,37714,0.00912556009798875,0.00330022518725996,0.00265711873095922,0.0155940014650183,0.00569783089623254
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,40354,-0.0103076114528906,0.00372857238026633,-0.0176156133182126,-0.00299960958756855,0.00570770222017853
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,37562,0.0137750664894167,0.00498537607933156,0.00400372937392689,0.0235464036049066,0.00573359801958601
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,0.00837980873198093,0.00303305943474169,0.00243501223988722,0.0143246052240747,0.00573836994280244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,37482,0.00945190548387613,0.00342948959554629,0.0027301058766054,0.0161737050911469,0.00585822136498871
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-0.0149203078201268,0.00542224479853354,-0.0255479076252525,-0.00429270801500102,0.0059356644817103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00773233565431625,0.00281564097632612,0.00221367934071706,0.0132509919679154,0.00603681192592138
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,-0.00860873057133968,0.00313561450984247,-0.0147545350106309,-0.00246292613204843,0.00605045019114527
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,0.00845853983933129,0.00308930383930185,0.00240350431429967,0.0145135753643629,0.00618813541658631
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,37482,0.0119328380774369,0.00437053725990118,0.0033665850480306,0.0204990911068432,0.00633635066319683
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,37990,0.00672498476167351,0.00246648636908527,0.00189067147826637,0.0115592980450806,0.00640837079619295
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,-0.00760364849395427,0.00279252381803499,-0.0130769951773029,-0.00213030181060569,0.00647897437973459
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,-0.0315345590959714,0.0116231810119873,-0.0543159938794665,-0.00875312431247622,0.00667338810919837
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,37482,0.00823928902737513,0.00303765275959502,0.00228548961856889,0.0141930884361814,0.00668882891589635
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,37482,-0.00948204587711234,0.00349910326004054,-0.0163402882667918,-0.00262380348743288,0.00674016487169722
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,40044,-0.00994998658012182,0.00367804153056924,-0.0171589479800375,-0.00274102518020611,0.00683291323756328
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,40536,-0.0184052525221809,0.00680451577397679,-0.0317421034391754,-0.00506840160518636,0.0068405422223798
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.0251612450549569,0.00932785432601039,-0.0434438395339373,-0.00687865057597655,0.00699503787704156
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,39961,-0.0112988660894905,0.0042021842395468,-0.0195351471990022,-0.00306258497997873,0.00717843127343682
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,-0.012657789500957,0.00472942402373568,-0.021927460587479,-0.00338811841443509,0.00745121685227996
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.00524918509165329,0.00196279839915905,0.00140210022930156,0.00909626995400502,0.00749538738934365
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0154137501655626,0.00576498282085078,0.00411438383669502,0.0267131164944301,0.00750994999653116
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,-0.0104168185997498,0.00390555956031891,-0.0180717153379748,-0.00276192186152468,0.00765829708503864
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.00640031455881268,0.00240338810006757,0.00168967388268023,0.0111109552349451,0.00775159235922882
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRNN,Cornulin,39857,0.0167982998311213,0.0063103769101168,0.0044299610872924,0.0291666385749503,0.00777557125366268
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,37959,-0.00764660569062729,0.00287488306110069,-0.0132813764903846,-0.00201183489086993,0.00782800291108091
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.0137238253736717,0.00516118294038163,0.00360790681052373,0.0238397439368197,0.00784573577377217
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,0.0100275739635434,0.0038112083207443,0.00255760565488454,0.0174975422722022,0.00851974733375087
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,39831,-0.0148168002991821,0.00563163941218635,-0.0258548135470674,-0.00377878705129688,0.00852208442027503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,0.0131257586878699,0.00499479969242505,0.00333595129071684,0.022915566085023,0.00860175892187341
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,-0.0159416720787467,0.00608249827662865,-0.0278633687009389,-0.00401997545655457,0.00877808485269812
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,40305,-0.0466405821081345,0.0178228618219502,-0.0815733912791569,-0.0117077729371121,0.00888174881769586
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,37598,0.0111724955279787,0.00427124343465876,0.00280085839604755,0.0195441326599099,0.00891340321309907
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,0.00793513931790604,0.00303564853886451,0.00198526818173161,0.0138850104540805,0.00895952985528106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,37942,0.00657337107065736,0.00252124576454949,0.00163172937214036,0.0115150127691743,0.0091388704585007
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.0190071123617196,0.00731346919632675,-0.03334151198652,-0.00467271273691918,0.0093606308868297
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,40268,-0.00922605300739385,0.00355165117204318,-0.0161872893045985,-0.00226481671018923,0.00939428949743606
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.0176166422232613,0.00679495274409992,-0.0309347496016972,-0.00429853484482548,0.00953543007165294
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,40516,-0.0100822669661345,0.00389090846658018,-0.0177084475606316,-0.00245608637163736,0.00957180105547466
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,-0.0118091604278777,0.00456310363329725,-0.0207528435491404,-0.00286547730661513,0.00966481203324232
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,-0.0114058061688867,0.00440794962046527,-0.0200453874249986,-0.00276622491277475,0.00967661677733395
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,37541,-0.0215223094081648,0.00834516272295201,-0.0378788283451507,-0.00516579047117887,0.00991902848589883
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRTN,Neurturin,40044,-0.0121376998284927,0.0047074095602297,-0.0213642225665429,-0.00291117709044253,0.00993428550665522
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00360923957693923,0.00140800343885703,0.000849552836779454,0.006368926317099,0.0103767570856957
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,40048,-0.010132504662773,0.00395842617776498,-0.0178910199711923,-0.00237398935435361,0.0104846743937057
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,0.0150544994685193,0.005886358664044,0.00351723648699305,0.0265917624500455,0.0105532171354482
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,0.00788231774905402,0.00308672625818227,0.00183233428301678,0.0139323012150913,0.0106722406584947
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,-0.0103180556283794,0.00404278928349143,-0.0182419226240226,-0.00239418863273618,0.0107153159381711
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,-0.0139994167471452,0.00549145570185415,-0.0247626699227793,-0.0032361635715111,0.0108049521126073
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,37562,0.0102782019911482,0.00403372612491154,0.00237209878632162,0.0181843051959749,0.0108434924082128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.0050922552647545,0.00200095752767041,0.00117037851052049,0.00901413201898851,0.0109399390054676
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,-0.00846863155981066,0.00332992458241312,-0.0149952837413404,-0.00194197937828095,0.0109941171836336
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,36179,-0.0252711751546964,0.00996279120787675,-0.0447982459221348,-0.00574410438725795,0.0112077484383317
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,0.00616172823601245,0.00244317972248827,0.00137309597993544,0.0109503604920895,0.0116803943127254
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,40456,0.0103452520230734,0.0041022805738839,0.00230478209826096,0.0183857219478859,0.0116842522938169
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,39947,-0.0208561179833667,0.00827459392434844,-0.0370743220750897,-0.00463791389164379,0.0117287660939425
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,37671,-0.00677312565453458,0.00269538609425776,-0.0120560823992798,-0.00149016890978938,0.0119875149556909
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,-0.0120193322467759,0.00480117107835005,-0.021429627560342,-0.00260903693320977,0.0123118177316687
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,40379,0.00783330074471354,0.00313030766649247,0.00169789771838829,0.0139687037710388,0.0123451784156718
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.0196951449440327,0.00789758961784768,-0.0351744205950142,-0.0042158692930513,0.0126499240009479
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,40372,-0.00598035440789506,0.00240243978179577,-0.0106891363802148,-0.00127157243557535,0.0128102053666845
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,37541,0.0227012749075261,0.00911940397591727,0.00482724311472827,0.040575306700324,0.0128104598397963
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,-0.00966169435764686,0.00388491634018618,-0.0172761303844118,-0.00204725833088194,0.0128957450198046
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,-0.00915651885312637,0.00368383578168651,-0.0163768369852319,-0.00193620072102082,0.0129456100144111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,40228,-0.0102272871038754,0.00411714683795207,-0.0182968949062614,-0.00215767930148933,0.0129992703036653
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,37598,-0.00992199330513925,0.00399849545090616,-0.0177590443889153,-0.00208494222136317,0.013097982519594
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,40044,-0.0156452721006432,0.00632213539447735,-0.0280366574738189,-0.00325388672746763,0.013346055896717
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,37482,0.0109626123851436,0.004432326215935,0.00227525300191096,0.0196499717683762,0.0133986427660638
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,-0.0138585727683699,0.00561385162938623,-0.0248617219619669,-0.00285542357477288,0.0135750495387467
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,0.00719018103004063,0.00291271114276151,0.00148126719022808,0.0128990948698532,0.0135764836449411
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0215277984419055,0.00872840707608157,0.00442012057278563,0.0386354763110254,0.0136603593646108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,0.0103891061447676,0.00421242700816856,0.00213274920875717,0.0186454630807779,0.0136644165352277
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,37900,-0.0123721961726335,0.00502971128875551,-0.0222304302985943,-0.00251396204667266,0.0139130700555643
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,40359,-0.00621271068186817,0.00252631997769805,-0.0111642978381564,-0.00126112352557999,0.0139355059048494
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00997678430443585,0.00407693423191614,0.00198599320988021,0.0179675753989915,0.0144129222098332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,-0.0129502702787486,0.00529748067761295,-0.02333333240687,-0.00256720815062725,0.0145139913567028
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00523245977222905,0.00214899115201108,0.00102043711428734,0.00944448243017076,0.0149089781843903
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,37562,0.0130205329256154,0.00535794438375641,0.00251896193345288,0.023522103917778,0.0151064919261587
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,-0.0150587424390597,0.00620944107386708,-0.0272292469438391,-0.00288823793428017,0.0153141224107861
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C5,Complement C5,38013,-0.00353009405785046,0.00146054826928228,-0.00639276866564373,-0.000667419450057189,0.0156636307633038
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,37714,-0.00680914834279257,0.00282408604021671,-0.0123443569816173,-0.00127393970396783,0.0159180788470691
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,-0.0157415895019306,0.0065507296506254,-0.0285810196171564,-0.00290215938670484,0.0162736602220595
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,39801,-0.00804668272547799,0.00336381742302451,-0.014639764874606,-0.00145360057634995,0.0167629431210723
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,37525,-0.0218025977567325,0.00913614344476614,-0.0397094389084742,-0.0038957566049909,0.0170278407811802
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,-0.00714439900486929,0.00299769279183008,-0.0130198768768562,-0.00126892113288233,0.0171723549205602
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,37562,0.00908127820464764,0.00383287484269218,0.00156884351297098,0.0165937128963243,0.0178355911631929
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,-0.0152381011884349,0.00643960246665395,-0.0278597220230766,-0.00261648035379311,0.0179806878955135
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,-0.00879797827121749,0.0037343398553439,-0.0161172843876915,-0.00147867215474344,0.0184891995551622
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,0.0165838718713343,0.00705438591184706,0.00275727548411412,0.0304104682585546,0.0187446523678402
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,40228,0.0124904697848702,0.00531822880133342,0.00206674133425673,0.0229141982354837,0.0188556724570603
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,37959,0.0081101114090832,0.00345862713310941,0.00133120222818876,0.0148890205899776,0.0190469267546715
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,-0.0243760672752905,0.0103975946831258,-0.0447553528542171,-0.00399678169636383,0.0190702522582884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,-0.00976072845751711,0.00416771799572595,-0.01792945572914,-0.00159200118589424,0.0191941102632289
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,37572,-0.0172235337100172,0.00735785977917556,-0.0316449388772013,-0.00280212854283309,0.019255577643731
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,-0.0105225837401352,0.00450485945977796,-0.0193521082813,-0.00169305919897042,0.0195151237138517
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,-0.0102703978366966,0.004398385034743,-0.0188912325047929,-0.00164956316860036,0.0195540363313063
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,-0.0101035694566714,0.00433324099541225,-0.0185967218076795,-0.00161041710566343,0.0197345688575786
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCT,Secretin,37572,-0.0102200881761619,0.00439119990482871,-0.0188268399896262,-0.00161333636269761,0.0199590042028652
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,40003,-0.0138003571349079,0.0059569830119892,-0.0254760438384068,-0.00212467043140912,0.0205347045706751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,-0.0102700522308958,0.00443388126952881,-0.0189604595191723,-0.00157964494261932,0.0205588697698215
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.00711780160337453,0.00308116068547243,0.00107872665984856,0.0131568765469005,0.0208950290732417
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,-0.0125113033744973,0.00542307326786117,-0.0231405269795052,-0.00188207976948945,0.0210651018138339
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BSND,Barttin,37482,0.00755409366437047,0.00328071000866518,0.00112390204738671,0.0139842852813542,0.0213182283892513
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,-0.0128289912268633,0.00558855600121194,-0.0237825609892387,-0.00187542146448791,0.0217129759512627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_DRA,,40288,-0.00784717543831123,0.00342343983730439,-0.0145571175194278,-0.00113723335719462,0.0219077217591787
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,37942,0.00855169513155817,0.00373174639654615,0.00123747219432771,0.0158659180687886,0.0219436825704836
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,40489,-0.00977148448232426,0.00427448140543715,-0.0181494680369811,-0.00139350092766745,0.0222669656211777
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,40359,0.0182035917694219,0.00797626152087191,0.00257011918851295,0.0338370643503308,0.0224894360935011
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,37959,-0.0167912523054422,0.00737140630363688,-0.0312392086605705,-0.00234329595031392,0.0227486869870314
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,37482,0.00816640063528313,0.00358557835532742,0.00113866705884138,0.0151941342117249,0.0227684203557799
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,-0.00636207727231634,0.00279433251836325,-0.0118389690083083,-0.000885185536324366,0.0228125087313593
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,37959,-0.0149065281516987,0.00654865477109429,-0.0277418915030435,-0.0020711648003539,0.0228452350410618
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,37824,-0.00635419682743528,0.00279260788414349,-0.0118277082803565,-0.000880685374514042,0.0228999115799989
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,-0.0155785172026832,0.00685636951004286,-0.0290170014423672,-0.0021400329629992,0.0230950011573541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,40411,-0.0171062680326279,0.00754179409322904,-0.0318881844553568,-0.00232435160989897,0.0233305588549551
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,37562,0.0115552980120426,0.00509847394568523,0.00156228907849956,0.0215483069455857,0.023441728774748
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,0.00924250041769975,0.00407832286244736,0.00124898760730292,0.0172360132280966,0.0234523163228279
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FN1,Fibronectin,38013,-0.00566205207947487,0.00250119127925769,-0.0105643869868199,-0.000759717172129792,0.0236057103869037
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,40332,-0.0076263325000243,0.00337319820989077,-0.0142378009914102,-0.00101486400863839,0.0237813370681077
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,-0.0143760968921209,0.00636005475573513,-0.0268418042133617,-0.00191038957088002,0.0238142467375711
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,37998,0.019607963034771,0.0086895131282081,0.00257651730348313,0.0366394087660589,0.02405465490521
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,-0.0097114661639053,0.00431725088065069,-0.0181732778899806,-0.00124965443782995,0.0244996032038436
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00882570802420607,0.00393014974502948,-0.0165288015244639,-0.00112261452394829,0.0247435595328026
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,39961,0.011227452522729,0.00500464463721976,0.00141834903377828,0.0210365560116798,0.0248846672297921
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,0.00558659573957598,0.00249159934619521,0.000703061021033359,0.0104701304581186,0.0249667880103558
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,37562,-0.0132582326006537,0.00594832530975952,-0.0249169502077823,-0.00159951499352501,0.0258373266238546
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,37787,-0.0131047190779956,0.00588812800570575,-0.0246454499691788,-0.00156398818681228,0.0260564861499914
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,-0.0077695179323068,0.00349487766398767,-0.0146194781537226,-0.000919557710890966,0.0262249598595035
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.0134657689549641,0.00606575765341291,-0.0253546539556534,-0.00157688395427479,0.0264351011819422
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,-0.00497786393360526,0.00225771796563318,-0.00940299114624629,-0.000552736720964234,0.0274810693447288
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,37998,-0.00988443573715528,0.00448644384910734,-0.0186778656814057,-0.00109100579290489,0.0275989556453717
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,-0.0140868644653985,0.00639462602410115,-0.0266203314726368,-0.00155339745816026,0.0276175572174656
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,0.00624692705074795,0.00283805639849754,0.000684336509692772,0.0118095175918031,0.0277442397352428
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,-0.0612752696636951,0.0278485743934419,-0.115858475474841,-0.00669206385254891,0.0277998111538434
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,0.00793469590950196,0.00361159711146792,0.000855965571024829,0.0150134262479791,0.0280375447745202
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,39961,-0.00681103903454357,0.0031018857732989,-0.0128907351502094,-0.00073134291887773,0.0281229053625733
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,-0.0113411309833774,0.00516866865009606,-0.0214717215375657,-0.00121054042918911,0.0282374944849627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAG,S-arrestin,37541,0.0112216360330957,0.00511783094075744,0.00119068738921111,0.0212525846769803,0.0283498060748997
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,0.00632723502749647,0.00288590431954258,0.000670862561193002,0.0119836074937999,0.0283637987796488
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,40044,0.00626521610846237,0.00286727933620581,0.00064534860949898,0.0118850836074258,0.0288982899303516
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.0120929429453435,0.00553440983793057,0.00124549966299961,0.0229403862276874,0.0289031054494153
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,37628,-0.0175159163706021,0.00806185621953942,-0.0333171545608994,-0.00171467818030486,0.0298214009547995
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,39961,-0.0122559202244781,0.0056451323158557,-0.0233203795635553,-0.00119146088540097,0.0299417609065705
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,37572,0.00613282579893861,0.00283809671113974,0.000570156245104715,0.0116954953527725,0.0307215763043098
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,37541,0.0189479085221329,0.00878227449852025,0.00173465050503324,0.0361611665392326,0.0309835242510098
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00318422376311143,0.00147720678891568,0.000288898456836704,0.00607954906938616,0.0311319846611263
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.00778287259401013,0.00361054302657842,-0.0148595369261038,-0.000706208261916433,0.0311328225776913
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.00744312224300151,0.00346773042927597,0.000646370601620621,0.0142398738843824,0.0318563402913222
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,-0.00469290266310466,0.00218754593796333,-0.00898049270151279,-0.00040531262469654,0.0319453046173108
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,-0.0221441476380035,0.010338943684127,-0.0424084772588925,-0.00187981801711458,0.032226894174396
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,-0.0150454111439504,0.0070387475281548,-0.0288413562991338,-0.00124946598876703,0.0325742281584541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,0.0098873441005907,0.00462738162421731,0.000817676117124765,0.0189570120840566,0.0326405445152868
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,-0.0289419489031905,0.0135482195629495,-0.0554964592465715,-0.00238743855980951,0.0326772674472444
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.0145319908477828,0.00680757260780608,0.00118914853648285,0.0278748331590827,0.0328056572752821
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,-0.0178477997602527,0.0083808036071243,-0.0342741748302163,-0.00142142469028905,0.0332227768855289
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,37562,0.0103700870701777,0.00487312905458558,0.000818754123190015,0.0199214200171655,0.0333545204132385
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,-0.00989792378521087,0.00465918093565222,-0.0190299184190892,-0.000765929151332514,0.0336560918263227
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,37900,-0.00904433941046555,0.0042586597815849,-0.017391312582372,-0.000697366238559146,0.0337090460392076
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,37562,0.0073720071603847,0.00347161439961374,0.000567642937141781,0.0141763713836276,0.0337298316679853
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.035270263284416,0.0166281137502124,0.00267916033399967,0.0678613662348324,0.0339271609910872
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,37598,0.00575289251340278,0.00271504639550036,0.000431401578222079,0.0110743834485835,0.0341182197346933
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,-0.00609606888870696,0.0028832865714701,-0.0117473105687884,-0.000444827208625555,0.0345074589789959
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.00824095637021925,0.00391469953944088,0.000568145272915123,0.0159137674675234,0.0352983828478995
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,-0.0160187059873894,0.00762830246880637,-0.0309701788262499,-0.00106723314852889,0.035753279123847
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,0.00664549608033472,0.00316695470759582,0.000438264853446919,0.0128527273072225,0.0358866725214434
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,-0.0091172024564652,0.00436553731440854,-0.0176736555927059,-0.000560749320224464,0.0367735903594797
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,-0.00565550344065727,0.00271093121508479,-0.0109689286222235,-0.000342078259091072,0.0369806844072715
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,-0.0109681151251029,0.00525964735487023,-0.0212770239406485,-0.000659206309557212,0.0370585151361328
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,37598,0.00543367621350158,0.00260783677669514,0.000322316131179108,0.0105450362958241,0.0372162721798093
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.00687348019527841,0.00330285012909619,0.000399893942249891,0.0133470664483069,0.037446484788154
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,0.00822843617814761,0.00395671678230293,0.000473271284833864,0.0159836010714614,0.0375805406075639
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,37990,0.020804357424707,0.0100150842000729,0.00117479239256409,0.04043392245685,0.0377924747710724
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,40489,-0.00402254880365985,0.00193658814306027,-0.00781826156405798,-0.000226836043261716,0.0378052758492064
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,39961,-0.0110626016836136,0.00534410544244488,-0.0215370483508056,-0.000588155016421671,0.0384635417752564
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.0125793086177551,0.00610217257465694,0.00061905037142752,0.0245395668640827,0.039280065710753
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.00522034930348652,0.00253526515999563,0.000251229589895073,0.010189469017078,0.0395014548386933
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,37671,-0.00850620252804484,0.00413460131735726,-0.0166100211100651,-0.000402383946024609,0.0396749207549932
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,40044,0.00630837664416436,0.00306658362947414,0.000297872730395051,0.0123188805579337,0.0396898330777334
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,37934,-0.00506684510904503,0.00246515052610306,-0.00989854014020703,-0.000235150077883031,0.0398605942142386
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,0.0122600091963119,0.00597691955912292,0.000545246860430936,0.0239747715321928,0.040264830199493
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,0.00898998236239372,0.0043842545467321,0.000396843450798814,0.0175831212739886,0.0403339276909941
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,37598,-0.00579716995712052,0.00282818293926567,-0.0113404085180812,-0.000253931396159796,0.0404051090039908
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,37714,0.00606880417882115,0.00296392069571726,0.000259519615215317,0.011878088742427,0.0406228313445069
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,37231,0.0136413821141444,0.00666587299435021,0.000576271045218036,0.0267064931830708,0.040732440998611
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,40236,-0.0134645887055438,0.00658385297482203,-0.026368940536195,-0.00056023687489261,0.0408622813419613
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,0.0120649244230903,0.00591833125951495,0.000464995154441037,0.0236648536917396,0.0415131530300687
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,37671,-0.0152217777189797,0.00747751652695988,-0.0298777101118211,-0.000565845326138372,0.0418031126703719
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,-0.00505131309689,0.00248273466290283,-0.00991747303617955,-0.000185153157600457,0.0419131002846739
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,0.00873626191743646,0.00431058012986194,0.000287524862907059,0.0171849989719659,0.0427130697691089
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,37959,-0.0091792836219248,0.00453447617783214,-0.0180668569304758,-0.000291710313373815,0.0429556805699372
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,37541,0.00885506822699054,0.00440086834950204,0.000229366261966546,0.0174807701920145,0.044227905319387
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00630373068243127,0.00313339364422005,0.000162279139759969,0.0124451822251026,0.0442592278957993
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,37998,-0.00839152258175814,0.00417210795207154,-0.0165688541678184,-0.000214190995697918,0.0443094534029255
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,40044,-0.0117468244231655,0.00584279905726567,-0.0231987105754062,-0.000294938270924784,0.044397709849937
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,40341,-0.0169012433681946,0.00843065305411399,-0.0334253233542581,-0.000377163382131229,0.045008088864
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,37598,0.00642087457226425,0.0032160572793401,0.000117402304757657,0.0127243468397708,0.0458995635118398
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,0.00503203248480786,0.00252356346717329,8.58480891482074e-05,0.00997821688046752,0.0461708272391992
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,37959,-0.0121386921023379,0.00609180071021129,-0.024078621494352,-0.000198762710323751,0.0463222964864092
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,0.00611640223110745,0.00307351605082658,9.23107714873479e-05,0.0121404936907276,0.0466078809778719
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.00536352083531758,0.00269609258895859,-0.0106478623096764,-7.91793609587364e-05,0.0466807379438259
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,40359,0.0223480617689242,0.0112582156428924,0.000281959108855034,0.0444141644289934,0.0471566408181818
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,37900,0.0110424660018128,0.00558898666261282,8.805214309166e-05,0.0219968798605339,0.0482029890725622
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,37714,0.00791275559156596,0.00400550449670117,6.1966778031667e-05,0.0157635444051003,0.0482354892888637
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,40044,-0.00537296906690289,0.00272631765955218,-0.0107165516796252,-2.93864541806264e-05,0.0487668423963283
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,37671,-0.00716174982164072,0.00364937770767037,-0.0143145301286746,-8.96951460679658e-06,0.0497301508156492
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,-0.00834046988128576,0.00426372856619796,-0.0166973778710338,1.64381084622345e-05,0.0504692605260834
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,-0.0193452606538691,0.00992606418833233,-0.0388003464630005,0.000109825155262224,0.0513243901419867
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,37598,0.00645529923999253,0.00332367563291329,-5.9105000517516e-05,0.0129697034805026,0.0521321687034897
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,-0.0100666481055021,0.00519525824799028,-0.020249354271563,0.000116058060558874,0.0526858251119452
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,F2,Prothrombin,38013,0.00272087677414974,0.00140482808953642,-3.25862813416364e-05,0.00547433982964112,0.0527900426328175
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,0.00707157755069323,0.00365220318851081,-8.67406987879599e-05,0.0142298958001744,0.0528585850047217
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.00605307520352369,0.00313103408603905,-8.37516051128435e-05,0.0121899020121602,0.0532267733050899
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,37572,-0.00971508470311247,0.00502806988032122,-0.0195701016685421,0.000139932262317125,0.0533600558335481
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,-0.0114299734998362,0.00592744263175954,-0.0230477610580849,0.000187814058412469,0.0538376240378448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,40044,0.00739868741120134,0.00386119349794965,-0.000169251844779967,0.0149666266671826,0.0553622431114675
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,37643,-0.0151914520196395,0.00793217733617445,-0.0307385195985414,0.000355615559262465,0.0554926857955068
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,0.00661068685656436,0.00345431153873508,-0.000159763759356399,0.0133811374724851,0.0556739273584186
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,0.00897373977600211,0.00469085359219777,-0.000220333264705523,0.0181678128167097,0.0557660618637676
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,0.00859789680816321,0.00449475665127281,-0.000211826228331487,0.0174076198446579,0.055786261400089
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,-0.00618506087235089,0.0032343799825009,-0.0125244456380527,0.000154323893350876,0.0558578484263775
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,39961,0.00599985543539545,0.00313866168123036,-0.000151921459816049,0.012151632330607,0.0559463475650403
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,40500,-0.0110955803061909,0.00580979041549941,-0.0224827695205697,0.000291608908187952,0.0561758348528214
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,40396,0.00553633667910342,0.00290239525936684,-0.000152358029255589,0.0112250313874624,0.0564730298388041
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,0.00452921335115922,0.00238104792275074,-0.000137640577432228,0.00919606727975068,0.0571670927033094
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.00730251737122606,0.00384760195272748,-0.0148438171985719,0.000238782456119796,0.0577259405559251
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,-0.0132356010000619,0.0069947335120825,-0.0269452786837436,0.000474076683619817,0.0584824897012269
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.00514243878035596,0.00272760064320415,-0.0104885360410361,0.000203658480324184,0.059403941235059
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALLD,Palladin,37598,0.00747758423671966,0.00396684796818138,-0.000297437780915844,0.0152526062543552,0.0594492942006747
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,40044,-0.016051275454412,0.00854485105017457,-0.0327991835127541,0.000696632603930169,0.0603350750138311
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,-0.00849350439714839,0.00452540693114017,-0.0173633019821831,0.000376293187886333,0.0605575607569252
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,-0.009553811117711,0.00511690267453884,-0.0195829403598071,0.000475318124385133,0.0619085919690096
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,-0.0068407147923427,0.00366585724095474,-0.014025794984614,0.000344365399928603,0.0620512239000525
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00843098532779768,0.00452849260001188,-0.000444860168225611,0.017306830823821,0.0626579951289468
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,0.00926424661064518,0.00498290675153307,-0.000502250622359634,0.01903074384365,0.0630204329016534
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,-0.00592955249234602,0.00320537786813485,-0.0122120931138903,0.000352988129198294,0.0643500181092838
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRTG,Protogenin,40489,0.00440864488439754,0.00239070575258512,-0.000277138390669287,0.00909442815946438,0.0651903903304174
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00528042919368284,0.00287461022076015,-0.000353806839007051,0.0109146652263727,0.066244356724312
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,37714,0.00691212710791416,0.00377696652135571,-0.000490727273943027,0.0143149814897713,0.0672613515935941
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,37482,-0.0128172092850807,0.00701923639508174,-0.0265749126194409,0.000940494049279499,0.0678713404132208
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,39961,-0.00679523833002903,0.00372179200148565,-0.0140899506529409,0.000499473992882834,0.0678999970326151
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,-0.00823895471511545,0.00452329300160475,-0.0171046089982608,0.000626699568029852,0.0685611691270832
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,-0.0143001334533245,0.00785478606430509,-0.0296955141393625,0.00109524723271344,0.068696227409617
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00512562541971272,0.00281587071601391,-0.0106447320231,0.000393481183674544,0.0687410249158785
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,37562,0.00805500057186111,0.00442724913967554,-0.000622407741902961,0.0167324088856252,0.0688710388204541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,40359,-0.013617186573137,0.0074965398962687,-0.0283104047698237,0.00107603162354962,0.0693182075674326
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,37572,-0.0105858529710941,0.00583145462682103,-0.0220155040396633,0.000843798097475158,0.0695002868827881
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,37482,-0.0123688425350468,0.00682510500264917,-0.0257460483402391,0.0010083632701456,0.069969542958704
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.00779700298526252,0.00431117563112729,-0.016246907222272,0.000652901251746967,0.0705387144975919
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,0.00488685412851003,0.00270886728518266,-0.000422525750447985,0.010196234007468,0.0712468862277651
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.0208077996638255,0.0115446588133832,-0.00181973161040555,0.0434353309380566,0.0715058744660038
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,37714,-0.00396160538185673,0.00219844537904167,-0.00827055832477839,0.000347347561064934,0.0715676174657504
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,37628,-0.00492197209293348,0.00273622428792989,-0.0102849716972761,0.000441027511409112,0.0720702013186658
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,0.014773694827088,0.00824137516233941,-0.00137940049109724,0.0309267901452732,0.0730525691107527
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,-0.00921947735478488,0.00515835615939724,-0.0193298554272035,0.000890900717633701,0.0739101589023266
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.0126469837333234,0.00707764008716788,-0.0265191583041724,0.00122519083752565,0.0739779590592275
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.00846873906558195,0.00474155427825972,-0.017762185450971,0.000824707319807105,0.0741076534863171
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,40411,0.00461146054635893,0.00259317919247743,-0.000471170670896835,0.0096940917636147,0.0753729977979942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,40359,-0.00764143027012576,0.00430029939507241,-0.0160700170844677,0.000787156544216163,0.0755950645978877
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,37482,0.00778028086228362,0.00439404782165015,-0.000832052868150667,0.0163926145927179,0.0766438091759197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,40422,-0.0034452538896755,0.00194779589801852,-0.0072629338497918,0.000372426070440794,0.0769469838457542
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,37562,0.00800645329345383,0.00453154160445243,-0.000875368251272934,0.0168882748381806,0.0772803498166879
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,40398,-0.0250622674910898,0.014197795871861,-0.0528899473999373,0.00276541241775774,0.0775455300842222
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00851398646359514,0.00482356305309351,-0.000940197120468148,0.0179681700476584,0.0775731248024661
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,-0.0104362044756596,0.00592260277763802,-0.0220445059198302,0.00117209696851087,0.0780755148540645
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,37541,0.00845346282724327,0.00479984864368606,-0.000954240514381413,0.017861166168868,0.0782289826626752
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,37541,0.0164895359891319,0.00940950783445936,-0.00195309936640843,0.0349321713446723,0.0797227220447261
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,0.0109522415950343,0.00625088151033995,-0.00129948616523196,0.0232039693553006,0.0797780466038502
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,-0.0101144522435192,0.0057838507426243,-0.0214507996990628,0.00122189521202443,0.0803592784024205
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEO1,Neogenin,37959,0.00355624754005258,0.00203617637771255,-0.000434658160264026,0.00754715324036918,0.0807412534240324
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,-0.0131184726176387,0.00752110094956324,-0.0278598304787827,0.00162288524350526,0.0811436915038974
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,37900,0.00950183629468323,0.00546876825002913,-0.00121694947537387,0.0202206220647403,0.0823266377189284
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,37562,-0.0147172279797996,0.00849862469675294,-0.0313745323854354,0.00194007642583615,0.0833471687559481
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,37934,-0.00771578214949546,0.00445578074256204,-0.0164491124049171,0.00101754810592613,0.083361594603849
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,37671,-0.00853230750344266,0.00492748698178957,-0.0181901819877502,0.0011255669808649,0.0833727994244769
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.00565192024761154,0.00326574555461298,-0.000748941039429902,0.012052781534653,0.0835344673132521
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,37562,0.00784649859679355,0.00454197206943799,-0.00105576665930491,0.016748763852892,0.0840919022067759
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,37981,0.0024244627287432,0.00140588065694641,-0.00033106335887176,0.00517998881635817,0.0846376971660502
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,-0.010626685224949,0.00617175426121978,-0.0227233235769397,0.00146995312704181,0.0851246179140229
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C7,Complement component C7,37678,0.00516900706271931,0.00301465790061188,-0.000739722422479963,0.0110777365479186,0.0864374738399088
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,-0.017629282992778,0.0102827780877086,-0.0377835280446868,0.00252496205913087,0.0864701449264012
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,-0.00873721609147946,0.00509706607393465,-0.0187274655963914,0.00125303341343245,0.0865216549275191
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,40411,-0.00349954945851896,0.00204468692072064,-0.0075071358231314,0.000508036906093491,0.0870021662344937
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,40471,-0.00475669797696233,0.00278212728464636,-0.0102096674548692,0.000696271500944546,0.0873344145632462
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,40044,-0.00888813296766731,0.00520200808633499,-0.0190840688168839,0.00130780288154927,0.0875456142794128
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,40044,-0.00526664995624391,0.00308982319119209,-0.0113227034109804,0.000789403498492589,0.0883048400429607
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,-0.00769169565976198,0.00455679005327376,-0.0166230041641786,0.00123961284465459,0.0914383016426848
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.00426295957177139,0.0025311711833101,-0.000698135947516403,0.00922405509105918,0.092165616658131
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,37598,-0.00761394716235999,0.00452806471576481,-0.016488954005259,0.00126105968053902,0.0926893176021072
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,-0.00769594309765444,0.0045869704705493,-0.0166864052199311,0.00129451902462218,0.0934091915016908
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,-0.00356587631207185,0.00212737890623117,-0.00773553896828494,0.000603786344141235,0.0937220507275394
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,37698,0.0049266585390998,0.00294473459160409,-0.00084502126044422,0.0106983383386438,0.0943430505629858
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,0.00614816415495872,0.00368032890885187,-0.00106528050639095,0.0133616088163084,0.0948350038342113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,0.00608265526729598,0.00364558791908551,-0.00106269705411162,0.0132280075887036,0.095240836272618
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,37457,-0.00559163502110436,0.00335992392994852,-0.0121770859238035,0.000993815881594732,0.0960936092908932
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.0153481577336529,0.00922522960813838,-0.0334296077656041,0.00273329229829833,0.0961931924585237
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,-0.00855555040401999,0.00514965568731333,-0.0186488755511541,0.00153777474311413,0.0966604424177778
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,40341,0.0077484069957561,0.00466409919449968,-0.00139322742546326,0.0168900414169755,0.0966755640603062
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,-0.00377899874053225,0.0022759013683688,-0.0082397654225351,0.000681767941470595,0.096845650634063
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00301379003517798,0.00181593567627654,-0.000545443890324034,0.00657302396067999,0.0970110661787815
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARTN,Artemin,40044,-0.00700860700178078,0.00423449455317782,-0.0153082163260093,0.00129100232244775,0.0979197874423837
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,37857,-0.0112412698008822,0.00682635579545531,-0.0246209271599746,0.0021383875582102,0.0996338347841576
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,0.00734707908704602,0.00447479042960176,-0.00142351015497344,0.0161176683290655,0.100638427619037
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,-0.00631976383478243,0.0038619309215968,-0.0138891484411122,0.00124962077154729,0.10177428500177
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NCLN,Nicalin,40044,-0.00828600832200491,0.00508014315918186,-0.0182430889140013,0.00167107226999153,0.102898270921692
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,40341,0.00541163736960559,0.00331826497099482,-0.00109216197354426,0.0119154367127554,0.102938935350561
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,37648,-0.00891506120957956,0.00546987638919862,-0.0196360189324088,0.00180589651324974,0.103157720878631
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.010242366547943,0.00629763304607828,-0.0225857273182564,0.00210099422237047,0.103892130294757
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCIN,Adseverin,37541,-0.011439598977806,0.00703946811160953,-0.0252369564765607,0.00235775852094869,0.104172612527537
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,-0.00613656782795434,0.00377982366323238,-0.0135450222078898,0.00127188655198113,0.104501018126325
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,40332,-0.00429214522900419,0.00265252075789945,-0.00949108591448711,0.000906795456478728,0.105652672617634
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,-0.0100227828001987,0.00619846742934775,-0.0221717789617203,0.00212621336132285,0.105906577333922
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,37874,-0.00878527099173549,0.00543539429132278,-0.0194386438027281,0.00186810181925715,0.106051251001193
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.00766664218282138,0.00474440291063726,-0.00163238752202765,0.0169656718876704,0.106131861466908
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,40411,0.00563655540771141,0.00352004917669851,-0.00126274097861766,0.0125358517940405,0.109336529256319
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,37598,0.00853694718360446,0.0053518198159095,-0.00195261965557816,0.0190265140227871,0.110703077538078
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,-0.0103918501957016,0.00652305926760794,-0.0231770463602132,0.00239334596880993,0.111162482720502
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,39961,-0.00739290266544595,0.00464511260535092,-0.0164973233719337,0.00171151804104184,0.111507506204444
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,-0.0127831757310372,0.00805803283488332,-0.0285769200874085,0.00301056862533407,0.112675181131985
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CGN,Cingulin,37572,-0.00636946868665887,0.00401743416729683,-0.0142436396545607,0.00150470228124291,0.1128866641165
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,-0.00385968107030612,0.00243452711946372,-0.00863135422445502,0.000911992083842779,0.112897160494911
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,0.00672184933896977,0.0042709328648266,-0.00164917907609036,0.0150928777540299,0.115544155167437
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00586219187010633,0.00372759054914177,-0.00144388560621154,0.0131682693464242,0.115824226497513
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIT,Vitrin,37990,0.00551782657788666,0.00351495126847268,-0.00137147790831978,0.0124071310640931,0.116481305351206
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,39953,0.0132623354565166,0.00847343907420722,-0.00334560512892951,0.0298702760419628,0.117564495366059
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,-0.013609548787351,0.00876441950523439,-0.0307878110176104,0.00356871344290843,0.120490471567397
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00896669318911137,0.00578439139846504,-0.00237071395188011,0.0203041003301028,0.121128911955576
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,37714,-0.00775952626337065,0.00502020073222773,-0.017599119698537,0.0020800671717957,0.122210428194124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,37959,-0.00563600786338609,0.00364835308012081,-0.0127867799004229,0.0015147641736507,0.122415950897495
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,37457,0.0121096703367261,0.00785525938392662,-0.00328663805577003,0.0275059787292223,0.123195079493255
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,-0.0061898570814387,0.00401546993028304,-0.0140601781447935,0.00168046398191606,0.123218053282147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,37482,0.00703340880677517,0.0045700762771733,-0.0019239406964845,0.0159907583100348,0.123825297773437
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,37714,-0.00874794711377795,0.00569074922581389,-0.0199018155963732,0.00240592136881728,0.124262716144841
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,0.00526283851021302,0.00342831924550367,-0.00145666721097418,0.0119823442314002,0.124777483326469
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,-0.0130592901773106,0.00850829459922829,-0.0297355475917981,0.0036169672371768,0.124835306523597
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,37572,0.00549294252534725,0.00359870365535092,-0.00156051663914055,0.012546401689835,0.126942594723783
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,37482,-0.00906906354511469,0.00595916314193993,-0.0207490233033169,0.00261089621308758,0.128066262837511
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,0.00399036870312382,0.00262210375235132,-0.00114895465148477,0.00912969205773241,0.128074128683895
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERVV_1,,37562,0.00698071472713835,0.00461471729321798,-0.0020641311675689,0.0160255606218456,0.130378228781448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,37541,0.00698995127930706,0.00463064510077704,-0.00208611311821594,0.0160660156768301,0.131195606712074
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.0039110958187828,0.00259626084999911,-0.00117757544721545,0.00899976708478106,0.131975496398893
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,-0.0116027417287715,0.0077171738331476,-0.0267284024417408,0.00352291898419779,0.132731491360568
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,-0.0120995313369836,0.00806393096066348,-0.027904836019884,0.00370577334591682,0.133517930015856
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,-0.00501131894423248,0.00334315320691146,-0.0115638992297789,0.00154126134131398,0.133902208715946
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,37482,0.00605354854884462,0.00404518001755225,-0.00187500428555778,0.013982101383247,0.134551706134275
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,37572,0.00500545795935508,0.00334694682101959,-0.00155455780984332,0.0115654737285535,0.134800339114113
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,0.00476172094346665,0.00319988832898501,-0.00151006018134397,0.0110335020682773,0.136751284659628
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,-0.00462721965863874,0.00311516890062232,-0.0107329507038585,0.00147851138658101,0.137466312857763
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,37998,0.00434491852517574,0.00294012530913397,-0.00141772708072684,0.0101075641310783,0.139484445372257
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,37998,0.00323768733604406,0.0021910946077821,-0.00105685809520885,0.00753223276729696,0.139522729711155
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,40403,-0.00819162949574163,0.00554749687933359,-0.0190647233792355,0.00268146438775221,0.139793175764471
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,0.00514221952873569,0.00348343508485223,-0.00168531323757468,0.0119697522950461,0.139916481179711
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,37598,0.00606208443202053,0.00411047609097626,-0.00199444870629294,0.014118617570334,0.140293259005961
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,-0.00694645099796651,0.00471281345231355,-0.0161835653645011,0.00229066336856805,0.140515372703258
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,0.0101069660253016,0.00686832833016226,-0.00335495750181638,0.0235688895524197,0.141171259303203
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,37942,-0.00753463655721255,0.00512192139987117,-0.01757360250096,0.00250432938653494,0.14129912097751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,0.00550530926515398,0.0037526820474978,-0.00184994754794171,0.0128605660782497,0.142390984940884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,40332,-0.00611484443170295,0.00417186809044646,-0.014291705888978,0.0020620170255721,0.142740859191103
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,39961,-0.00958448879480698,0.00654782179107504,-0.0224182195053141,0.00324924191570009,0.143277749753942
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,0.00617987758746352,0.00423069115647249,-0.00211227707922255,0.0144720322541496,0.144114743236679
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,40374,-0.00924180923488436,0.00632824971678489,-0.0216451786797827,0.00316156021001402,0.144198456480406
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,-0.00608629745488922,0.00417417304346132,-0.0142676766200734,0.00209508171029497,0.144841112984147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,0.00743326384931659,0.00510173223382923,-0.00256613132898869,0.0174326590276219,0.145134497688264
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,40228,-0.00487730419531327,0.00336632173966534,-0.0114752948050573,0.00172068641443078,0.147398610401102
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,37541,-0.00899425627897668,0.00620836351550375,-0.021162648769364,0.00317413621141067,0.147436332974428
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,0.00353553517394696,0.00244241746107293,-0.00125160304975598,0.00832267339764991,0.147764481073209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,37714,0.00623006366390161,0.00431103015316636,-0.00221955543630445,0.0146796827641077,0.148440789122211
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,37900,0.00632490821830387,0.00438153098641275,-0.00226289251506512,0.0149127089516729,0.148892157754969
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.00414352381394899,0.0028862359124909,-0.00980054620243116,0.00151349857453318,0.151131962639068
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNLY,Granulysin,40332,-0.00692920194775187,0.00482690754520281,-0.0163899407363494,0.00253153684084564,0.151153971920091
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,37959,0.00735962849305856,0.00513294456757649,-0.00270094285939136,0.0174201998455085,0.151651794061823
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,0.010838648310214,0.00759446930162121,-0.00404651152096354,0.0257238081413916,0.153552817272174
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,0.00594124301201456,0.00417129336125833,-0.00223449197605175,0.0141169780000809,0.15437874812263
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,-0.00355973748464408,0.0025027047653825,-0.00846503882479379,0.00134556385550563,0.154942564437051
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,37572,-0.00784109745857601,0.00554243141832084,-0.0187042630384849,0.00302206812133284,0.157168577816751
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,37714,-0.00597644383763126,0.00423025044525263,-0.0142677347103264,0.0023148470350639,0.157741759151547
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,37671,0.0121342992751399,0.00861721076458132,-0.00475543382343954,0.0290240323737193,0.159111070480041
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,40042,-0.00652582551232317,0.00464743877517156,-0.0156348055116594,0.00258315448701309,0.160286141719202
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,-0.00892385409063086,0.00638776534064433,-0.0214438741582938,0.00359616597703204,0.162430385314192
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,37541,0.00451649749684149,0.00324716198656236,-0.00184793999682073,0.0108809349905037,0.164277538982502
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,-0.00414121409994444,0.0029886125986845,-0.00999889479336607,0.00171646659347718,0.165872440640482
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,40184,0.00871414725366707,0.00629745540952608,-0.00362886534900406,0.0210571598563382,0.166452542255286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,37598,-0.00282954239855244,0.00205758686495028,-0.00686241265385498,0.00120332785675011,0.169100573751598
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0029711515607283,0.00217833595340117,-0.00129838690793799,0.00724069002939459,0.17260091008028
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,0.012427381437792,0.00912904126555742,-0.00546553944270053,0.0303203023182845,0.173441834947879
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,-0.00602224346824772,0.00443743433891002,-0.0147196147725114,0.00267512783601591,0.1747547506105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,0.00364742610122614,0.00269233683936515,-0.00162955410392956,0.00892440630638183,0.175518661526068
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,0.00336112008472199,0.00248743630342889,-0.00151425506999863,0.00823649523944262,0.1766416559735
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,37562,0.00581800932862139,0.00430796455160684,-0.00262560119252802,0.0142616198497708,0.176871285897653
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.0101335715550173,0.00750636654820751,-0.00457890687946945,0.024846049989504,0.177040267090371
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,40396,0.0106145925034619,0.00788164875165866,-0.00483343904978907,0.0260626240567129,0.178080639303539
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,37721,-0.0032409895845815,0.00240779982130743,-0.00796027723434407,0.00147829806518106,0.178313320688302
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,37572,-0.00402225602258402,0.00298951386887038,-0.00988170320556997,0.00183719116040193,0.178501634941622
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,40044,0.0186420931212596,0.0138746080533366,-0.00855213866328013,0.0458363249057994,0.179093364137035
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,37562,0.00671168466775093,0.00501020725807173,-0.00310832155806967,0.0165316908935715,0.180397928787194
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,39980,-0.00995295479392244,0.00743412712353398,-0.024523843956049,0.00461793436820416,0.180649021241804
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,40391,0.00502641725235756,0.0037705522432277,-0.00236386514436873,0.0124166996490839,0.182527262089892
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,37572,-0.0087752427937631,0.00659475688555586,-0.0217009662894526,0.00415048070192638,0.183330844740674
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,40044,-0.00561281686916,0.00421962544059796,-0.013883282732732,0.00265764899441199,0.183481901602946
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,40406,-0.0050891228720442,0.00382901269346809,-0.0125939877512416,0.00241574200715325,0.183835528710033
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,-0.00512206654521036,0.00385722520543685,-0.0126822279478666,0.00243809485744586,0.18422535718461
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,0.00516991282987881,0.00389761838601516,-0.0024694192067109,0.0128092448664685,0.184720848237012
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,0.00699063643315615,0.00527902974277724,-0.00335626186268725,0.0173375347289995,0.185450618448466
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,39961,-0.00608312088276813,0.00460265966970942,-0.0151043338353986,0.00293809206986233,0.186303081883082
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,-0.00495574521784786,0.00375030557161578,-0.0123063441382148,0.00239485370251907,0.186382961295595
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,-0.00340666682320043,0.00257930242999775,-0.00846209958599602,0.00164876593959516,0.18659725166197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,37901,-0.0327622333423052,0.0248193840241939,-0.0814082260297252,0.0158837593451147,0.186848788663568
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00732429573803769,0.00555243358333102,-0.00355847408529112,0.0182070655613665,0.187153906877281
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,-0.0054388998836173,0.00413107770055081,-0.0135358121766969,0.00265801240946229,0.188001490159744
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,40042,0.00638981779954152,0.0048648578547394,-0.0031453035957477,0.0159249391948307,0.189045825233643
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,-0.00559016421226267,0.00427837656580974,-0.0139757822812498,0.00279545385672441,0.191364581408005
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,39980,-0.00504686099374337,0.00388954288609465,-0.0126703650504889,0.00257664306300214,0.194462648057408
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,37671,-0.0104656239591959,0.00809778643712238,-0.0263372853759558,0.00540603745756394,0.196239333888826
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.00455345113644838,0.00352467878125924,-0.0114618215477165,0.00235491927481972,0.196421878587963
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESPL1,Separin,37482,0.0070792624101209,0.0054846272257621,-0.00367060695237281,0.0178291317726146,0.196814558292206
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,37714,-0.0210909627302057,0.0163414771976465,-0.0531202580375929,0.0109383325771814,0.196851068215825
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,-0.00690899904547782,0.00538633550150064,-0.0174662166284191,0.00364821853746342,0.199622719857414
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,37598,0.00713081784521891,0.00556174337473303,-0.00377019916925784,0.0180318348596957,0.199823451558811
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,37562,0.00422105690022453,0.00329886484055784,-0.00224471818726884,0.0106868319877179,0.200726686209799
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,0.00875011763502422,0.00683872686490544,-0.00465378702019044,0.0221540222902389,0.200745401196118
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,-0.00842317394667609,0.00659544985522054,-0.0213502556629083,0.00450390776955617,0.201582211216428
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,-0.00328836431079466,0.00257662427024851,-0.00833854788048174,0.00176181925889242,0.201896203964887
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,37714,0.00699336971694289,0.00549978860203986,-0.00378621594305524,0.017772955376941,0.203548012672586
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.00800578578787781,0.00629830230474648,-0.0203504583051809,0.0043388867294253,0.203714656275543
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,0.00757693126646279,0.00597157484587435,-0.00412735543145094,0.0192812179643765,0.204523095861397
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00810707433675622,0.00641461142225811,-0.00446556405086966,0.0206797127243821,0.206308150784068
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,-0.00504644378356637,0.00401550285523948,-0.0129168293798358,0.00282394181270301,0.208869589053639
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,39961,-0.00366679390601416,0.00292526636031786,-0.00940031597223717,0.00206672816020885,0.210046110958362
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,37429,-0.00418591425145133,0.00334019848840675,-0.0107327032887286,0.0023608747858259,0.210157959124543
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,37541,0.00947900225950467,0.00758423270985405,-0.00538609385180928,0.0243440983708186,0.21138396767925
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,39961,-0.00522951812218672,0.00418531106676839,-0.0134327278130528,0.00297369156867933,0.211503559982396
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,40475,-0.00258291306757778,0.00206775040238152,-0.00663570385624556,0.00146987772108999,0.211631531675502
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,0.00295527736695138,0.00238171211393438,-0.00171287837636,0.00762343311026277,0.214693531878704
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.00827508995498852,0.00667942428114938,-0.00481658163606427,0.0213667615460413,0.215403318044215
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,0.00538512846130389,0.00435314771436739,-0.00314704105885618,0.013917297981464,0.216081011704823
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,37628,0.00743091752700133,0.00601092316154884,-0.00435049186963439,0.0192123269236371,0.216393018221232
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,40384,-0.0066571452263215,0.0053976106704908,-0.0172364621404835,0.00392217168784047,0.217463261298679
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,37942,-0.00452545901704629,0.00369122475430384,-0.0117602595354818,0.00270934150138924,0.220218295284713
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,0.00615559473802166,0.00503901021500088,-0.00372086528338007,0.0160320547594234,0.221885409980071
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,37934,-0.003655737604614,0.00301108800658066,-0.0095574700975121,0.0022459948882841,0.224733893303713
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,37541,0.0105812313638362,0.00874007393641184,-0.00654931355153097,0.0277117762792034,0.226048763402402
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,40536,-0.0046217799541262,0.00382389021105035,-0.0121166047677849,0.00287304485953249,0.226811583871949
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,0.0199570440148626,0.0165560482618139,-0.0124928105782927,0.0524068986080179,0.228061193203358
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,-0.00339240796092349,0.0028222699459736,-0.00892405705503175,0.00213924113318478,0.229379802262372
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.004831534581351,0.00402000547216169,-0.00304767614408592,0.0127107453067879,0.229434527020621
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,0.00488094503086675,0.00407259694063653,-0.00310134497278086,0.0128632350345143,0.230749504224395
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,37998,-0.00614016558957375,0.00512935528988469,-0.0161937019577477,0.00391337077860025,0.231302632473773
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,-0.00437672829632186,0.00365892128572173,-0.0115482140163364,0.00279475742369273,0.231647974755293
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,-0.00831348109552158,0.00696066956502945,-0.0219563934429793,0.00532943125193614,0.232362375143543
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,37572,-0.00695540671144199,0.0058306399874108,-0.0183834610867672,0.00447264766388318,0.232927674965241
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,0.00571972325931009,0.00480823202914253,-0.00370441151780926,0.0151438580364294,0.234237455362689
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,37541,0.00415059070216241,0.00349318257362009,-0.00269604714213296,0.0109972285464578,0.234777178413209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,37562,0.00597323783432817,0.00502938058674599,-0.00388434811569398,0.0158308237843503,0.234985482332109
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSPN,Claspin,39925,-0.00385276133558401,0.00324904282455435,-0.0102208852717105,0.00251536260054252,0.235713865392197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,37572,0.00374946788906292,0.00318549339580638,-0.00249409916671758,0.00999303494484341,0.239199046912603
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,-0.00312066256929222,0.00266180992174882,-0.00833781001591991,0.00209648487733547,0.241060597354311
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,-0.00790389692253753,0.00677717148329333,-0.0211871530297925,0.00537935918471741,0.243533121032946
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,37987,0.00724482734421507,0.0062172474525575,-0.00494097766279762,0.0194306323512278,0.243926647989912
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00359644662876764,0.00309081708171474,-0.00965444810892853,0.00246155485139324,0.244607720323541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,-0.00294850727410855,0.00253432403900911,-0.00791578239056641,0.0020187678423493,0.244676602889123
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,37482,0.00668989481768564,0.00576051909251215,-0.00460072260363819,0.0179805122390095,0.245526797349421
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,37541,0.00562428589601317,0.0048562037121306,-0.00389387337976281,0.0151424451717892,0.24681777912225
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,40044,-0.00873695582410044,0.00756644349294827,-0.0235671850702791,0.00609327342207817,0.248231888076458
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,37541,0.00381397788234317,0.00331177546659758,-0.00267710203218808,0.0103050577968744,0.249489478509514
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,39961,-0.00390396496948515,0.00339073463452904,-0.0105498048531621,0.00274187491419176,0.249600851965447
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,-0.00855178750941244,0.0074330072222003,-0.023120481664925,0.00601690664610015,0.249952497217469
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,0.00405177623886896,0.00352240448415348,-0.00285213655007186,0.0109556890278098,0.250046030264003
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,40042,-0.00666684584387578,0.00580116015142289,-0.0180371197406647,0.00470342805291309,0.250480307367758
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.00829697981030173,0.00724510513210468,-0.00590342624862345,0.0224973858692269,0.252153807063653
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,37572,0.00653625540217244,0.00571098245333134,-0.00465727020635699,0.0177297810107019,0.252434605211427
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,37998,0.00988879870964297,0.00864484076724892,-0.00705508919416492,0.0268326866134509,0.252686986633407
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.0039444630983706,0.00345094065714289,-0.00281938058962946,0.0107083067863707,0.253054884353883
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,0.0062972186849482,0.00552345570597382,-0.00452875449876048,0.0171231918686569,0.254271021440298
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,37598,0.00382655416913524,0.00336616771011355,-0.00277113454268731,0.0104242428809578,0.255655702297546
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,40299,-0.00851992449001162,0.00752942370740035,-0.0232775949565163,0.00623774597649306,0.25784050941731
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,-0.00464258759151721,0.00410433703515392,-0.0126870881804189,0.00340191299738447,0.258012861945904
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,-0.00847044261487898,0.0074903043127084,-0.0231514390677875,0.00621055383802948,0.258137153517787
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,-0.003545793741202,0.00315699955076286,-0.0097335128606972,0.00264192537829319,0.261392477415745
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,37572,-0.00715480294450473,0.00637990997152858,-0.0196594264887007,0.00534982059969129,0.262113360061141
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.00911485298593222,0.00813314364884198,-0.0250558145376625,0.00682610856579806,0.262433558495037
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,-0.00941106402993738,0.00842742567832793,-0.0259288183594601,0.00710669029958537,0.264131527807655
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0190785071955027,0.017110660010639,-0.0144583864253497,0.0526154008163551,0.264864306952596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,-0.00348648087704912,0.0031318031221925,-0.00962481499654643,0.00265185324244819,0.265621238523159
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,40411,-0.0028909722125014,0.00260480112700326,-0.00799638242142778,0.00221443799642499,0.26707481924793
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,-0.00233870539679673,0.00211711538454223,-0.00648825155049951,0.00181084075690605,0.269324037760331
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,40017,-0.00586476317886884,0.00531627740784289,-0.0162846668982409,0.00455514054050321,0.269969958640593
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,37541,0.00669591066511184,0.0060803721626789,-0.00522161877373881,0.0186134401039625,0.270815213399246
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,0.00741588972548461,0.00673736277407578,-0.00578934131170391,0.0206211207626731,0.271042640211968
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0144507889088095,0.0131335360074747,-0.0401925194834599,0.0112909416658409,0.27122233637136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,-0.00355050157718827,0.00323064507651754,-0.00988256592716264,0.00278156277278611,0.27178459798393
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,40305,0.00911479720917208,0.00836755974800287,-0.00728561989691354,0.0255152143152577,0.276037413582762
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,40489,0.00617720785529086,0.00567734786588839,-0.00495039396185039,0.0173048096724321,0.276591756988383
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,0.00508794785677885,0.00467855698643473,-0.00408202383663321,0.0142579195501909,0.276834273771837
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,-0.00923573447866,0.00850078572567727,-0.0258972745009875,0.00742580554366745,0.277297144665209
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,-0.00422296367552059,0.00388982366114075,-0.0118470180513565,0.00340109070031528,0.277656492095386
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.0081242950979164,0.00748999864343264,-0.0228046924390444,0.00655610224321156,0.278080203297491
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,-0.00464471938242234,0.0043010987160942,-0.013074872865967,0.00378543410112229,0.2802101953149
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,37598,-0.00306237406188813,0.00284806520340998,-0.0086445818605717,0.00251983373679543,0.282283813817315
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,-0.00634156649051387,0.00590483293390282,-0.0179150390409634,0.00523190605993565,0.282859402401626
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,-0.00800797509024808,0.00747348931810111,-0.0226560141537263,0.00664006397323009,0.283956486139281
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,-0.00493775660184724,0.0046149910602878,-0.0139831390800113,0.00410762587631684,0.28466669115469
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.00517737377922229,0.00484118106108066,-0.0043113411004958,0.0146660886589404,0.284889209187192
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,0.00553337484204046,0.0052018980433796,-0.00466234532298356,0.0157290950070645,0.287474152218581
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00573349293180066,0.00540138528649459,-0.00485322222972874,0.0163202080933301,0.288488928059795
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,40332,-0.00487626920763411,0.0045944066592709,-0.0138813062598051,0.00412876784453685,0.288547436922916
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,-0.00947761257487047,0.00895009402923318,-0.0270197968721675,0.00806457172242655,0.289646562142703
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,-0.00535354622196748,0.00507350866027964,-0.0152976231961156,0.00459053075218062,0.291354899474918
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,40419,0.00334631121316544,0.00318071394452707,-0.00288788811810763,0.00958051054443851,0.292786602285337
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,37598,-0.00637493755680956,0.00605995071648667,-0.0182524409611234,0.00550256584750431,0.292828773433683
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,0.00489621314203155,0.00465914857828533,-0.00423571807140768,0.0140281443554708,0.293332530770492
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,-0.0120265903908281,0.0114549135519075,-0.0344782209525668,0.0104250401709105,0.293780398933389
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,0.00417523741082223,0.0039790766899961,-0.00362375290157013,0.0119742277232146,0.29406042465126
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,-0.00291595771584936,0.00279116342372639,-0.00838663802635308,0.00255472259465437,0.296176174327328
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,37482,0.00621066911598263,0.00598267059438108,-0.0055153652490043,0.0179367034809696,0.299238191873955
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,40044,0.00292763552981171,0.0028231338763064,-0.00260570686774882,0.00846097792737225,0.299744394974247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,37572,-0.00647754040696453,0.00625072291622205,-0.0187289573227597,0.00577387650883069,0.300087554106333
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.00406139956327975,0.00392101427175839,-0.0117465875359262,0.00362378840936669,0.300312965518715
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NPHS2,Podocin,37598,0.0103646809360753,0.0100243327652155,-0.00928301128374706,0.0300123731558976,0.301177528951628
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,-0.00486425240670248,0.00473356779306041,-0.0141420452811009,0.00441354046769592,0.304150238947095
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,37598,-0.00864734334276431,0.00849421660606302,-0.0252960078906478,0.00800132120511921,0.308683776231075
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,37598,0.00212097357875874,0.00209748579369246,-0.00199009857687849,0.00623204573439596,0.311940252109693
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00283563198135115,0.00281192956842354,-0.00834701393546129,0.00267574997275898,0.313266508834707
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,37541,-0.0043308414170942,0.00430417369682704,-0.0127670218628752,0.00410533902868681,0.314340001366884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,-0.0104226783891308,0.0103710620602964,-0.0307499600273118,0.00990460324905016,0.314926523736545
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00225612082563973,0.00225659973179446,-0.00667905629995687,0.00216681464867741,0.317431133414633
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.0046773708018391,0.00469700627481546,-0.0045287614967992,0.0138835031004774,0.319356195761518
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,37998,-0.00494383115834741,0.00497400516762401,-0.0146928812868905,0.00480521897019566,0.320272919964677
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00541761963644975,0.00546026014093179,-0.0161197295126761,0.00528449023977655,0.321122779011366
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,37572,-0.0066137396268978,0.00667192712488415,-0.0196907167916707,0.00646323753787514,0.321567763941144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,-0.00643351226983147,0.00652313298688314,-0.0192188529241224,0.00635182838445948,0.324023158241597
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,-0.00277267143301664,0.00281137386010093,-0.00828296419881446,0.00273762133278118,0.324036633509853
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VIM,Vimentin,40042,-0.0111056147562629,0.0112725849325063,-0.0331998812239753,0.0109886517114495,0.324547051235619
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,-0.00389290035449861,0.00395351894223956,-0.0116417974812881,0.00385599677229094,0.324802389694933
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,37900,-0.0033168176599876,0.00337896259946926,-0.00993958435494735,0.00330594903497215,0.326310526399284
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,0.00602575427839635,0.0061397320275548,-0.00600812049561104,0.0180596290524038,0.326395983685244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,37562,-0.00347929966685396,0.00354720626182603,-0.010431823940033,0.00347322460632505,0.326681702064701
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.00333137561243199,0.00340095488010115,-0.00333449595256626,0.00999724717743023,0.327330180756331
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00906752316033267,0.00927823230452655,-0.00911781215653938,0.0272528584772047,0.328443661276446
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,37482,0.00755713810382776,0.0077395101868436,-0.00761230186238569,0.0227265780700412,0.328866465159962
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,37410,-0.00408740614017977,0.00420253799775876,-0.0123243806157869,0.00414956833542739,0.330768205327639
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,-0.00361055298106206,0.00371238461327134,-0.0108868268230739,0.00366572086094975,0.330785112315829
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRN1,Neuritin,37959,-0.00339711066925731,0.0034982962962442,-0.0102537714098959,0.00345955007138133,0.331527951707057
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRELP,Prolargin,40357,0.00214070246043674,0.00220842101625088,-0.00218780273141498,0.00646920765228847,0.332392207647687
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,37562,0.00313921272038091,0.00324942806875989,-0.00322966629438846,0.00950809173515029,0.334021163254423
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,-0.0039941404695583,0.00415027930634622,-0.0121286879099969,0.00414040697088029,0.33587670359073
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,0.00456869976728728,0.00475247826703635,-0.00474615763610398,0.0138835571706785,0.336400901820766
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,-0.00351935623270867,0.00367553745151945,-0.0107234096376868,0.00368469717226946,0.338328460125675
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,-0.00771775871930739,0.00807223974494589,-0.0235393486194013,0.00810383118078656,0.339043482515499
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,40458,0.00271942064128167,0.00284874750193448,-0.00286412446250992,0.00830296574507326,0.339793319012825
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,37942,0.0021051101772317,0.00221550027575468,-0.00223727036324748,0.00644749071771088,0.342041003005822
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,40227,-0.00476493828034077,0.00501791275382292,-0.0146000472778337,0.00507017071715217,0.342337345897651
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,40355,0.00406030436256154,0.00429996975362198,-0.00436763635453755,0.0124882450796606,0.345049373328093
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,39980,-0.00762302590492678,0.00808576302939269,-0.0234711214425365,0.00822506963268288,0.345812525087352
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,37541,-0.00659888671974307,0.0069995065466963,-0.0203179195512678,0.00712014611178169,0.34581874234494
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,37482,0.0064277807127529,0.00685510258707571,-0.0070082203579155,0.0198637817834213,0.348434654234004
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,39980,0.0149901262581859,0.0160868829305846,-0.0165401642857599,0.0465204168021316,0.351442533874296
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,-0.00787619059078576,0.0084661828750771,-0.0244699090259369,0.00871752784436536,0.352226753245217
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,-0.00245727878303171,0.00264678609856855,-0.00764497953622608,0.00273042197016265,0.353213646647861
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",37900,-0.00393357045841359,0.00424138919166269,-0.0122466932740725,0.00437955235724529,0.353722548955795
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,-0.00893432863750905,0.00963731602496075,-0.0278234680464321,0.00995481077141401,0.353914513631149
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00504804794589772,0.00547887651698872,-0.00569055002740016,0.0157866459191956,0.356876602300539
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,0.00625836440678719,0.00680368239815605,-0.00707685309359867,0.019593581907173,0.357668320812176
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,-0.0104716428066294,0.0114071735442739,-0.0328297029534064,0.0118864173401475,0.358642293999217
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.00196502298595538,0.00214619132074034,-0.00224151200269569,0.00617155797460644,0.359897877181247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,0.00687387162267283,0.00753354907906474,-0.00789188457229406,0.0216396278176397,0.361556732792968
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.0228914317589968,0.0251228086007118,-0.0721321366163919,0.0263492730983983,0.362216559016897
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,0.0035379552241565,0.00390995826057028,-0.00412556296656126,0.0112014734148743,0.365557299436694
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,37714,-0.00631514267570931,0.00701035627530343,-0.020055440975304,0.00742515562388541,0.36769481179569
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,37628,0.00586524772526362,0.00651478209574567,-0.00690372518239789,0.0186342206329251,0.367977940580627
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,37598,0.00507959006841662,0.00564958561155991,-0.0059935977302408,0.016152777867074,0.368611374595322
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,0.00333978676766434,0.00371730019126016,-0.00394612160720557,0.0106256951425342,0.368965285355586
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,39961,-0.00321849817818391,0.00358870806319122,-0.0102523659820387,0.00381536962567088,0.369818036784918
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,-0.00800450528065067,0.00896226228190659,-0.0255705393531876,0.00956152879188624,0.371801520173154
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,37900,0.00235740545848843,0.00264131253565533,-0.00281956711139601,0.00753437802837287,0.372134062001077
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,37763,-0.00534828640093268,0.00600172289100867,-0.0171116632673097,0.00641509046544431,0.372878123823202
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,40341,0.00472519622257327,0.00530623747483951,-0.00567502922811217,0.0151254216732587,0.373211785947985
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,0.00596752944180565,0.00670986808888398,-0.00718381201240696,0.0191188708960183,0.373822645592852
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,-0.00382295810311525,0.00437094343975283,-0.0123900072450308,0.0047440910388003,0.381790849440611
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,0.00271898785125121,0.00311365325105235,-0.0033837725208114,0.00882174822331382,0.382544643486105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.0072848556992557,0.00834951831855168,-0.00908020020510559,0.023649911603617,0.382955262383256
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,40203,0.00258929742602744,0.00297218709553198,-0.00323618928121524,0.00841478413327012,0.383671457142347
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,-0.00225565899423805,0.00258973268642609,-0.00733153505963319,0.00282021707115709,0.383766876703654
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,37598,0.00395964887812431,0.00460655887232998,-0.00506920651164245,0.0129885042678911,0.390043100724336
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.0041511711960155,0.0048400361393798,-0.00533529963716891,0.0136376420291999,0.391088499239994
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00329307310551939,0.00385044255142761,-0.00425379429527873,0.0108399405063175,0.39242812828791
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,-0.00226778974406003,0.00265880553001171,-0.00747904858288298,0.00294346909476291,0.393707832447147
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,0.00414209645432521,0.00487092645748844,-0.00540491940235213,0.0136891123110026,0.39513417267908
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,-0.00326504358457175,0.00384564257957591,-0.0108025030405405,0.00427241587139704,0.39588086565888
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,37942,-0.00556329942755919,0.00655927092030059,-0.0184194704313483,0.00729287157622996,0.396364920529807
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,37598,-0.00541345268912152,0.00641102920563588,-0.0179790699321678,0.0071521645539248,0.398463063343878
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,37572,-0.00390204939010854,0.00463217306438444,-0.012981108596302,0.00517700981608496,0.399590706547507
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,0.00269717280893172,0.0032126933255868,-0.0035997061092184,0.00899405172708184,0.401181276814748
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,37598,0.00225183953185978,0.00268322854257303,-0.00300728841158335,0.00751096747530292,0.401356845496394
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00455906085263114,0.00543623428525234,-0.00609595834646344,0.0152140800517257,0.401684882531198
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00283872704419423,0.00339753355810423,-0.00382043872969006,0.00949789281807852,0.403434565717096
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,39961,-0.00479456319955709,0.00575263622918913,-0.0160697302087678,0.00648060380965359,0.404601024719298
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,0.00514104942535669,0.00619092926475896,-0.00699317193357088,0.0172752707842843,0.40631852124858
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,40042,-0.00260514494455102,0.00315364823451629,-0.00878629548420295,0.00357600559510091,0.408775092716989
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,37598,0.00208399471526899,0.00254287156835822,-0.00290003355871312,0.0070680229892511,0.412491061071006
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,40042,-0.00476158520373618,0.00581783210073238,-0.0161645361211717,0.00664136571369929,0.41311470193262
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,39961,0.00508323431718014,0.00622389474797657,-0.00711559938885393,0.0172820680232142,0.414095953001373
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,-0.00434459773868495,0.00532957675762013,-0.0147905681836204,0.00610137270625051,0.414980365472606
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,37572,0.00305940175530415,0.00376020322205087,-0.00431059655991556,0.0104294000705238,0.41587360018278
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,0.00269291961887708,0.00331295234864632,-0.0038004669844697,0.00918630622222386,0.416320761950881
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.00321424984313324,0.00395510429579998,-0.00453775457663472,0.0109662542629012,0.416414022673529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,-0.00522964189931387,0.00644666646642117,-0.0178651081734994,0.00740582437487163,0.417253828125304
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,37981,-0.00172128820300372,0.00213290548695837,-0.00590178295744212,0.00245920655143469,0.419671627904953
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,37482,0.00402323682342281,0.00498611567029621,-0.00574954989035776,0.0137960235372034,0.419745749487864
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00429812120406833,0.00532735773099628,-0.00614349994868438,0.014739742356821,0.419793119066937
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,0.00210544863701545,0.00263266438131122,-0.00305457355035455,0.00726547082438544,0.42387512675129
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.0020157580807743,0.00252575495383303,-0.00293472162873843,0.00696623779028703,0.424837246010191
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.00448828175609653,0.00562885993711232,-0.00654428372064363,0.0155208472328367,0.425248466896095
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,37562,0.00476266448999661,0.00599759582922139,-0.00699262333527731,0.0165179523152705,0.427154149198581
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,37482,0.00517175167098261,0.00652736467062226,-0.00762188308343702,0.0179653864254022,0.428189422014032
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,39871,0.00525338266662398,0.0066516081325704,-0.00778376927321401,0.018290534606462,0.429661767980177
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,40417,-0.00839153715349662,0.0107189353352688,-0.0294006504106234,0.0126175761036301,0.433714835474294
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,-0.00275892924313677,0.00352727938903581,-0.00967239684564696,0.00415453835937342,0.434129239615808
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,0.00289979261995511,0.00371356083302029,-0.00437878661276467,0.0101783718526749,0.434895522189957
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,37482,0.00703328257295222,0.0090136155997208,-0.0106334040025005,0.024699969148405,0.435231207997992
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,40341,0.00287949436328102,0.00369409469462549,-0.00436093123818494,0.010119919964747,0.435705208178363
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,0.00245391988661116,0.00315375654924891,-0.0037274429499167,0.00863528272313902,0.436525298322207
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.00546315390435273,0.00706593654443734,-0.0193123895314499,0.00838608172274445,0.439434646852959
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,-0.00153766695717767,0.00201132822549523,-0.00547987027914831,0.00240453636479297,0.444578782204572
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,0.00332489564195239,0.00435613368562474,-0.00521312638187209,0.0118629176657769,0.445317405986519
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00463680616433288,0.0060941116951667,-0.00730765275819385,0.0165812650868596,0.446750506684714
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,37990,0.00246064030439879,0.00324009783706807,-0.00388995145625462,0.0088112320650522,0.447606233113765
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,37572,-0.0046248639357359,0.00609691065029295,-0.0165748088103101,0.00732508093883828,0.448130279221129
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,37642,0.00231211349359072,0.00305035879022305,-0.00366658973524647,0.0082908167224279,0.448475999746133
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,39980,-0.00772828495088206,0.0102392892511373,-0.0277972918831112,0.0123407219813471,0.450399815154714
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,-0.00273522873144647,0.00364841559144704,-0.00988612329068266,0.00441566582778973,0.453446948979735
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFP,Properdin,38013,-0.00156154513602332,0.00208624365843606,-0.00565058270655801,0.00252749243451136,0.454173988230016
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,37562,-0.00469089315427977,0.0062717733897745,-0.0169835689982378,0.00760178268967826,0.454511403361745
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,0.0019253354178432,0.0025862055328479,-0.00314362742653868,0.00699429826222508,0.456609195641676
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,-0.00324435697438753,0.00436057967148119,-0.0117910931304907,0.00530237918171559,0.456877920053531
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,37572,-0.0049850600812862,0.00670689631870982,-0.0181305768659575,0.00816045670338505,0.457329260334106
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,37482,-0.00560194901808368,0.00754916836902806,-0.0203983190213787,0.00919442098521131,0.458063304742124
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,37785,0.00293777028417694,0.00399535952963305,-0.00489313439390384,0.0107686749622577,0.462172420433241
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,37482,0.00290416823973255,0.00400579991955721,-0.00494719960259958,0.0107555360820647,0.468470670080989
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,37671,0.00233056778106642,0.00323526234002527,-0.00401054640538311,0.00867168196751596,0.471313406732247
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00252448157105147,0.003526562198304,-0.00438758033762437,0.00943654347972731,0.474098111862757
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,37541,0.00338472922511575,0.00474852792318668,-0.00592238550433014,0.0126918439545616,0.475985031543475
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,-0.0050705904483998,0.00714531244352715,-0.019075402837713,0.00893422194091342,0.477940671901986
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTTG1,Securin,37714,-0.00280039282022447,0.00395370873877816,-0.0105496619482297,0.00494887630778072,0.478774421779215
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,37697,0.00666318004849247,0.00941940340950317,-0.0117988506341337,0.0251252107311187,0.479337369118239
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,0.00410154198432804,0.00580447997097442,-0.00727523875878182,0.0154783227274379,0.479817319407868
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,39980,-0.0062968899609704,0.00892894998399859,-0.0237976319296076,0.0112038520076668,0.480682810182119
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,39602,-0.00187457727078906,0.00266171436074326,-0.00709153741784585,0.00334238287626772,0.48127273392244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,37598,0.0031610389537429,0.00452716159079351,-0.00571219776421238,0.0120342756716982,0.485040343356809
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,-0.00167595937257848,0.00240292521228655,-0.00638569278866012,0.00303377404350316,0.485521099763741
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00372508327783951,0.00537218301813851,-0.014254561993391,0.00680439543771196,0.488069570391549
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,37541,-0.00758549202777863,0.0110259069875102,-0.0291962697232985,0.0140252856677413,0.491483933521163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,37572,-0.00281364466729808,0.00411162679101566,-0.0108724331776888,0.00524514384309262,0.493788858531607
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,40044,-0.00415159222133701,0.00607369965133011,-0.016056043537944,0.00775285909527,0.494278382247552
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,0.00167838497997702,0.00246975866225654,-0.00316234199804579,0.00651911195799983,0.496785539748403
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,-0.00291459313870849,0.00428984753912997,-0.0113226943154032,0.00549350803798624,0.496885822927713
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,37959,-0.00197515085539904,0.00290868352185819,-0.00767617055824108,0.00372586884744301,0.497115788907621
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.0037363527881687,0.00550616100922994,-0.0145284283662594,0.00705572278992199,0.497415997554087
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.00326443718410832,0.00483699440104274,-0.00621607184193546,0.0127449462101521,0.49975767787791
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,-0.004111026126881,0.00613422292593324,-0.0161341030617102,0.00791205080794815,0.502755696843055
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,39992,-0.00305296960606818,0.00455583086588873,-0.0119823981032101,0.00587645889107373,0.502788983658599
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,37541,0.00480053262531726,0.00716951215605229,-0.00925171120054524,0.0188527764511798,0.503139985990582
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HLA_A,,37959,-0.00208808280360143,0.00312229046448181,-0.00820777211398577,0.00403160650678291,0.50365596314832
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,-0.00561068601860795,0.00843511678724121,-0.0221435149216007,0.0109221428843848,0.505959015851421
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,37482,0.00286643193485611,0.00431276172778814,-0.00558658105160864,0.0113194449213209,0.506292840195469
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.00214734135388778,0.00324831637227426,-0.00421935873576978,0.00851404144354534,0.508583628828296
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,37482,-0.00362806892907811,0.00551095749701279,-0.0144295456232232,0.00717340776506697,0.510333040642078
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,-0.00227088108465532,0.00345240547497685,-0.00903759581560994,0.0044958336462993,0.510698777547766
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,0.00262398775120285,0.00399744723294525,-0.00521100882536985,0.0104589843277755,0.511568102686658
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.00325980568706177,0.0049685766548855,-0.0064786045565138,0.0129982159306374,0.511781328397985
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,-0.0014057133399819,0.00214462946958336,-0.00560918710036528,0.00279776042040148,0.51218279150758
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,40379,0.00184995593263621,0.00282304804166407,-0.00368321822902536,0.00738313009429778,0.512281223425734
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,-0.00258046718966792,0.00397341103380892,-0.0103683528159334,0.00520741843659756,0.516069508748242
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.00502989041131683,0.0077574425073266,-0.0101746969030433,0.020234477725677,0.516740588080553
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,0.00325150281386984,0.00502266114206438,-0.00659291302457634,0.013095918652316,0.517405966912695
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,37598,-0.00196866307404332,0.00304879660901412,-0.00794430442771099,0.00400697827962435,0.518473223739938
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,0.00259814717489951,0.00405013515154986,-0.00534011772213822,0.0105364120719372,0.521211424989071
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,-0.00139827992105718,0.00220290319398299,-0.00571597018126384,0.00291941033914948,0.525604471488289
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,-0.00485013481933323,0.00786364151435939,-0.0202628721874776,0.0105626025488112,0.537390453211998
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,37937,0.00136995768456484,0.00222670529042657,-0.00299438468467124,0.00573430005380093,0.538406759187666
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,40044,-0.00280528796635468,0.00456286750084504,-0.011748508268011,0.0061379323353016,0.538690421399481
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00170620611021306,0.00277969231589401,-0.00374199082893919,0.00715440304936531,0.539349089509104
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,38013,-0.00146970341882698,0.00239540931579263,-0.00616470567778054,0.00322529884012657,0.539523014273983
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,40341,-0.00348978259475995,0.00570349878890103,-0.014668640221006,0.00768907503148607,0.540634522922965
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,40044,-0.00309331422315955,0.00512383214591732,-0.0131360252291575,0.0069493967828384,0.546044530919364
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,0.00201241174060506,0.00339142193303921,-0.00463477524815179,0.0086595987293619,0.552935174984805
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NEB,Nebulin,37562,-0.00204162867963435,0.00347652438722353,-0.00885561647859246,0.00477235911932376,0.557038254955182
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,0.00202394021974375,0.00344785448594189,-0.00473385457270236,0.00878173501218987,0.557204138727404
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,37562,0.00415582287342426,0.00708833536678909,-0.00973731444548236,0.0180489601923309,0.557690484895899
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00277508503967891,0.00474225008724245,-0.00651972513131629,0.0120698952106741,0.55843463358378
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.00280362078417703,0.00483978210267433,-0.00668235213706466,0.0122895937054187,0.562405683667326
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,40042,-0.00300501989811629,0.00518895660446269,-0.0131753748428632,0.00716533504663058,0.562517697801281
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,0.00253243324144886,0.00445149969428601,-0.00619250615935172,0.0112573726422494,0.56943730728595
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,-0.00305676402843054,0.00540174397094635,-0.0136441822114854,0.00753065415462432,0.571481937713821
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,-0.00207381274584422,0.00369313316436755,-0.00931235374800461,0.00516472825631617,0.574442938367526
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,0.00261012326965795,0.0046771347990741,-0.0065570609365273,0.0117773074758432,0.57681249507563
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,40044,-0.00261233201267089,0.00469211413589173,-0.0118088757190187,0.00658421169367691,0.57770660945872
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,37598,0.00289101519377524,0.00520285119749709,-0.00730657315331906,0.0130886035408695,0.578452906894324
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,0.00336172084906479,0.00607557621993952,-0.00854640854201667,0.0152698502401463,0.580055715634702
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00222343578054119,0.00404539206343635,-0.0101524042248764,0.00570553266379406,0.582588139204949
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,39878,-0.00366709044226318,0.00668263455491425,-0.0167650541698951,0.00943087328536875,0.58318551096244
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,-0.00131544995154353,0.00241654922116695,-0.00605188642503076,0.0034209865219437,0.586209582759053
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,-0.00656033006414525,0.0120611365842988,-0.0302001577693709,0.0170794976410804,0.586502243376558
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.00133062823896369,0.0024779680412206,-0.00352618912182869,0.00618744559975608,0.591287998580193
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,37598,0.00222919637289734,0.00415229471673586,-0.00590930127190494,0.0103676940176996,0.591374168331037
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,0.00345132681220914,0.00642979097648429,-0.00915106350170006,0.0160537171261184,0.591434650992504
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,40489,-0.00308432467217916,0.00577800632711444,-0.0144092170733235,0.00824056772896515,0.593484331061704
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00237904703403366,0.0045050421937817,-0.00645083566577848,0.0112089297338458,0.597447374908895
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,0.00256527099015089,0.00491714375241092,-0.00707233076457452,0.0122028727448763,0.601888520575371
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,-0.000890267034379112,0.00170740825360717,-0.00423678721144916,0.00245625314269093,0.602086725021104
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,-0.00269137457209377,0.00521150427501195,-0.0129059229511172,0.00752317380692965,0.605563167002221
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,37959,-0.0012591305654776,0.00244490766809863,-0.00605114959495093,0.00353288846399572,0.606560556803397
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,-0.00631823414376718,0.0122924609344916,-0.0304114575753707,0.0177749892878363,0.607265598449814
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,-0.00184428636999307,0.00359527516894822,-0.00889102570113159,0.00520245296114545,0.607977391010382
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,40403,-0.00226086551590035,0.00443031238034056,-0.0109442777813678,0.00642254674956715,0.609836172686987
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,-0.000660403339323463,0.00129639495744621,-0.00320133745591803,0.00188053077727111,0.610469650917374
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,39980,0.00149728917090636,0.00295670543162167,-0.00429785347507211,0.00729243181688482,0.612579850124873
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,37942,-0.00456407121266658,0.00905308790735174,-0.022308123511076,0.0131799810857428,0.614167548519989
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00414963429926457,0.00823591125954353,-0.0202920203679699,0.0119927517694408,0.614377831815357
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,-0.00274206054324409,0.00545439318029131,-0.0134326711766151,0.00794855009012689,0.615164636423735
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00155289250734315,0.00310113716700627,-0.00452533633998913,0.00763112135467543,0.616555922818151
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,37598,-0.00333163717448062,0.00666150008318955,-0.0163881773375321,0.00972490298857089,0.616989680865959
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.00273315491281662,0.00548559005420868,-0.00801860159343239,0.0134849114190656,0.618321397741354
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,-0.00541463606213927,0.0108753616432002,-0.0267303448828118,0.0159010727585332,0.618576017005929
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,37482,-0.00385373688218813,0.00775421642037529,-0.0190520010661237,0.0113445273017474,0.619207319869448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TSC1,Hamartin,37598,-0.0035675909439743,0.007284462786848,-0.0178451380061964,0.0107099561182478,0.624316530782832
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,-0.00222645656453699,0.00455743904681836,-0.011159037096301,0.00670612396722699,0.62517955437833
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,37572,-0.0015690152479451,0.00321606583474727,-0.00787250428404975,0.00473447378815956,0.625651573347062
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,40044,-0.00284394880145354,0.00587337747069364,-0.0143557686440131,0.00866787104110599,0.628243557512418
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,-0.00435277154464511,0.00905086730030688,-0.0220924714532466,0.0133869283639564,0.630578948147724
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,-0.00196104460054487,0.00408347698498251,-0.00996465949111059,0.00604257029002086,0.631065483551368
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,-0.00164132075943459,0.00343463339403784,-0.00837320221174875,0.00509056069287957,0.632746843838665
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,37598,-0.00233252690717493,0.00492660876461876,-0.0119886800858277,0.00732362627147783,0.63589655382783
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NENF,Neudesin,37900,-0.00488221909709101,0.0103279104767371,-0.0251249236314957,0.0153604854373137,0.636419987960943
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,37482,0.0052634253545038,0.0111752672894201,-0.0166400985327597,0.0271669492417673,0.637656641670063
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,-0.00260556104003335,0.00554220271141907,-0.0134682783544147,0.00825715627434803,0.638269329560373
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,39934,-0.00160075155478066,0.00341700126113254,-0.00829807402660043,0.00509657091703912,0.639457422196163
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,-0.00257006303890987,0.00554419728854201,-0.0134366897244522,0.00829656364663247,0.642971328886449
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,37959,-0.00710502190242835,0.0153610881899417,-0.037212754754714,0.0230027109498573,0.643706047792358
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00284209621052311,0.0061685774144177,-0.00924831552173558,0.0149325079427818,0.644994353818864
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,37987,0.00112257259760152,0.00244297531496923,-0.00366565901973817,0.00591080421494121,0.645875055667332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,37482,-0.00237024909576068,0.0051603119667036,-0.0124844605504997,0.00774396235897837,0.64601001823625
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,37628,0.00257872050754092,0.00570808415082855,-0.00860912442808304,0.0137665654431649,0.651444728961967
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TTN,Titin,37562,-0.00281808916867053,0.00626623197046534,-0.0150999038307826,0.00946372549344152,0.652915257781274
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,-0.00371404561546208,0.00825958940515873,-0.0199028408495732,0.012474749618649,0.652959689670468
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,39961,-0.0022714915995062,0.00505991119959655,-0.0121889175507154,0.00764593435170303,0.653496172999596
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,37572,-0.00395827665722836,0.00885651790583633,-0.0213170517526676,0.0134004984382108,0.654930280432479
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,37562,-0.00309045736103791,0.00692095546020418,-0.0166555300630381,0.0104746153409623,0.655217323352863
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,-0.00151164987467325,0.00342413231601438,-0.00822294921406143,0.00519964946471493,0.658879170709786
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,40355,0.00772176511126674,0.0175297510105813,-0.0266365468694725,0.042080077092006,0.659584725754316
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,37942,-0.00127528055638207,0.00291386068309859,-0.0069864474952553,0.00443588638249116,0.661639704454783
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.00100659325088207,0.00230162617832357,-0.00350459405863212,0.00551778056039626,0.661870690065145
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,-0.00178894408344458,0.00410554702154286,-0.00983581624566858,0.00625792807877942,0.663033782147896
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,-0.00228322586232677,0.00525895235359032,-0.0125907724753638,0.00802432075071025,0.664179537007964
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,37942,0.0024401319153826,0.00569433374339092,-0.0087207622216636,0.0136010260524288,0.668279926364062
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,37572,0.00245224970952595,0.00574220440883074,-0.0088024709317823,0.0137069703508342,0.669344677073254
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,-0.00160628198702943,0.00377120363262337,-0.00899784110697123,0.00578527713291236,0.670162209504311
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.00167480236681025,0.00394004747139246,-0.00604769067711898,0.00939729541073948,0.67079136122245
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,37901,-0.0045731804018599,0.0108153448370848,-0.0257712562825462,0.0166248954788264,0.672417413147904
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,0.00369354332239982,0.00885094715900274,-0.0136543131092455,0.0210413997540452,0.676462244028585
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,40305,0.000758784685959026,0.00181869054946414,-0.00280584879099069,0.00432341816290874,0.676526921400432
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,37598,0.00193638394272678,0.00469213907613748,-0.00726020864650269,0.0111329765319563,0.679842814402554
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00177901116191171,0.00431603688590311,-0.00668042113445838,0.0102384434582818,0.680209467074769
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,37598,0.0015246976781442,0.00370980729697943,-0.00574652462393549,0.00879591998022389,0.681085780345144
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,-0.00233128977087836,0.00568414588655231,-0.0134722157085209,0.00880963616676418,0.681710746132434
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,37900,0.00315897733317578,0.00770774515026159,-0.0119482031613369,0.0182661578276885,0.681926512715895
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,-0.00155838824259788,0.00380542311484213,-0.00901701754768845,0.00590024106249269,0.682166258845136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,0.00335261545736429,0.0082044550855614,-0.0127281165103361,0.0194333474250646,0.682815304192831
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.00188150024844354,0.00462643514212094,-0.0109493131270006,0.00718631263011351,0.684245082777015
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,0.00157256051413488,0.00389100239616858,-0.00605380418235555,0.0091989252106253,0.686106730534404
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00145608899069096,0.00360484517229461,-0.00560940754700649,0.0085215855283884,0.686273996204959
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,37598,-0.00240335221718892,0.00597740097735742,-0.0141190581328095,0.00931235369843161,0.687636756497531
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,37998,0.00176037989934155,0.00440432052722357,-0.00687208833401666,0.0103928481326998,0.689388312331712
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,40357,0.00136439744266226,0.00342450665912167,-0.00534763560921621,0.00807643049454073,0.690324782297071
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,37900,-0.00139469202034962,0.00354232065550579,-0.00833764050514097,0.00554825646444173,0.693792029040483
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,37577,-0.00255367185212104,0.00659020971980406,-0.015470482902937,0.0103631391986949,0.698396233508338
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,37572,-0.00129119810756919,0.00333500999384394,-0.00782781769550332,0.00524542148036493,0.698640569355998
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,-0.00307269402172369,0.00808823614815547,-0.0189256368721084,0.012780248828661,0.704028198708353
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,37572,0.0015646343297767,0.00411946256184179,-0.00650951229143321,0.0096387809509866,0.704088776246456
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,37766,0.00118445728280948,0.00316194603579119,-0.00501295694734125,0.00738187151296022,0.707965750993601
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,37562,-0.00393531895311242,0.0105623599129168,-0.0246375443824293,0.0167669064762044,0.709467442944127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,-0.00132970274297793,0.00356917289311692,-0.00832528161348709,0.00566587612753124,0.709486916243225
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,0.00145770242426361,0.00391948601230876,-0.00622449015986157,0.00913989500838878,0.709964694999077
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,-0.00224736868714145,0.00604806271581342,-0.0141015716101358,0.00960683423585285,0.710206994602862
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,0.00215973545064121,0.0058151493882128,-0.00923795735025588,0.0135574282515383,0.710347049768615
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,37562,0.00300260093754052,0.00811189860816077,-0.0128967203344546,0.0189019222095356,0.711278392216004
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,-0.00174386403796835,0.00474710374735695,-0.011048187382788,0.00756045930685126,0.713360537281799
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,-0.00355100728771256,0.00971863961779183,-0.0225995409385845,0.0154975263631594,0.714832833410823
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,37562,-0.00190505513349173,0.0052152583197801,-0.0121269614402607,0.00831685117327727,0.714904638893111
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,39802,-0.000911780557057828,0.00250212035182639,-0.00581593644663755,0.0039923753325219,0.715561997411404
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,37880,0.00178005026768269,0.00488712598134881,-0.00779871665576098,0.0113588171911264,0.715690111439443
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,40387,-0.00105309014624151,0.00289191835107292,-0.00672125011434443,0.00461506982186141,0.71575132920999
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,-0.00206777487562644,0.00572581646799488,-0.0132903751528964,0.00915482540164352,0.718006680118417
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,0.00148007891929644,0.00410854695977514,-0.00657267312186284,0.00953283096045572,0.718670558009228
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00170178394685359,0.00472927035869756,-0.00756758595619362,0.0109711538499008,0.718972062641002
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00251679902271042,0.007001948321531,-0.0112070196874903,0.0162406177329112,0.719269754591429
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,-0.00195608656785342,0.00548746058416483,-0.0127115093128165,0.00879933617710966,0.721498097061427
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.000950058658396488,0.00269221581147369,-0.00432668433209195,0.00622680164888493,0.724175836070812
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,37572,-0.00293343695274509,0.00831574445668446,-0.0192322960878466,0.0133654221823564,0.724276299994901
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,37541,-0.00326139756793218,0.00932002439415302,-0.0215286453804721,0.0150058502446077,0.726393525967274
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00117207244502241,0.00338447680094733,-0.00546150208483435,0.00780564697487917,0.729116576557746
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,40042,-0.000910345647729464,0.00263481463360099,-0.00607458232958739,0.00425389103412847,0.72971826747437
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,-0.00176949418932134,0.00524591925211571,-0.0120514959234681,0.00851250754482546,0.735889467838802
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,37482,0.00134163727972663,0.00400497241811497,-0.00650810865977871,0.00919138321923198,0.737635843052775
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,37598,-0.000883512110012925,0.00265808146366031,-0.00609335177878712,0.00432632755876127,0.739602243426529
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,37998,0.00140734576534881,0.0042518047693223,-0.0069261915825229,0.00974088311322051,0.740649891954233
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.00206336522641471,0.00624790093019559,-0.0143092510495981,0.0101825205967687,0.741216020780672
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,37482,-0.00191043541813827,0.00583717325699955,-0.0133512950018574,0.00953042416558084,0.743455499377532
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.00174071319043824,0.00537388021082412,-0.00879209202277703,0.0122735184036535,0.746002876885908
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,-0.00154111254539866,0.00479779419364111,-0.0109447891649352,0.00786256407413792,0.748053444919208
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,37562,-0.00145373660843256,0.0046198741864418,-0.0105086900138585,0.00760121679699336,0.753017100905842
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,0.00150569420683228,0.00482501952504659,-0.00795134406225903,0.0109627324759236,0.7550001365114
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,-0.0017029291402158,0.00558899019792061,-0.0126573499281402,0.00925149164770859,0.760603662830855
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,37541,0.00135766377965068,0.0044865447904363,-0.00743596400960446,0.0101512915689058,0.762193521833782
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,37598,0.000870157889974615,0.00291187542056766,-0.00483711793433799,0.00657743371428723,0.76507391753946
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,37598,-0.00137586007383117,0.00460989440170615,-0.0104112531011752,0.00765953295351288,0.765358309596926
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,40228,0.000345928369911022,0.0011595336471002,-0.00192675757840538,0.00261861431822742,0.765452147156876
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.00156606276017578,0.00525801853861819,-0.00873965357551588,0.0118717790958674,0.765827026395219
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,-0.000929056092521236,0.0031194709801183,-0.0070432192135531,0.00518510702851063,0.765841545759127
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.00138578548760528,0.00467563486501453,-0.00777845884782319,0.0105500298230338,0.766941330245264
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,-0.00169713168460427,0.00573858291020517,-0.0129447541886064,0.00955049081939785,0.767432105263014
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.00154589624756844,0.00524729913924819,-0.0118306025604949,0.00873881006535802,0.768298010362766
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.00153001687040353,0.00520370867934054,-0.011729285881911,0.00866925214110392,0.76874392623537
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,40042,0.00300423571616685,0.0102348584052064,-0.0170560867580377,0.0230645581903714,0.769121148968965
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,37628,0.000494858005987574,0.00170910363190154,-0.00285498511253945,0.0038447011245146,0.772170876674362
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,-0.0017201812561515,0.00600854061779079,-0.0134969208670214,0.0100565583547184,0.774661029376885
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.00132220954933306,0.00464314550421044,-0.00777835563891939,0.0104227747375855,0.775827990045718
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,37562,-0.00129771448635859,0.00456902114541863,-0.0102529959313791,0.00765756695866193,0.776396000048772
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,-0.00127692020240643,0.00453050044180158,-0.0101567010683375,0.00760286066352465,0.778063206728125
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,37482,0.000819381953998549,0.00296523048633736,-0.00499246979922268,0.00663123370721978,0.78229904681608
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,37900,0.000881762273012923,0.00323293816988407,-0.00545479653995985,0.0072183210859857,0.785054723875036
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,-0.0011357818344317,0.00416523383309221,-0.00929964014729244,0.00702807647842904,0.785102427617374
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,40489,-0.000756175393192726,0.00278817005996035,-0.00622098871071502,0.00470863792432956,0.786234173825503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,40044,-0.00130980392171138,0.00485259684787524,-0.0108208937435468,0.00820128590012408,0.787226802394405
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,37901,-0.00273759929803741,0.0101924350387917,-0.0227147719740691,0.0172395733779943,0.788248333624344
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.0016125738204619,0.0060361392506986,-0.0102182591109074,0.0134434067518312,0.789355374157896
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,37562,-0.00116243814503515,0.00448227593243933,-0.00994769897261623,0.00762282268254593,0.795376181513979
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,-0.000550738698877183,0.0021376052843272,-0.00474044505615849,0.00363896765840413,0.796686595780995
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,0.00140177022037831,0.00553658575194627,-0.00944993785343638,0.012253478294193,0.800130656672166
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,37900,-0.000966568707442079,0.00384282850122305,-0.00849851256983927,0.00656537515495511,0.801411824199467
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0028674810956533,0.0114240806075018,-0.0195237168950502,0.0252586790863568,0.801814921974039
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,38013,-0.000472803769969802,0.00190157787615688,-0.00419989640723729,0.00325428886729768,0.803644881828546
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,38013,0.000772122490669825,0.00312036261029026,-0.00534378822549909,0.00688803320683874,0.804566515453449
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,40471,-0.00300249508454739,0.0122137344741882,-0.0269414146539564,0.0209364244848616,0.805817442580963
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,0.00120106124113293,0.00488876892510523,-0.00838092585207332,0.0107830483343392,0.805935028775524
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00190525340476544,0.00788802813715302,-0.0173657885535854,0.0135552817440545,0.809142407202422
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,0.0010326023142257,0.00433519286310984,-0.00746437569746958,0.00952958032592099,0.811736316587932
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,0.000757297218429015,0.00321412689365423,-0.00554239149313328,0.00705698592999131,0.813734964205302
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.000907210365306898,0.00385259366868788,-0.00845829395593514,0.00664387322532135,0.813839560206383
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.000602591888945372,0.00256640020127654,-0.00442755250555664,0.00563273628344739,0.814367187681286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00172582779999608,0.00742171928519754,-0.0162723975989833,0.0128207419989911,0.816124129190314
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EPGN,Epigen,37900,-0.00109724941613417,0.00472085314656538,-0.0103501215834023,0.00815562275113397,0.816210627353241
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,40042,0.0015735530246116,0.006904897210589,-0.0119600455081428,0.015107151557366,0.819735196070705
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,-0.00181831981131154,0.00800356811271335,-0.0175053133122297,0.0138686736896066,0.820280595012823
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,40044,-0.00143046982271321,0.00632658274912126,-0.0138305720109909,0.0109696323655645,0.821122986302616
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,0.000851154205304068,0.0038060622689461,-0.00660872784183029,0.00831103625243843,0.82304768442494
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,-0.000561290661182415,0.00251956827427164,-0.00549964447875483,0.00437706315639,0.823715912472031
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,0.000829219358393991,0.00382148702269882,-0.0066608952060957,0.00831933392288368,0.828220034569983
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,37572,-0.00136761660385972,0.00633060364900575,-0.013775599755911,0.0110403665481915,0.828965714761053
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,-0.000997181767938955,0.0046373977327914,-0.0100864813242101,0.0080921177883322,0.829746905892004
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.000679373342449883,0.00318402696839809,-0.00556131951561038,0.00692006620051014,0.831042201546583
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,0.000882324541899509,0.00413969734010829,-0.00723148224471273,0.00899613132851175,0.831222516263874
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,37714,-0.00154142056101516,0.00725924274324935,-0.0157695363377839,0.0126866952157536,0.831845811553069
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,-0.000720331824484071,0.00339843900132132,-0.00738127226707386,0.00594060861810572,0.832141752690486
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,0.000932098978652122,0.00440134579393845,-0.00769453877746724,0.00955873673477148,0.832285166289981
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00136048291489666,0.00642781510204459,-0.0112380346851107,0.0139590005149041,0.832379034770899
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,37562,0.000859205354984081,0.00411064725436324,-0.00719766326356788,0.00891607397353604,0.83443627845213
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,0.0011028616290436,0.00534076230017244,-0.00936503247929438,0.0115707557373816,0.836404437347083
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.000957675991569754,0.0047768510463542,-0.00840495205928448,0.010320304042424,0.841106202163743
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,37959,0.000802738925156617,0.0041834217148564,-0.00739676763596192,0.00900224548627515,0.847834600867774
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,37598,-0.00105822173561973,0.00556311377307329,-0.0119619247308434,0.00984548125960391,0.849138798586262
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,37562,0.00118398549195184,0.00624762048175222,-0.0110613506522825,0.0134293216361862,0.849696185696475
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,37998,0.00103324603835638,0.00545492289422233,-0.00965840283431939,0.0117248949110321,0.849770145634143
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,37541,0.00103227164186061,0.00558700802228082,-0.00991826408180979,0.011982807365531,0.853417893667992
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,37562,0.000857281229860467,0.00478752229588161,-0.00852626247006748,0.0102408249297884,0.857888848646471
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,37959,0.000619996484024435,0.00346452169952658,-0.00617046604704766,0.00741045901509653,0.857975039439645
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,-0.000487222866612262,0.00277282777329941,-0.00592196530227911,0.00494751956905458,0.860521850368912
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,37572,0.000813246345005715,0.00466987849420112,-0.00833971550362849,0.00996620819363992,0.861752452918065
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,0.000729833922991956,0.00419767778919747,-0.00749761454383509,0.008957282389819,0.861972896910551
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.000482511135666437,0.00280825228914027,-0.00502166335104849,0.00598668562238137,0.863581979472954
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.000595629450142486,0.00346756788307088,-0.00620080360067643,0.0073920625009614,0.863619790392995
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,37714,0.00139593176392423,0.00815331245817091,-0.0145845606540908,0.0173764241819392,0.864060954153726
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,39980,-0.00230317286502846,0.0136468564160175,-0.0290510114404228,0.0244446657103658,0.865980163320179
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,40536,0.000423015922588591,0.00252020088395077,-0.00451657780995492,0.0053626096551321,0.866703332740431
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,37990,0.000458212700682613,0.00278536264822773,-0.00500109808984373,0.00591752349120895,0.869334196578664
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,-0.000769182735241317,0.00475064662693435,-0.0100804501240326,0.00854208465355,0.871378302788649
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.00138033475500802,0.00866885076576139,-0.0156106127458843,0.0183712822559004,0.873490713985669
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,0.000362520182077842,0.00232521970055924,-0.00419491043101828,0.00491995079517396,0.876107577920197
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,37714,0.000859106650864958,0.0058987465195367,-0.010702436527427,0.0124206498291569,0.884206034941936
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00084678779164959,0.00610384494652105,-0.0128103238868308,0.0111167483035317,0.889665438184747
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLPS,Colipase,40311,-0.000860802432310725,0.00651765155757248,-0.0136353994851528,0.0119137946205313,0.894928635132282
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.000484638862609866,0.0036930366804267,-0.0077229907562462,0.00675371303102647,0.895594958072481
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,37572,-0.000580152178810826,0.00446205041379377,-0.00932577098984662,0.00816546663222497,0.896553237685396
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,37959,-0.000428420011984985,0.00357648420409876,-0.00743832905201856,0.00658148902804859,0.904652842615884
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,37482,0.000479041507667299,0.00403194778925312,-0.00742357615926882,0.00838165917460341,0.905426579581757
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,37541,0.000615434177989106,0.00525478264988336,-0.00968393981578229,0.0109148081717605,0.906767657721139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,40044,-0.000340491022851317,0.00298010450316328,-0.00618149584905134,0.0055005138033487,0.909037342098389
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,37990,0.000540711724964839,0.00475999202323572,-0.00878887264057718,0.00987029609050686,0.909560463729834
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,-0.000526549342743644,0.0046755693234612,-0.0096906652167276,0.00863756653124032,0.910335798698913
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,0.000271485801357793,0.00255033400327217,-0.00472716884505567,0.00527014044777126,0.915226090270286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,40044,0.000413730935465254,0.00391502616567948,-0.00725972034926652,0.00808718222019703,0.915839438608644
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,39311,-0.000479730543869073,0.00459044339937204,-0.00947699960663827,0.00851753851890012,0.916768929556934
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.000657219369282856,0.00650228995818177,-0.0120872689487534,0.0134017076873191,0.919492401177478
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,-0.00133977609624249,0.0135415889620371,-0.0278812904618352,0.0252017382693503,0.921189114932994
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,-0.000783992274341885,0.00871662882198268,-0.0178685847654279,0.0163006002167442,0.928334325390996
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,0.000401625334818776,0.00478130681328065,-0.0089697360192113,0.00977298668884886,0.933058451230016
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PRL,Prolactin,40471,0.000577698147574413,0.00728560288430692,-0.0137020835056671,0.014857479800816,0.936800472921843
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.000382988683984076,0.00486904612761092,-0.00992631909410147,0.00916034172613332,0.937305974543891
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.000309078593307398,0.00392945550172826,-0.00801081137669479,0.00739265419008,0.937306767987205
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,40203,0.000330816096513786,0.00431781516149907,-0.0081321016200244,0.00879373381305197,0.93892956662495
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,37482,-0.00045405703683843,0.00595935750182126,-0.0121343977404081,0.0112262836667312,0.939267294069707
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,37671,0.000231315806988187,0.0030550616996379,-0.0057566051243021,0.00621923673827848,0.939646516288975
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,-0.00030373337668922,0.00407040144399746,-0.00828172020692424,0.0076742534535458,0.940518161726389
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,0.000344026605519197,0.00473827062301588,-0.00894298381559192,0.00963103702663032,0.942120811988812
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,37482,0.000498195775752615,0.00705890752205504,-0.0133372629674753,0.0143336545189805,0.943735582685067
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CLC,Galectin-10,40333,-0.000432964820050369,0.00625941261602465,-0.0127014135474587,0.0118354839073579,0.944855014414778
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,-0.000282470864781083,0.004200196090292,-0.00851485520175339,0.00794991347219123,0.946382225520275
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.000457782927005533,0.00685769554713469,-0.0129833003453785,0.0138988661993895,0.946777876110462
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,37541,0.000375825890424968,0.00623357496677095,-0.0118419810444461,0.012593632825296,0.951925119694448
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,-0.000324906922439847,0.00543135946267191,-0.0109703714692768,0.0103205576243971,0.952299310604687
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,39695,0.000263706147065059,0.00448889966888165,-0.00853453720394297,0.00906194949807308,0.953154968665301
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,40044,-0.000256838923137162,0.00447215456393539,-0.00902226186845053,0.0085085840221762,0.954202852045525
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,37714,0.000332607357234866,0.00581488674208679,-0.0110645706572552,0.011729785371725,0.954387310363201
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.000184868226645759,0.00331502323644525,-0.00631257731678694,0.00668231377007845,0.955528279756273
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,40536,0.000170742567554631,0.00307323992826911,-0.00585280769185282,0.00619429282696208,0.955694742687498
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,40341,-0.000307600459781218,0.00561530380850894,-0.0113135959244587,0.0106983950048963,0.956315257529585
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,37714,0.000220099852303224,0.0041001913980468,-0.00781627528786851,0.00825647499247495,0.957190619417915
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,-0.000249236191306511,0.00473711570783336,-0.0095339829786599,0.00903551059604688,0.958040545785172
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,37572,-0.000127808758943082,0.00259754321289883,-0.00521899345622479,0.00496337593833862,0.960757704899564
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,-0.000325526812862384,0.00664411980019014,-0.0133480016212351,0.0126969479955103,0.960924238682289
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,0.000158186478859284,0.00324939586420317,-0.00621062941497893,0.0065270023726975,0.96117349414612
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,37562,0.000164210528557949,0.00387470268846658,-0.00743020674083655,0.00775862779795245,0.966196287775136
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.000220082942637623,0.00559699859540574,-0.0107500343043576,0.0111902001896329,0.96863458234466
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.000124330350704407,0.00329622038815155,-0.00633626161007263,0.00658492231148145,0.969912252264332
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,37562,0.000150633201818122,0.00455445616749586,-0.00877610088647376,0.00907736729011001,0.973616234229488
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,8.22511511277365e-05,0.00261281771792698,-0.00503887157600914,0.00520337387826461,0.974887239546541
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.000198709435372549,0.00659965898977098,-0.0127366221845786,0.0131340410553237,0.97598047385105
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,-0.000141192974860074,0.00480409171697504,-0.00955721274013115,0.009274826790411,0.97655389720221
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,37598,0.00027086515040867,0.00989507354962123,-0.0191234790068489,0.0196652093076663,0.978162059979644
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,-8.6802994134518e-05,0.00340625025550471,-0.00676305349492375,0.00658944750665472,0.979669727825971
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,4.63745379052208e-05,0.00187022531602742,-0.00361926708150852,0.00371201615731897,0.980217862651809
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.000158548237923484,0.00693651163544078,-0.0134370145675404,0.0137541110433874,0.981764643033445
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,0.000131840576811287,0.00580123050946263,-0.0112385712217355,0.011502252375358,0.981868934995139
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-8.64910655952829e-05,0.00471945867849616,-0.00933663007544776,0.00916364794425719,0.985378683537223
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,37572,3.33913964034596e-05,0.00223505756809975,-0.00434732143707205,0.00441410422987897,0.988080405063503
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,39980,-0.000123891245270291,0.00851642611664447,-0.0168160864338935,0.0165683039433529,0.988393507748851
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,6.44200985808112e-05,0.00550291201459947,-0.0107212874500341,0.0108501276471958,0.990659885777948
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,9.3316670047202e-05,0.00829375157760712,-0.0161624364220628,0.0163490697621572,0.991023008122826
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,39980,4.84863634282735e-05,0.00536746269782062,-0.0104717405243001,0.0105687132511567,0.9927926146949
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,40044,2.68193749089316e-05,0.00325628507043163,-0.00635549936313706,0.00640913811295493,0.993428652692878
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,37482,-2.23894780338068e-05,0.00520035233710559,-0.0102150800587608,0.0101703011026931,0.996564882579326
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,37714,-3.94136573778227e-06,0.0052844900751494,-0.0103615419130306,0.010353659181555,0.999404919821286
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,-5.5275841152849e-06,0.00812149945657139,-0.0159236665189952,0.0159126113507646,0.999456961049045
NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,37531,-3.85804569771726e-06,0.00838108643607236,-0.0164307874603995,0.0164230713690041,0.999632718720614
